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ABSTRACT 
 
The neural crest is a transient population of cells that arises at the border between the 
neural and non-neural ectoderm. These cells are induced, undergo an epithelial-to-
mesenchymal transition, and then migrate along stereotypical pathways to form a wide 
array of derivatives. While these cells have long been studied, much about these cells 
and their interactions is still not understood. In order to better define these cells, we 
performed a screen for genes involved in neural crest cell development based on an in 
vitro culture system that produces neural crest cells. This highly successful screen 
resulted in a large number of candidates to examine, and we performed in situ 
hybridization to define the mRNA expression of 112 these genes. Moreover, we 
performed QPCR on several transcription factors that resulted from this screen to 
determine the level at which they were upregulated in our in vitro culture system. We 
also present loss-of-function analyses of two different genes that were discovered in our 
screen for neural crest effectors. These genes, Adh5 and Ccar1, are both functionally 
relevant in neural crest cells and the loss of either one through morpholino knockdown 
significantly decreases the mRNA of Sox10 on the injected side. Furthermore, we also 
show that Adh5 morpholino knockdown also results in a reduction of Snail2 and FoxD3 
mRNA. Taken as a whole, this body of work represents the discovery of many new 
genes involved neural crest cell development, and the demonstration that at least two of 
these genes are functionally important for neural crest cells.   
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Chapter I: Introduction 
 
Portions of this chapter are published as: The role of neural crest cells in the 
endocrine system. Adams MS and Bronner-Fraser M. Endocrine Pathology. 2009 
Apr 18.  Other portions were written in collaboration with Katherine Fishwick, 
Herve A, and M. Angela Nieto to be published as: Epithelial-to-Mesenchymal 
Transitions:  Importance of changing cells’ state in development and disease. 
Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA;  Journal of 
Clinical Investigations. [In Press]. 
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1.1: Neural crest cells 
The neural crest (NC) is a pluripotent cell population that arises at the junction of the 
neural tube and the dorsal ectoderm (Figure 1). The neural crest has been widely 
studied and been the subject of pivotal advances in areas of developmental biology 
such as inductive interactions and long-range migration. More recently, studies of 
neural crest cells have also proven useful in areas such as cancer research, stem cell 
research (including regenerative medicine), and understanding the evolution of 
structures as well as gene networks (Zito, Richiusa et al. 2008; Sieber-Blum, Schnell 
et al. 2006; Song, Lee et al. 2008).  
 
NC cells are first specified at the end of gastrulation at the border between neural and 
non-neural tissues (Basch, Bronner-Fraser et al. 2006). After neurulation, NC 
precursors within the neural tube undergo an epithelial to mesenchymal transition and 
subsequently migrate away from the neuroepithelium in a rostral to caudal 
progression. These highly migratory cells subsequently form many divergent 
derivatives including neurons and glia of the sensory, sympathetic, and enteric 
systems, melanocytes, and the bones, cartilage, and connective tissues of the face 
(Figure 1) (Anderson 1993; Unsicker 1993; Baker and Bronner-Fraser 1997; Le 
Dourarin and Kalcheim 1999; Hall 1999). In addition, they contribute to endocrine 
cells like the chromaffin cells of the adrenal medulla, and the C-cells (parafollicular 
cells) of the thyroid gland (Le Douarin and Teillet 1974; Le Douarin, Fontaine et al. 
1974; Pearse 1966; Bussolati and Pearse 1967; Polak, Pearse et al. 1974). The advent 
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of neural crest cells is linked to the development of the “new head” (and, as some 
argue, the “new neck”) and the evolution of predatory behaviors in vertebrates (Gans 
and Northcutt 1983; Kuratani 2008). The gene regulatory network underlying NC 
formation is predicted to have evolved over 500 million years ago during the early 
Cambrian period leading up to the inception of the vertebrate lineage (Meulemans 
and Bronner-Fraser 2005; Sauka-Spengler and Bronner-Fraser 2006; Sauka-Spengler, 
Meulemans et al. 2007; Sauka-Spengler and Bronner-Fraser 2008). 
 
Neural crest cells can be divided into several subpopulations based on their site of 
origin and the locations to which they migrate. These groups are the cranial, trunk, 
cardiac, and vagal neural crest cells. The cranial neural crest cells are those that 
emerge from the presumptive brain region to form many of the craniofacial cartilages 
and bones as well as nerves and connective tissues. The skeletogenic potential of the 
cranial neural crest has been widely explored and documented throughout the 
Vertebrata subphylum. Though it was for some time assumed that trunk neural crest 
cells did not form bone or cartilage elements, they have since been shown to 
contribute in a limited way to to these derivatives in a few extant and extinct animals 
(Clark, Bender et al. 2001; Smith, Murray et al. 1994; Sanchez-Martin, Rodriguez-
Garcia et al. 2002; Cebra-Thomas, Betters et al. 2007; Smith, Murray et al. 1994; 
Cano, Perez-Moreno et al. 2000; Freitas, Zhang et al. 2006; Graveson, Smith et al. 
1997; Lumsden 1988). These examples, however, are the exception rather than the 
rule as the trunk neural crest cells of many model organisms have been shown to not 
have the ability to give rise to cartilage or bone (Smith and Hall 1990; Noden 1991; 
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Couly, Coltey et al. 1992; Couly, Coltey et al. 1993). The vagal neural crest cells, 
originating in the neck region, colonize the intestine to form the ganglia of the enteric 
nervous system (ENS), which controls intestinal peristalsis. Defects in innervation 
can lead to megacolon disorder, also known as Hirschsprung’s disease (Heanue and 
Pachnis 2007).The cardiac neural crest, a subpopulation of the vagal neural crest, is a 
relatively recent discovery and has been shown to contribute to the 
musculoconnective tissue of the primary blood vessels as well as the septum that 
divides the outflow tract from the heart into the aorta and pulmonary artery (Le 
Lievre and Le Douarin 1975; Jiang, Choudhary et al. 2002). In quail, clonal analysis 
of derivatives has shown that the cardiac neural crest cells can give rise to 
melanocytes, smooth muscle, chondrocytes, connective tissue, and sensory neurons 
(Ito and Sieber-Blum 1991).  
 
 
1.2: Historical aspects 
 
Beginning in the time of Aristotle (about 350 B.C.), we have records of studies based 
on the chicken embryo.  Long domesticated, the chicken and its eggs have been not 
only a valuable food source, but also a source of material for scientific inquiry. When 
using chicken embryos as a model organism, there are not only opportunities to 
perform classical embryological studies involving grafting, excision or implantation, 
but one can also place beads soaked in myriad solutions, inject cloned constructs or 
manufactured oligonucleotides and elecroporate them into cells, or even use viral 
transfection techniques. Further studies are made possible by the elucidation of the 
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chicken genome, and on the genomes of other organisms as they can be used for 
comparative inquiries. Our lab and others use chicken embryos of different ages to 
study neural crest cells.  
 
Neural crest cells were first described in 1868 by Wilhelm His in chicken embryos 
when he named a band of cells between the dorsal ectoderm and the neural tube the 
“Zwichenstrang” or “intermediate cord” (His 1868; Hörstadius 1950).  This initial 
appellation gave way to the more descriptive and familiar term “neural crest” in a 
1879 paper by Arthur Milnes Marshall (Hall 1999). Initially, neural crest cells were 
thought to simply be the precursors of the cranial and spinal ganglia and neurons. 
This first impression was soon questioned and in 1888 Kastschenko suggested that 
cranial mesenchyme was derived from neural crest cells based on his observations in 
shark embryos.  In the 1890s, Julia Platt was the first person to demonstrate that the 
neural crest cells were the origin of the mesenchyme of the visceral arch and further 
demonstrated that they were also the origin of the cartilage of the visceral skeleton 
and the dentine of the teeth (in the mud puppy, Necturus) (Hall 1999). A quarter of a 
century passed before Landacre (1921) confirmed a neural crest origin for visceral 
cartilages in Ambystoma jeffersonianum, and the ramifications of this work continue 
to be important in the community (Landacre 1921). Most of the original studies of 
neural crest cells were performed using amphibian embryos, but many laboratories 
subsequently moved into chicken embryos and mammals such as the mouse in order 
to exploit the many advantages offered by these embryos. In the 1960s, Chibon and 
Weston used tritiated thymidine to label cells in amphibians and avians (respectively) 
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in order to determine the fates of the cells they were examining (Chibon 1967; 
Weston 1963). This technique, though transient, opened up these organisms to new 
questions that were more thoroughly answered by the more stable quail-chicken 
chimeras pioneered by Nicole Le Douarin. Among others, these techniques allowed 
for the construction of fate maps beginning in the 1970s—work that continues to the 
present day. There are discrepancies between different fate maps, both because of the 
organisms in which they were performed as well as the techniques used. It will be 
critical to resolve these differences in order to understand the behavior of NC cells in 
humans, where such lineage analyses are not possible (Gross and Hanken 2008).  
 
More interspecific grafts were used in an attempt to understand the nature of the 
induction of the neural crest cells. In the late 1970s and the early 1980s, Rollhäuser-
ter Horst performed a series of experiments using grafts between different species of 
urodeles that suggested the necessity of both neural and non-neural ectoderm in the 
induction of neural crest cells (Rollhauser-ter Horst 1979; Rollhauser-ter Horst 1980). 
Moury and Jacobson went on to use pigmented and albino axolotl embryos to 
demonstrate that boundaries created between neural plate and epidermal tissues 
would give rise to both neural folds and neural crest cells (Moury and Jacobson 1989; 
Moury and Jacobson 1990). Selleck and Bronner-Fraser created quail-chicken 
chimeras in which the neural plate of quail were cultured with chicken non-neural 
ectoderm in vivo; these gave rise to migratory HNK-1 positive neural crest cells 
(Selleck and Bronner-Fraser 1995). These experiments, while informative, used in 
vivo techniques in which one could not separate the effects of neural plate-epidermal 
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interactions from the presence and influence of the underlying mesoderm. Therefore, 
in vitro culture techniques were used to determine what tissues could induce neural 
crest cell formation. To this end, further experiments were performed to show that 
combining neural and non-neural ectoderm induces Slug, a gene seen in neural crest 
cells (Dickinson, Selleck et al. 1995; Gammill and Bronner-Fraser 2002; Adams, 
Gammill et al. 2008) or demonstrates the formation of melanocytes and 
catecholaminergic neurons (Dickinson, Selleck et al. 1995). Mancilla and Mayor also 
demonstrated the upregulation of Slug in co-cultured neural plate and epidermis from 
Xenopus laevis embryos (Mancilla and Mayor 1996). Furthermore, the neural crest 
cells were shown to come from both of the cultured tissues (Selleck and Bronner-
Fraser 1995; Mancilla and Mayor 1996). This co-culturing scheme was then used to 
perform a successful subtractive screen to identify members of the genetic cascade 
that is involved in the induction and migration of neural crest cells (Gammill and 
Bronner-Fraser 2002; Adams, Gammill et al. 2008).   
 
The use of vital dyes in vivo combined with imaging has also been useful for 
examining contributions of neural crest populations (one example: (Bronner-Fraser 
and Fraser 1988)). As the use of vital dye has some limitations, electroporations of 
avian embryos in ovo and in various types of culture dishes were developed in order 
to study the effect of over-expression and knock-down of genes in a spatially and 
temporally controlled manner (Funahashi, Okafuji et al. 1999; Nakamura, Watanabe 
et al. 2000; Katahira and Nakamura 2003;  Sauka-Spengler and Barembaum 2008).  
The use of constructs such as morpholinos and RNAi has been invaluable for 
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dissection of genetic interactions in organisms that are less amenable to classical 
genetic manipulations.  These can be used to investigate the effect of knocking down 
genes that are involved in vital processes like gastrulation as well as later processes 
like the migration of neural crest cells (in which genetic null embryos would not 
survive past gastrulation and thus the gene’s effect could not be examined at the later 
stage) (Sauka-Spengler and Barembaum 2008; Katahira and Nakamura 2003). The 
advances in imaging techniques have also allowed striking advances in this area, 
especially because better signal collection and the use of less laser power, have 
allowed for less damaging imaging techniques and the possibility of longer 
observation times in live tissue imaging. 
 
Some antibodies have served as useful neural crest markers.  For example, the HNK-
1 (CD57) antibody identifies a cell surface sulfoglucuronyl glycolipid and is used to 
label avian premigratory and early migratory neural crest cells as well as neural crest 
cells in some other species (some reptiles and mammals). It is not exclusive to the 
crest populations (as it also stains cerebellar and motor neurons as well as some 
leukocytes) and is not useful as a label in amphibians ; Erickson, Loring et al. 1989; 
Chou, Schachner et al. 2002). Despite these limitations, it is a good marker for neural 
crest cells in avian embryos (Tucker and Erickson 1984;  Rickmann, Fawcett et al. 
1985; Bronner-Fraser 1986; Erickson, Loring et al. 1989; Sadaghiani and Vielkind 
1990;  Jeffery, Strickler et al. 2004) and has been shown to also stain turtle neural 
crest cells (Hou 1999). 
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1.3: The EMT process in NCC with distinct involved 
factors 
 
      General information  
The neural crest represents a definitive example of a cell type that undergoes a 
classical epithelial to mesenchymal transformation (EMT) in which epithelial cells in 
the dorsal neural tube are transformed into a migratory mesenchymal phenotype 
(Newgreen and Gibbins 1982; Nichols 1987).  Neural crest cells form at the border of 
the neural plate and non-neural ectoderm (Selleck and Bronner-Fraser 1995; Le 
Dourarin and Kalcheim 1999) as a result of signals emanating from both of these 
tissues. This phenomenon gives rise to the ‘neural plate border specifier’ signals 
expressed by both of these populations (Knecht and Bronner-Fraser 2002; Meulemans 
and Bronner-Fraser 2004).  Cells at the border form the dorsal neural folds and 
further signaling refines a sub-population of these into pre-migratory neural crest 
cells that express ‘neural crest specifier’ genes such as Sox-10, Snail, and FoxD3 
(Meulemans and Bronner-Fraser 2004; Sauka-Spengler and Bronner-Fraser 2006). 
These cells then undergo a crucial epithelial-to-mesenchymal transition, escape the 
neural folds and migrate to distinct regions of the developing embryo prior to re-
aggregation and further differentiation.  
 
Epithelial and mesenchymal cells make up the majority of the body plan in metazoan 
animals. These cell types differ both morphologically and functionally. Epithelial 
cells display a characteristic apico-basal polarity and are adherent cells that are 
 10 
attached to their neighbors by intercellular adhesion complexes, thereby forming 
coherent layers. Mesenchymal cells lack this polarity and intercellular junctions, and 
have the ability to move throughout the extracellular matrix as individual cells 
(Thiery and Sleeman 2006). However, the epithelial- and mesenchymal-cell 
phenotypes are not irreversible, and during embryonic development, cells can convert 
between the epithelial and mesenchymal states. Using the chick primitive streak (a 
structure that forms early in avian, reptile, and mammal development and that is one 
of the first signs of gastrulation) as a model, Elizabeth Hay was the first to propose 
that epithelial cells can undergo dramatic phenotypic changes that reflect their 
"transformation" to mesenchymal cells (Hay 1968). The term “transition” is now 
preferred, since this "transformation" is reversible and mesenchymal cells can revert 
to epithelial cells via MET (mesenchymal to epithelial transition). This EMT process 
is essential for germ layer formation and cell migration in the early vertebrate 
embryos (Hay 1968). 
 
The sequential events in EMT have been defined as individual steps by Levayer & 
Lecuit in 2008:  
“1) specification of a group of cells destined to undergo EMT 
 2) loss of intercellular adhesion mediated by cadherins at adherens junctions 
 3) loss of polarity markers 
 4) cytoskeletal reorganization to actively drive cell delamination 
 5) degradation of the basement membrane.  
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These steps do not necessarily occur consecutively and are not all necessarily present 
in a given example of EMT” (Levayer and Lecuit 2008). It is worth noting that, 
although many signaling pathways and molecules have been shown to be consistently 
involved in neural crest formation and migration, as yet there have been no individual 
or combinatorial signals that have been shown to function identically in these 
processes (Sauka-Spengler and Bronner-Fraser 2008). In addition, large amounts of 
the information that are gathered on the EMT process derive from work with cell 
lines and work on different forms of cancer (since this is a crucial process that cancer 
cells need to undergo to become migratory, and therefore metastatic).  Despite this 
heterogeneity, some studies pinpoint the action of certain molecules and pathways in 
the EMT process undertaken by neural crest cells as they migrate out of the neural 
tube.  
 
 
      Regulation of the Cadherin proteins during EMT  
Snail family genes bind to targets sites on DNA via conserved E-box sequences 
within both their own promoter (Sakai, Suzuki et al. 2006) and the promoters of their 
targets such as E-Cadherin (Cano, Perez-Moreno et al. 2000), claudin-3,-4 and -7, and 
occludin (Ikenouchi, Matsuda et al. 2003).  This interaction appears dependent on 
these elements and at least in some cases, the presence of the N-terminal SNAG 
domain within the Snail genes (Ikenouchi, Matsuda et al. 2003).  Further transcription 
factors have been found which bind these target sites but do not belong to the Snail 
superfamily; these are SIP-1 and SIP-2 (Smad Interacting Proteins -1 and -2, 
respectively).  SIP-1 (also known as ZEB-2, ZFHX1B, or SMADIP1) is necessary for 
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EMT in neural crest cells in the mouse as crest cells in homozygous null embryos are 
unable to exit the neural tube, and vagal neural crest (forming at the level of somites 
1–7) does not form at all, suggesting a particular requirement of this subtype of crest 
for SIP-1 (Van de Putte, Maruhashi et al. 2003). 
 
Neural crest cells delaminate from the neural folds or dorsal neural tube shortly 
before or after its closure.  A crucial step in this is the transition from polarized 
epithelial cells tightly linked together to individual mesenchymal cells; therefore 
initiation of neural crest migration relies upon a decrease in cell-cell adhesion.  For 
any given cell, cadherin expression is a  critical determinant of adhesion to 
neighboring cells or to the extracellular matrix (ECM).  Cadherins are transmembrane 
proteins which mediate attachments to neighboring cells through homophillic binding 
to cadherins expressed on neighboring cells. This homophilic interaction initiates 
signal transduction from the ECM to the cytoskeleton within the cell (reviewed in 
(Gumbiner 2005).  Ectodermal cells express epithelial cadherins such as E-Cadherin 
(also known as L-CAM in chick), a product of the Cdh1 gene which is initially 
expressed through the entire ectoderm and is subsequently downregulated in cells 
undergoing EMT (Edelman, Gallin et al. 1983).  Loss of E-Cadherin can occur 
through several mechanisms; the most common appears to be transcriptional 
repression through transcription factors such as Snail, Snail2, or SIP-1 (Batlle, 
Sancho et al. 2000; Cano, Perez-Moreno et al. 2000; Comijn, Berx et al. 2001; Perez-
Moreno, Locascio et al. 2001; Bolos, Peinado et al. 2003).  However, E-Cad levels 
may also be reduced by ubiquitination and lysosomal targeting of the protein 
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(Palacios, Tushir et al. 2005); hypermethylation of the E-Cad promoter (Graff, 
Herman et al. 1995); methylation of the promoter (Machado, Oliveira et al. 2001) or 
mutations in the E-Cad gene in regions regulating its adhesive properties, reviewed in 
(Hajra and Fearon 2002).  These latter mechanisms have been uncovered in 
transformed cell lines and it would be interesting to investigate their occurrence 
during EMT in normal embryonic development.   
 
E-Cadherin is not the only cadherin that must be repressed in order for EMT to occur. 
In the chick, both E-cadherin and Cadherin 6B (Cad6B) are expressed within the 
neural folds (Nakagawa and Takeichi 1995; Taneyhill, Coles et al. 2007), but only 
Cad6B is known to be a direct target of Snail2, which binds E-box elements within 
the Cad6B promoter to act as a transcriptional repressor (Taneyhill, Coles et al. 
2007).  This was the first work to describe a direct target of Snail2 during neural crest 
EMT within the developing embryo.  Furthermore, Cadherin 6B was shown to 
regulate the timing of EMT and neural crest cell emigration from the neural tube 
(Coles, Taneyhill et al. 2007).  Another type I cadherin, N-cadherin (N-Cad, also 
known as A-CAM) is also present in the neural plate but downregulated during EMT 
in vivo. Interestingly, the downregulation of N-Cad can stimulate premature neural 
crest cell migration (Newgreen and Gooday 1985).  Expression of N-Cad returns in 
specific lineages such as the dorsal root ganglia as cells reaggregate (Duband, 
Volberg et al. 1988; Akitaya and Bronner-Fraser 1992; Hatta and Takeichi 1986).  
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As neural crest cells exit the neural tube, cadherins such as Cad-7 are expressed on 
migratory cells in place of E-Cad and Cad6B (Nakagawa and Takeichi 1995; 
Nakagawa and Takeichi 1998).  A further type II cadherin, Cad11 has also been 
described on migrating neural crest cells in Xenopus (Hadeball, Borchers et al. 1998) 
and mouse (Hoffmann and Balling 1995; Kimura, Matsunami et al. 1995).  
 
       Signaling cascades mediating crest cell EMT 
Wnts have been shown to regulate several important stages in neural crest cells such 
as induction, the proliferation of NC precursors, the regulation of neural crest cell 
delamination through modulation of cell division, and the regulation of their 
migration (Garcia-Castro, Marcelle et al. 2002). Wnt signaling cooperates with other 
signal cascades such as the BMP signaling pathway during the specification and 
differentiation process of neural crest cells (LaBonne and Bronner-Fraser 1998). 
 
The protolithic member of the TGFB superfamily was named a “transforming growth 
factor” due to its ability to “transform” the phenotype of cells grown in soft agar (de 
Larco and Todaro 1978). This name is quite appropriate for our purposes in that 
several family members are associated with the epithelial to mesenchymal 
transformation.  There is a great deal of difficulty in interpreting the effect of TGFb 
family members and signaling pathways on the EMT, not least because three TGFb 
isoforms have been documented in mammals and four reported in the chicken 
(Ahmed and Nawshad 2007). In addition to being involved in EMT (Boyer, 
Ayerinskas et al. 1999), the TGFb family of peptide growth factors regulates many 
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different biological functions such as inhibiting cell growth, inducing cell 
proliferation and inducing ECM synthesis (Massague 1990). Antisense 
oligonucleotides to TGFb2 mRNA were shown to inhibit EMT in chicken by Potts et 
al. in 1991 and other labs have gone on to demonstrate that functional antibodies to 
TGFB type II and type III receptors can inhibit EMT and the migration of the 
mesenchymal cells after transformation (Brown, Boyer et al. 1996; Boyer, Ayerinskas 
et al. 1999; Brown, Boyer et al. 1999). Additionally, Potts et al. also showed that 
TGFb3 is required for EMT in the chicken (Potts, Dagle et al. 1991). Further studies 
have gone on to show that although exogenous TGFB1, 2, or 3 can promote EMT, 
these factors are not sufficient and require the presence of additional ECM 
components to be effective (Nakajima, Krug et al. 1994).  
 
Pez/PTPN14 is a tyrosine phosphatase that is thought to regulate cell adhesion 
through tyrosine phosphorylation of adherens junction proteins (Muller, Choidas et al. 
1999; Wadham, Gamble et al. 2003). Overexpression of Pez/PTPN14 in epithelial 
MDCK cells is sufficient to cause TGF-beta mediated EMT, and knockdown in 
zebrafish resulted in defective pigmentation and craniofacial deformities (Wyatt, 
Wadham et al. 2007).  
 
The signaling of the bone morphogenetic protein (BMP) family (also members of the 
TGFb superfamily) has been shown to regulate the EMT in which neural crest cells 
delaminate from the neural tube (Sela-Donenfeld and Kalcheim 1999; Sela-
Donenfeld and Kalcheim 2000).  Individual family members are still being examined 
 16 
using new techniques to determine their specific effects throughout neural crest 
development in different species (Raible 2006; Correia, Costa et al. 2007).  Noggin, a 
BMP inhibitor, prevents neural crest cells from delaminating until it is downregulated 
by signals from the somite. Another regulator of BMP signaling in neural crest is Cv-
2, a vertebrate homolog of Drosophila crossveinless, which regulates BMP signaling 
and the onset of migration in trunk but not cranial neural crest cells (Coles, 
Christiansen et al. 2004).  Additionally, BMP signaling has been shown to upregulate 
the transcription of wnt1 while inhibiting wnt1 results in lower expression levels of 
BMP regulated genes, strongly suggesting that these two signaling pathways are 
interconnected during the neural crest EMT (Burstyn-Cohen, Stanleigh et al. 2004). 
In chick embryos, BMP4 is expressed in neural folds and has the ability to transform 
competent neural plate cells into migratory neural crest cells. (Selleck, Garcia-Castro 
et al. 1998; Sela-Donenfeld and Kalcheim 1999). In the avian neural crest, BMP4 
signaling activates c-myb, which activates transcription of msx-1 and Snail2, both 
genes required for the formation of neural crest (Liem, Tremml et al. 1995; Sela-
Donenfeld and Kalcheim 1999; Karafiat, Dvorakova et al. 2005). Notch signaling is  
also necessary for cranial neural crest to form (Endo, Osumi et al. 2002; Endo, Osumi 
et al. 2003).  
 
Role of the extracellular matrix during crest cell EMT 
Further to changes in cellular adhesion, there is a breakdown in the basement 
membrane that surrounds the neural tube from which cranial neural crest cells 
migrate. (Erickson and Perris 1993). This disruption in the basement membrane 
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occurs immediately before or after the onset of cranial neural crest cell migration in 
both mice and avians (Duband and Thiery 1987; Nichols 1981). In the trunk region, 
no basal lamina (and therefore, no basement membrane) exists at the neural fold 
before neural crest cell migration begins, which removes this step in neural crest cell 
development (Martins-Green and Erickson 1987).  
 
MMP-2, or matrix metalloprotease- 2 (MMP-2, 72-kD type IV collagenase or 
gelatinase A), is a protein important for degrading a variety of extracellular matrix 
(ECM) molecules including collagen type I, IV, V, VII, X, XI, elastin, gelatins, 
laminin, aggrecan, and vitronectin (Alexander and Werb 1992; Parsons, Watson et al. 
1997). It is expressed during EMT in several cell types including the neural crest, and 
is rapidly downregulated as the crest cells migrate away. MMP inhibitors, including 
BB-94 and TIMP-2 (tissue inhibitor of metalloprotease-2), prevent EMT in vitro and 
in vivo during neural crest formation. Additionally, in the Patch mouse mutant (which 
has lost the alpha subunit of the platelet derived growth factor receptor), craniofacial 
mesenchyme does not disperse properly and Robbins et al showed that MMP-2 
activity is depressed (Robbins, McGuire et al. 1999). Specific morpholino 
knockdown of MMP-2 expression in the dorsal neural tube perturbs the neural crest 
cell EMT (Duong and Erickson 2004).  
 
The ECM is not a passive structure allowing the movement of neural crest cells but 
rather provides an active signaling input into cell migration from the neural tube.  It is 
also important to consider that the ECM is not a homogenous entity and different 
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basement membranes may differentially regulate cell movement.  Studies point to 
several components of the ECM being of primary importance in NC cell migration 
and as such are defined as ‘permissive’ i.e. supporting and allowing cell movement 
(Perris and Perissinotto 2000): namely fibronectin, laminins, proteoglycans and the 
movement inhibitory aggrecan proteoglycan.  In addition, the complement of integrin 
molecules expressed by the migrating cells that recognize these ECM components 
also appears to be necessary for the correct regulation of migration.  Genes regulating 
EMT may also contribute to determining the surrounding ECM; In epithelial cells 
overexpressing Snail, Snail2 or a further transcriptional repressor of E-Cadherin, E-
47, all have upregulated collagen1a2 and integrin-a5 gene expression and 
downregulated expression of keratin-19 and integrin-b6; these cells also have 
upregulated expression of an ECM modifying protein, TIMP-1 (Moreno-Bueno, 
Cubillo et al. 2006).  Much work has been done to understand the many interactions 
between ECM and E-Cadherin and adherens junctions in cancerous cells. Just as 
work on neural crest may inform our understanding of metastasis, the reverse is also 
true (e.g. (Giehl and Menke 2008)).   
 
1.4: Neural crest stem cell plasticity and pluriopotency 
 
The first direct evidence of neural crest cell multipotency came in 1980, when Sieber-
Blum and Cohen took individual trunk neural crest cells from quail and cultured 
them. They found that these cells gave rise to one of three types of clones: 
unpigmented (which solely consisted of adrenergic neurons), pigmented (which 
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solely consisted of melanocytes), and mixed clones (containing both types of cells) 
(Sieber-Blum and Cohen 1980).  When cultured quail neural crest cell colonies were 
reintroduced back into embryos, these cells were able to contribute to neural crest 
derivatives such as the sympathetic ganglia, adrenal gland, and aortic plexus as well 
as various populations of neurons. Furthermore, when single neural crest cells were 
injected into host embryos, they proved able to give rise to many daughter cells of 
different neural crest cell lineages (Bronner-Fraser, Sieber-Blum et al. 1980). 
 
These results were later confirmed in vivo without the inherent complications of 
transplantation when Bronner-Fraser and Fraser used lysinated rhodamine dextran 
(LRD) to label individual dorsal neural tube cells in vivo. Descendants of these 
individual cells were not only found in the neural tube, but also went on to form such 
diverse neural crest derivatives as sensory neurons, pigment cells, glia, and 
adrenomedullary cells (Bronner-Fraser and Fraser 1988). This was the first evidence 
for the pluripotency of neural crest cells in vivo and later work went on to definitively 
confirm the pluripotency of both premigratory and early migrating neural crest cells 
(Bronner-Fraser and Fraser 1989).  Pluripotent neural crest cells have been found in 
avians (Sieber-Blum and Cohen 1980; Bronner-Fraser and Fraser 1988; Bronner-
Fraser and Fraser 1989; Sieber-Blum 1989; Ito and Sieber-Blum 1991) as well as in 
mammals (Stemple and Anderson 1992; Morrison, White et al. 1999), demonstrating 
the conservation of this concept, at least among these groups. 
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Although avian, murine, and human NCSCs have been reported, it is important to 
note that these cells are vastly in the minority and that not all migratory neural crest 
cells show the same degree of commitment—approximately 80% of some populations 
of neural crest cells demonstrated some level of pluripotency, while the remaining 
20% gave rise to only one type of cell (Baroffio, Dupin et al. 1988; Baroffio, Dupin et 
al. 1991; Le Douarin, Creuzet et al. 2004).  Since it was not possible to “challenge” 
these cells to see if they could give rise to more derivatives under other 
circumstances, their full range of developmental potential could not be assessed.   
 
In the cardiac neural crest cells, Ito and Sieber-Blum showed that a small percentage 
of the cells can give rise to all the described derivatives, that more can give rise to 
restricted progeny (melanocytes and smooth muscle) and that still others are 
committed early to becoming only melanocytes (Ito and Sieber-Blum 1991). Mice 
have also been shown to have similar unipotent and multipotent cardiac neural crest 
cells, with some of the multipotent cells displaying the property of self-renewal 
(Youn, Feng et al. 2003).  Additionally, in mice an enriched population of NCSCs has 
been obtained through p75 sorting (Stemple and Anderson 1992). In the quail, in vitro 
analysis of neural crest cells grown on fibroblast feeder cells with endothelin 3-
supplemented media have shown the existence and rarity (approximately 1% of the 
trunk and 3% of cranial clones) of NCSCs that can generate many different expected 
cell types (Trentin, Glavieux-Pardanaud et al. 2004). Human NCSCs have been 
derived from human embryonic stems cells (HESCs) at the neural rosette stage and 
can be propagated and differentiated in vitro to give rise to many neural crest cell 
 21 
derivatives, such as Schwann cells, smooth muscle cells, peripheral neurons, 
osteogenic cells, and chondrogenic cells. Furthermore, transplantation of the human 
NCSCs into embryonic chickens and adult mice have demonstrated the viability, 
migratory and differentiation capacities of these cells (Lee, Kim et al. 2007).  
 
While the pluripotency of these cells had been demonstrated in short-term analysis, it 
remained to discover how long these cells retain stem cell properties in the embryo.  
It is now apparent that some cells capable of forming a broad range of neural crest 
derivatives appear to persist into adulthood. In 2004, pluripotent NCSCs were 
identified in the adult mouse hair follicle and termed the epidermal NCSCs (eNCSCs 
or EPI-NCSCs). Clonal analysis from bulge explants yielded neurons, smooth muscle 
cells, Schwann cells and melanocytes while serial cloning revealed the self-renewing 
capacity of these cells (Sieber-Blum, Grim et al. 2004). Further work has revealed the 
existence of NCSCs in bone marrow, the dorsal root ganglia, and the whisker pad of 
adult mice (Nagoshi, Shibata et al. 2008). Hu et al have also provided data describing 
genes that are differentially expressed in the EPI-NCSCs and have generated a 19 
gene “molecular signature” to help identify and isolate these cells (Hu, Zhang et al. 
2006). NCSCs are already being utilized with some success in attempts to repair 
disorders such as the lesioned spinal cord (Sieber-Blum, Schnell et al. 2006; Song, 
Lee et al. 2008).  
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1.5: Neural crest cells and neuroendocrine tumors 
 
The established neural crest derivatives give rise to pheochromocytomas and extra-
adrenal paragangliomas, neuroblastomas and medullary thyroid carcinomas. The 
tumors can be sporadic or can occur as components of hereditary syndromes with 
variable penetrance [71]. Although controversies concerning embryological origin 
appear to have mostly been resolved, questions persist concerning the pathobiology of 
each tumor type. The answers to those questions are likely to come from greater 
understanding of neural crest cells and the pathways involved in their formation, 
migration and differentiation. 
    
      Sympathoadrenal tumors 
Salient questions pertaining to sympathoadrenal neural crest cells include why 
pheochromocytomas in the adrenal gland are often adrenergic while extra-adrenal 
paragangliomas are almost always noradrenergic. The idea that the transcription 
factor Egr-1 is a simple master switch for the adrenergic phenotype (Wong 2003) has 
not held up in gene expression profiling studies of adrenergic and noradrenergic 
tumors (Huynh, Pacak et al. 2006). Likewise, the idea that adrenal glucocorticoids are 
the major adrenergic determinant has not held up in light of mouse studies showing 
that sympathoadrenal progenitors are already heterogeneous when they reach the 
adrenal cortical primordium (Unsicker, Huber et al. 2005). Other questions that 
remain unanswered include those that concern the increased malignancy of extra-
adrenal paragangliomas as compared to their intra-adrenal counterparts, and those 
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concerning the developmental basis for the varying manifestations of different 
hereditary syndromes that include pheochromocytomas/paragangliomas.  
 
Pheochromocytomas and extra-adrenal paragangliomas are both types of tumors of 
the autonomic nervous system found in neural crest-derived endocrine cells or organs 
(paraganglia). In 2004, the WHO (World Health Organization) formalized the current 
definition of pheochromocytomas as tumors that “arise in the adrenal medulla and are 
derived from chromaffin cells of neural crest origin” and that they are “intra-adrenal 
sympathetic paraganglioma[s]”. Those tumors that “arise from chromaffin cells in 
sympathoadrenal and parasympathetic paraganglia” are termed “extra-adrenal 
paragangliomas”. (DeLellis 2004). Pheochromocytomas and extra-adrenal 
paragangliomas show differences including a lower malignancy rate in 
pheochromocytomas (roughly four fold higher at ~20% in extra-adrenal 
paragangliomas associated with the sympathetic nervous system)(Linnoila, Keiser et 
al. 1990), a tendency to be associated with certain genetic disorders like multiple 
endocrine neoplasia type 2 (MEN2) (Bryant, Farmer et al. 2003), von Hippel-Lindau 
(VHL) disease, or familial paraganglioma syndrome and neurofibromatosis type 1 
(NF1) (Maher and Eng 2002) (Eisenhofer, Bornstein et al. 2004), and are more often 
adrenergic in nature (whereas extra-adrenal paragangliomas are more often than not 
noradrenergic) (Lloyd, Sisson et al. 1986). Despite their differences, these tumors 
have similar morphologies, neuroendocrine profiles, and some genetic predispositions 
(Tischler, Kimura et al. 2006).  
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The von Hippel-Lindau and neurofibromatosis 1 genes are named for the diseases that 
mutations in them can cause. All of the VHL mutations decrease its ability to 
suppress the function of JunB, which normally acts as an antagonist to cJun (Lee, 
Nakamura et al. 2005). The disease is divided into two types (type I and type II) 
based on the susceptibility to pheocychromotomas or paragangliomas (Tischler 
2008). Those patients who do develop pheochromocytomas may have examples that 
show some unusual characteristics like a thick vascular capsule, intermixed small 
vessels, myxoid (mucoid: resembling mucous) and hyalinized (glasslike or 
transparent) stroma, small cells with clear or amphophilic cytoplasm, and a lack of 
hyaline globules (Koch, Mauro et al. 2002), although the cause of these atypical 
features is not currently understood. These pheochromocytomas are usually 
noradrenergic and therefore phenylethanolamine N-methyltransferase negative 
(Tischler 2008; Eisenhofer, Huynh et al. 2004). It is possible to test for mutations in 
the VHL gene, which leads to easier identification of the genetic underpinning for 
people who suffer from this disease. The NF1 gene, on the other hand, is quite large 
and does not have the “hot spots”, or areas that are frequently mutated and might 
allow for genetic testing. However, some mouse NF1 heterozygous knockouts display 
incidence of pheochromocytomas at an increased frequency, providing a gene-
specific pheochromocytoma model for study (Jacks, Shih et al. 1994; Tischler, Shih 
et al. 1995). Furthermore, one study of these mice has shown that almost 20% of the 
genes expressed in these pheochromocytomas are also expressed in early neural 
development (Powers, Evinger et al. 2007), which makes the results of studies 
working to elucidate these early genes even more relevant. Interestingly, development 
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of the tumors depends on the genetic background of the mice, possibly mirroring the 
variable penetrance of hereditary human tumor syndromes. In mice, the influence of 
genetic background may be due to strain-dependent differences in tissue specific 
expression of Nf1 and other tumor suppressors (Reilly and Van Dyke 2008; Couto 
and Cardiff 2008). Contributions of the tumor microenvironment might also be 
critical for some types of tumors to develop (Reilly and Van Dyke 2008). 
Interestingly, some mutations of murine Nf1 have been to most types of tumors seen 
in neurofibromatosis (Joseph, Mosher et al. 2008). Kaelin and co-workers have 
proposed the attractive hypothesis that different genetic mutations that lead to 
pheochromocytoma/paraganglioma do so by promoting survival of progenitors that 
would otherwise undergo programmed death (Lee, Nakamura et al. 2005) (Nakamura 
and Kaelin 2006). The actions of the various tumor-susceptibility genes at different 
times in development would help to account for the genotype-phenotype correlations. 
 
 
  C-cell neoplasms 
The thyroid gland is formed from two different embryonic lineages: the thyroxine-
producing follicular cells (of endodermal origin) (Hilfer 1968) and the parafollicular 
calcitonin-producing C-cells (Pearse and Carvalheira 1967; Le Lievre and Le Douarin 
1975; Fontaine 1979).  According to current understanding, these two lineages are 
derived from the thyroid primordium, which arises from an outpocketing of the floor 
of the pharynx, and the ultimobranchial bodies (UBBs), which arise from caudal 
lateral outpocketings of the fourth pharyngeal pouches (Biddinger and Ray 1993; 
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Manley and Capecchi 1998; Di Lauro and De Felice 2001). The UBB are populated 
by neural crest-derived C-cell precursors and subsequently incorporated into the right 
and left thyroid lobes (Pearse and Carvalheira 1967; Moseley, Matthews et al. 1968; 
Pearse and Polak 1971; Le Lievre and Le Douarin 1975;  Williams, Toyn et al. 1989). 
The C-cells, which comprise only 0.1% (by mass) of the epithelial portion of the 
human thyroid gland (Biddinger and Ray 1993), are the major producers of the 
hormone calcitonin. 
 
Medullary thyroid carcinoma (MTC) is a cancer first described at the beginning of the 
20th century as “malignant goiter with amyloid” and definitively defined in 1959 as 
“solid non-follicular carcinoma with co-existing amyloid”, although the amyloid 
deposition is not a necessary feature (Hazard, Hawk et al. 1959; Gimm and Dralle 
1999). It arises from the parafollicular C-cells (calcitonin cells) and accounts for 
between 5–10% of thyroid carcinomas (Williams 1966; Al-Rawi and Wheeler 2006). 
As this tumor is derived from C-cells, those seeking identification and treatment for 
MTC are provided at least one invaluable immunohistochemical and biochemical 
marker, calcitonin. Additionally, TTF1 is reported to be strongly expressed in MTCs, 
while paragangliomas do not show expression (Agoff, Lamps et al. 2000). 
 
Medullary thyroid carcinoma is a good example of the sort of disorder that makes it 
so critical for scientists to more thoroughly understand the genetic network that 
functions during the normal and neoplastic states of cells and organs. While the 
current treatment modality for this and many other pathologies is surgical resection of 
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tissues, it is more than possible that understanding the disease would allow new 
treatments to be attempted in order to augment chances of patient survival and 
hopefully to someday obviate the need for drastic surgical intervention and, in the 
cases of other cancers, the use of agents damaging to healthy tissues. 
 
 
1.6: Known human craniofacial defects 
 
Syndromes with known genotypic basis 
Craniofacial defects are one of the most common birth defects and affect roughly 
10% of live births; generally somewhere between 1:500 and 1:1000 babies. 
Commonly, this may manifest as a cleft lip or palate or defects in dentition. There are 
three kinds of cleft palate: incomplete, complete and bilateral. These can occur with 
or without a cleft lip, and children who are born with this condition cannot create 
suction and will have trouble trying to suckle and get enough milk to thrive. 
Invariably, the cells that are affected in these difficulties are the neural crest cells. 
Craniofacial defects can also include serious malformations of the skull including 
missing or drastically reduced bones. This is critically important, as the frontal bones 
are necessary to protect the brain. Since these disorders are so numerous and 
widespread, there are many distinct named syndromes as well as several different 
gene mutations available for study.  
 
Apert syndrome is an autosomal dominant mutation named for the French neurologist 
who first described it in 1906. A brachysphenocephalic type of acrocephaly 
 28 
characterizes the skull malformations seen in patients in addition to a highly arched 
and sometimes cleft palate, a hypoplastic midface, and defects in the growth of the 
orbital bones. The underlying mutation was discovered to be fibroblast growth factor 
receptor type 2 (FGFR2) in 1995 by the group of Andrew Wilkie (Wilkie, Slaney et 
al. 1995). Similar defects in cartilage and bone development are seen in the 
FGFR2+/S252W mouse model (Wang, Xiao et al. 2005). Mutations in FGFR2 and 
FGFR3 have also been implicated in Crouzon syndrome (acanthosis nigricans is also 
a feature apparent with the FGFR3 mutation). Crouzon craniofacial dysostosis is an 
autosomal dominant disorder with craniosynostosis, hypoplastic orbital and facial 
bones and highly arched palate (Reardon, Winter et al. 1994; Glaser, Jiang et al. 
2000). Eswarakumar et al. generated an animal model of Crouzon syndrome in 2006 
using a dominant mutation in the mesenchymal splice form of Fgfr2 (Eswarakumar, 
Ozcan et al. 2006). One further syndrome associated with mutations in FGFR2 is 
Pfeiffer syndrome (Lajeunie, Ma et al. 1995; Rutland, Pulleyn et al. 1995; Schell, 
Hehr et al. 1995) and Muenke reported in 1996 that this was the mutation in the 
family originally described by Pfeiffer in 1964 (Pfeiffer 1964). Mutations in FGFR1 
have also been found in familial Pfeiffer syndrome (Muenke, Schell et al. 1994). 
There are three types of Pfeiffer syndrome, with types 2 and 3 being more severe. 
Patients with Pfeiffer syndrome display craniostenosis and craniofacial dysplasia, 
including midfacial hypoplasia (Muenke, Schell et al. 1994; Lajeunie, Ma et al. 1995; 
Rutland, Pulleyn et al. 1995; Schell, Hehr et al. 1995).  
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Human TFAP2A mutants have branchiooculofacial syndrome (BOFS) with bilateral 
branchial cleft sinuses, congenital strabismus, obstructed nasolacrimal ducts, broad 
nasal bridge, protruding upper lip, and carp mouth. Sometimes there are colomba, 
micropthalmia, auricular pits, lip pits, highly arched palate, and dental anomalies 
(Lee, Root et al. 1982; Hall, deLorimier et al. 1983; Fujimoto, Lipson et al. 1987; 
Milunsky, Maher et al. 2008). AP2 and AP2-alpha knockout mice have severe 
craniofacial defects such as severe dysmorphogenesis of the face, skull, sensory 
organs and cranial ganglia (Schorle, Meier et al. 1996; Zhang, Hagopian-Donaldson 
et al. 1996). Another TFAP family member, TFAP2B, has a role in facial 
development. TFAP2B mutations result in Char syndrome, in which typical facial 
features include a flat midface, wide-set eyes, a flat nasal bridge and a nasal tip that is 
both flat and broad, thickened and everted (“duck-bill”) lips and a triangular mouth 
(Char 1978; Satoda, Zhao et al. 2000). Attempts to study the neural crest cell defects 
in mouse models of TFAP2B have been unsuccessful as the knockout mice die soon 
after birth due to polycystic kidney disease (Moser, Pscherer et al. 1997).  
 
Those who suffer from Pierre Robin syndrome display craniofacial defects like high, 
narrow palates, fused mandibles, and micrognathia (Murray, Oram et al. 2007). It has 
been associated with deletion 2q32.3-q33.2 (Houdayer, Portnoi et al. 2001). In mice, 
a neural-crest specific deletion of snail1 in a snail2 knockout background has been 
found to resemble this syndrome, and while the defects are thought to result from 
problems in neural crest cells, they are not found to occur in the initial delamination 
or migration stages of their development (Murray, Oram et al. 2007). Knockouts of 
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Snail2 are also found in Waardenburg-Shah syndrome type 2 and non-Kit related 
piebaldism (heterozygous) (Waardenburg 1951; Read and Newton 1997; Sanchez-
Martin, Rodriguez-Garcia et al. 2002; Spritz, Chiang et al. 2003). Waardenburg 
syndrome type 2 has also been associated with MITF in some families. Two other 
Waardenburg-Shah syndromes, types 1 and 3, have mutations in the Pax3 gene  
(Waardenburg 1951; Read and Newton 1997; Spritz, Chiang et al. 2003). 
Waardenburg syndrome has a number of common features including pigment defects, 
hearing impairments, and cranial dysmorphisms like synophrys, telecanthus, broad 
and high nasal roots, and lower lacrimal dystopia (Pardono, van Bever et al. 2003).  
 
DiGeorge syndrome (DGS, also sometimes known as the DGA or DiGeorge 
anomaly) results in many cases from a deletion in the DGCR, or DiGeorge syndrome 
chromosome region, on chromosome 22 (Strong 1968; Wilson, Cross et al. 1991). 
Several genes including zinc finger transcription factor ZNF74 are known to be in 
this region (Aubry, Demczuk et al. 1993). The phenotype seen in patients includes 
cleft lip and is the result of cervical neural crest cell migration into the pharyngeal 
arches and pouches. Based on its presence among the genes in the DGCR, a 
transcription factor of the T-box family, Tbx1, was investigated by Jerome and 
Papaioannou in 2001. Mice homozygous null for this gene showed many mutations 
including abnormal facial structures (known as conotruncal anomaly face) and cleft 
palate (Jerome and Papaioannou 2001; Baldini 2002; Yagi, Furutani et al. 2003). 
Subsequent analysis of patients with this syndrome showed that mutations in Tbx1 
could result in this syndrome (Yagi, Furutani et al. 2003). A mouse knockout of 
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HoxA3 also produces a recessive phenocopy of DGS, but mutations in the human 
gene have not as yet been associated with this syndrome (Chisaka and Capecchi 
1991).  
 
TGFBR1 mutations have been described in LDS (Loeys-Dietz syndrome) type 1A 
and 2A along with non-FBN1-related Marfan syndrome while TGFBR2 mutations are 
associated with LDS type 1B and 2B along with non-FBN1-related Marfan syndrome. 
LDS types 1 and 2 are clinically indistinguishable based on symptoms, which are 
characterized by a triptych of arterial tortuosity and aneurysms, hypertelorism, and 
bifid uvula or cleft palate. LDS type 1 has craniofacial involvement such as 
craniosynostosis or cleft palate, while type 2 has no history of these traits (Loeys, 
Chen et al. 2005; Loeys, Schwarze et al. 2006). Marfan syndrome shows striking 
clinical variability but often displays a highly arched palate with crowded teeth 
(McKusick, Traisman et al. 1972; Pyeritz, Murphy et al. 1979). TGFBR2 conditional 
mouse mutants made with a Wnt-cre line show severe skull defects, missing frontal 
and severely retarded parietal bones, cleft palate, and reduced mandible and maxilla 
bones (Sponseller, Hobbs et al. 1995; Ito, Yeo et al. 2003; Loeys, Chen et al. 2005). 
TGFBR2 has been shown to be a direct target of EWS-FLI1 (Hahm, Cho et al. 1999), 
a translocation known to be commonly involved with another neurocristopathy called 
Ewing’s sarcoma (Giovannini, Biegel et al. 1994). Paris-Trousseau type 
Thrombocytopenia (TCPT) is in many cases the result of a homozygous deletion of 
Fli1, one of the two genes that form this translocation, in humans. In addition to 
thrombocytopenia, the characteristics of TCPT include mental retardation and facial 
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dysmorphism among other characteristic neural crest defects (Favier, Jondeau et al. 
2003).  
 
Mutations in the human Treacle gene result in Treacher Collins syndrome (TCS; also 
called Treacher Collins-Franceschetti or TCOF), a disorder presenting with severe 
neural crest abnormalities, including micrognathia, microtia, and other ear 
deformities, hypoplastic zygomatic arches and macrostomia as well as hearing loss 
and cleft palate (Dixon 1996). Mouse mutants haploinsufficient for Tcof1 have 
similar craniofacial defects including reduced head size, frontonasal dysplasia, poorly 
formed nasal passages, and cleft palate resulting from the failure of palatal shelves to 
fuse. Studies on these mice have shown that the gene product is required for ribosome 
biogenesis necessary for NC cell proliferation (Dixon, Jones et al. 2006; Dixon, 
Trainor et al. 2007). Treacle mutations or loss of mRNA and accompanying 
craniofacial defects have also been seen in additional animals such as Resus monkeys 
(Macaca mulatta) and dogs (Haworth, Islam et al. 2001; Shows, Ward et al. 2006). 
Nager acrofacial dystosis, another syndrome, resembles TCS in that it often displays 
with a high nasal bridge, micrognathia, external ear defects, cleft palate, cleft lip, and 
an absent soft palate. This syndrome in distinguishable in that it always presents with 
limb defects (McDonald and Gorski 1993). Saethre-Chotzen syndrome also displays 
limb deformities, but results from a mutation in the human gene Twist. The 
symptoms of Saethre-Chotzen syndrome also include craniosyntosis and dysmorphic 
facial features including facial asymmetry (el Ghouzzi, Le Merrer et al. 1997; 
Howard, Paznekas et al. 1997). In mice, the knockout is embryonic lethal and 
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displays branchial arch malformations (Chen and Behringer 1995). Therefore, a 
conditional mouse mutant was created in which the typical craniofacial defects can be 
seen (Chen, Akinwunmi et al. 2007).  
 
Human FoxD3 deficiencies present as autosomal dominant vitiligo and as a regulator 
of melanoblast differentiation [323]. Zebrafish FoxD3 mutant mother superior has a 
protruding lower jaw, loss of cartilage in the hyoid and posterior branchial arches, as 
well as pigment defects and a defective peripheral nervous system (Montero-
Balaguer, Lang et al. 2006). Complete FoxD3 mouse knockout embryos fail early in 
embryogenesis, around the time of implantation. Tissue specific knockout of FoxD3 
in the neural crest cells results in perinatal death with catastrophic loss of craniofacial 
structures and other neural crest derivatives (Teng, Mundell et al. 2008).  
 
SIP1 (Zeb2, ZFHX1B, SMADIP1) mutations result in Mowat-Wilson syndrome, a 
disorder including Hirschprung symptoms as well as microcephaly, mental 
retardation, hypertelorism, short stature and submucosal cleft palate (Mowat, Croaker 
et al. 1998; Wakamatsu, Yamada et al. 2001; Zweier, Albrecht et al. 2002; Ishihara, 
Yamada et al. 2004). In the mouse, it has been shown that the similar defects that are 
seen in mutants of this gene result from an early arrest in cranial neural crest cell 
migration (Van de Putte, Francis et al. 2007). 
 
Bardet-Biedl syndrome (BBS) patient have subtly flattened and hypoplastic midfacial 
bones resulting from aberrant NCC migration. Twelve genes have been discovered to 
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have involvement in this syndrome and are known as BBS1–12. Both zebrafish and 
mouse mutant models have been examined and show similar defects to the human 
condition (Tobin, Di Franco et al. 2008).  
 
Sox 9 mutation in humans results in campomelic dysplasia, a mutation that includes 
craniofacial defects such as a cleft palate, micrognathia, and a flat face (Houston, 
Opitz et al. 1983; Wagner, Wirth et al. 1994; Kwok, Weller et al. 1995).  The 
zebrafish mutant of Sox9a is the jellyfish mutant and lacks cartilaginous elements of 
the neurocranium and branchial arches (Yan, Miller et al. 2002).  
 
 
 
Syndromes with no known genotypic basis: 
Hemifacial Microsomia (HFM), also known as Goldenhar syndrome or 
oculoauriculovertebral dysplasia (OAVS), is a defect involving first and second 
branchial arch derivatives (Nijhawan, Morad et al. 2002). It has been hypothesized 
that maternal diabetes can interfere with neural crest cell migration as this syndrome 
has increased prevalence among the children of diabetic mothers (Wang, Martinez-
Frias et al. 2002).  Thus far, there have been no genotype-phenotype correlations 
among human patients with this syndrome, though different genes have been 
investigated (Kelberman, Tyson et al. 2001; Splendore, Passos-Bueno et al. 2002). A 
transgenic mouse line with the HFM phenotype has been isolated and described by 
Naora et al. They designated the locus of the autosomal dominant insertion HFM and 
mapped to mouse chromosome 10 (Naora, Kimura et al. 1994). Another syndrome 
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with no known genetic origin, Hallerman-Streiff syndrome, displays natal teeth and 
other dental abnormalities as well as a characteristic “bird like” face and dyscephalia 
with a small mouth and a highly arched palate (Nicholson and Menon 1995).  
 
1.6: Goal of this thesis 
This brief survery demonstrates the importance of the neural crest derivatives in adult 
organisms, and the fascinating properties of the developing neural crest as a model to 
study induction, migration, and determination of cellular fate. My thesis project 
specifically sought to expand the genes known to be involved in the induction and 
migration of neural crest cells, in order to refine our current understanding and 
illuminate mechanisms of normal development, while pointing out candidate 
protagonists in various human disorders. To do this, we took a two-pronged approach: 
to screen for involved molecules in vitro and then to test their functional relevance in 
neural crest cells in vivo. We have discussed the importance of this cell type as well 
as some of the normal and pathological situations it is involved in.  
 
In Chapter 2, we first show the results of the screen performed to identify new genes 
involved in neural crest induction and migration. This screen takes advantage of a 
culturing technique in which cDNA derived from individually cultured pieces of non-
neural ectoderm and intermediate neural plate are subtracted from cDNA expressed 
by co-cultures. This technique allows for the enrichment of gene transcripts that are 
whose expression levels are modulated concurrent with neural crest induction and 
 36 
development. Subsequently we discuss examinations of these genes by in situ 
hybridization as well as selected transcription factors by QPCR. Performing these 
experiments has allowed us to increase the number of genes likely involved in neural 
crest development by more than 100, and also to further define the in vitro culture 
assay system used in our screen. These results will allow us to more fully define the 
current neural crest genetic network.  
 
In Chapter 3, we examine a selected subset of the genes uncovered by the screen 
discussed in Chapter 2 for their involvement in neural crest cell development. To do 
this we study the effects of perturbations of these gene products through the use of 
morpholino oligos and overexpression vectors, performing classic loss-of-function 
and gain-of-function analysis of these genes.  
 
We have demonstrated here that Ccar1 mRNA is present in the both the dorsal neural 
folds and in the migratory neural crest cells in early chicken embryos (Figures 1 and 
2). It presence in migrating neural crest cells was then further confirmed by overlay 
with HNK-1 on a section of a Ccar1 in situ. We also quantitated the expression level 
of Ccar1 in non-neural ectoderm and intermediate neural plate isolates and conjugates 
as described above. Ccar1 showed a significant difference between these two 
populations with an average conjugate value of 0.777, standard deviation 0.104 and 
an average non-conjugate value of 0.464, standard deviation 0.149. The student t-test 
value is significant, with p=0.0405 (Chapter 3, Figure 2).  Upon perturbation using 
morpholino oligos, we discovered that loss of the Ccar1 protein causes a decrease in 
 37 
Sox10 mRNA on the injected side, and that there is an increase in death in the dorsal 
neural folds of these embryos (Chapter 3, Figure 3).  
 
 
The transcript of the second gene that we examined, Adh5, is also present in the 
dorsal neural folds and the migrating neural crest, and in early chicken embryos does 
not appear to be present at significant levels in other tissues. When injected with a 
morpholino against the 5’UTR of the Adh5 gene, chicken embryos show a marked 
reduction in the mRNA (by in situ hybridization) of three transcription factors known 
as neural crest specification: Sox10, FoxD3, and Snail2.  These results are statistically 
significant, at p<0.0001, p=0.0086, and p=0.0065, respectively.  
 
Thus, we have been able to not only increase the numbers of genes known to be 
involved in neural crest cell development, but we have also been able to confirm the 
functional relevancy of two of these genes.  
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Table I.  Disorders relating to neural crest genes/EMT 
 
Summary of genes that cause neural crest defects when mutated.  Increasing numbers of 
studies are probing the ways in which many genes involved in EMT have a dual nature with 
importance in both early embryonic development and cancer.  Mutations within these genes 
can lead to uncontrolled EMTs within the developing or adult organism resulting in tumor 
development (Ansieau, Bastid et al. 2008) and metastasis. This can cause spreading of the 
cancer to multiple sites within the body, which may lead to decreased chances of survival.  
The expression of several genes involved in EMT, such as Snail1 and Snail2, has been 
reported in human tumors (Peinado, Olmeda et al. 2007).   
 
Since the neural crest population is highly proliferative, migratory, and multipotent, it is not 
surprising to see the catastrophic effects of neural crest cell derived tumors, such as 
neuroblastomas and medulloblastomas. As neural crest cells contribute to a wide range of 
cell types, mutations in genes that specify the neural crest or its sublineages may lead to 
serious or even lethal consequences. Null mutations often lead to failure to survive past early 
developmental stages. Accordingly, conditional knockouts in mice have been employed to 
elucidate the role of these genes in later development. Occasionally, gene knockouts have 
mild effects that may be due to gene redundancy or plasticity within the neural crest 
population.   
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AP2 (TFAP2A) 
(human) 
Branchiooculofacial 
syndrome (BOFS) 
Low birth weight, retarded postnatal growth, 
bilateral branchial cleft sinuses, congenital 
strabismus, obstructed nasolacrimal ducts, 
broad nasal bridge, protruding upper lip, and 
carp mouth. Occasionally seen are coloboma, 
microphthalmia, auricular pits, lip pits, highly 
arched palate, dental anomalies, and 
subcutaneous cysts of the scalp 
(Lee, Root et 
al. 1982)  
 
AP2 (mouse) AP2-/- 
 
 
 
AP2 alpha -/- 
Die perinatally with cranioabdominoschisis 
and severe dysmorphogenesis of the face, 
skull, sensory organs, and cranial ganglia;  
 
Neural tube defects followed by craniofacial 
and body wall abnormalities 
(Schorle, 
Meier et al. 
1996)  
 
 
 
(Zhang, 
Hagopian-
Donaldson et 
al. 1996) 
 
TFAP2B Char syndrome Flat midface, wide-set eyes, flat nasal bridge, 
broad and flat nasal tip, thickened and everted 
“duck-bill” lips, triangular mouth 
(Lee, Root et 
al. 1982)  
 
FGFR1 (human) Familial Pfeiffer 
syndrome 
Craniostenosis and craniofacial dysplasia, 
including midfacial hypoplasia 
[257-261] 
FGFR2 (human) Apert syndrome 
 
 
 
 
Crouzon syndrome 
 
 
 
Pfeiffer syndrome 
Autosomal dominant; Characterized by 
brachiosphenocephalic skull defects; highly 
arched, sometimes cleft palate; hypoplastic 
midface; orbital bone defects. 
 
Autosomal dominant; craniosynostosis; 
hypoplastic orbital and facial bones; highly 
arched palate 
[252] 
 
 
 
 
[254, 255] 
 
 
 
[257-260] 
FGFR2 (mouse) FGFR2+/S252W 
 
 
Dominant mutation 
in mesenchymal 
splice form 
Similar to human Apert syndrome with 
defects in cartilage and bone development 
 
Similar to human Crouzon syndrome 
[253] 
 
 
[256] 
FGFR3 Crouzon syndrome Crouzon syndrome with acanthosis nigricans [254, 255] 
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Fli1 (human) Paris-Trousseau 
type 
Thrombocytopenia 
(TCPT): 
Homozygous 
deletion of Fli1. 
Mental retardation, facial dysmorphism, 
clinodactyly, pyloric stenosis, and 
thrombocytopenia 
(Favier, 
Jondeau et al. 
2003)  
FoxD3 (human)  Autosomal dominant vitiligo; regulator of 
melanoblast differentiation 
[323] 
FoxD3 (mouse)  Embryonic lethality at E6.5, required for 
maintenance of epiblast cells and expansion 
[324] 
FoxD3 (zebrafish) mother superior 
mutation 
Depletion of crest derivatives, leading to a 
protruding lower jaw, loss of cartilage in 
hyoid and posterior branchial arches, 
pigmentation defects particularly in the trunk 
iridophores and reduced number of neural 
precursors resulting in defective peripheral 
nervous system. 
(Montero-
Balaguer, 
Lang et al. 
2006) 
Mi200 family  Regulates EMT/MET by targeting ZEB1 and 
ZEB2, which control E-cadherin expression 
(Park, Gaur et 
al. 2008) 
Pax3 (human) Waardenburg-Shah 
syndrome 1 and 3 
 
 
Tumors 
Dystopia canthorum and type 3 also includes 
contractures or hypoplasia of upper-limb 
joints and muscles 
 
Rhabdomyosarcoma, tumors of NCC origin 
including melanoma and neuroblastoma 
(Waardenburg 
1951)  
SIP1 (Zeb2, 
ZFHX1B, 
SMADIP1) (human) 
Mowat-Wilson 
syndrome  
Hirschprung associated with microcephaly, 
mental retardation, hypertelorism, submucous 
cleft palate, short stature 
(Wakamatsu, 
Yamada et al. 
2001)  
SIP1 (Zeb2, 
ZFHX1B, 
SMADIP1) (mouse) 
 Early arrest in cranial neural crest migration  (Van de Putte, 
Francis et al. 
2007) 
Snail1/Snail2 
(mouse) 
Double knockout 
resembles Pierre 
Robin Sequence 
Micrognathia, fused mandible, enlarged 
parietal foramen in skull vault; defects occur 
in later development (not in initial 
delamination and migration) 
(Murray, 
Oram et al. 
2007)  
Snail2 (human) Waardenburg-Shah 
syndrome 2 
 
Piebaldism (non-
Kit related) 
Defects in melanocytes, also seen with Mitf 
mutation 
 
Congenital white forelock, scattered normal 
pigmented and hyperpigmented macules, and 
a triangular shaped depigmented patch on 
forehead. Caused by a heterozygous deletion 
of SNAI2 gene. 
(Waardenburg 
1951)  
 
 
(Sanchez-
Martin, 
Rodriguez-
Garcia et al. 
2002) 
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Snail2 (chicken)  Cooperates with ets-1 to recruit cells and 
initiate EMT 
(Theveneau, 
Duband et al. 
2007) 
Sox8 (mouse)  No effect as a single mutation but increases 
the severity of Sox10 heterozygote; may be 
jointly required with Sox10 for maintenance of 
vagal neural crest cells. 
(Maka, Stolt 
et al. 2005) 
Sox9 (human) Campomelic 
dysplasia 
Congenital skeletal malformation syndrome, 
includes cleft palate, low set ears, loss of the 
12th pair of ribs, abnormal pelvic bones, small 
chest and hip dislocations; may also include 
absence of the olfactory bulbs, renal and/or 
cardiac defects and XY sex reversal with 
genital malformations.  Also is frequently 
associated with conductive and sensorineural 
hearing loss.   
(Wagner, 
Wirth et al. 
1994; Kwok, 
Weller et al. 
1995) 
Sox9 conditional 
(mouse) 
Sox9flox/flox;Foxg1Cre 
 
Cre activity driven 
in the prospective 
otic ectoderm 
Sox9 controls adhesive properties of placode 
cells and regulates Epha4 expression; otic 
placodes are normally specified but 
invagination is impaired.  
(Barrionuevo, 
Naumann et 
al. 2008) 
Sox9a (zebrafish) Jellyfish mutation Lack cartilage elements of the neocranium, 
branchial arches and pectoral girdle; cartilage 
morphogenesis also disrupted.  
 
(Yan, Miller 
et al. 2002) 
Sox10 
haploinsufficiency 
(human) 
Hirschsprung’s 
disease (HSCR)  
 
 
Waardenburg-Shah 
syndrome 4 
Failure of enteric ganglia to populate the distal 
colon.  
 
 
Deafness/pigmentation defect in addition to 
HSCR; also seen in EDN3 and EDNRB 
mutants. 
 
(Badner, 
Sieber et al. 
1990; 
Herbarth, 
Pingault et al. 
1998; 
Pingault, 
Bondurand et 
al. 1998) 
 
 
 
(Herbarth, 
Pingault et al. 
1998) 
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Sox10-/- (mouse, 
Xenopus, zebrafish) 
Colorless (D. rerio) Loss of melanocytes, autonomic and enteric 
neurons and peripheral glia.  Crest cells form 
but fail to differentiate as these lineages and 
die, can result in embryonic lethality. 
(Southard-
Smith, Kos et 
al. 1998; 
Britsch, 
Goerich et al. 
2001; Dutton, 
Pauliny et al. 
2001; 
Paratore, 
Goerich et al. 
2001; 
Honore, 
Aybar et al. 
2003) 
Tbx1 (human) Di George 
syndrome 
Cardiac outflow tract anomalies, absence or 
hypoplasia of the thymus and parathyroid 
glands, nasal voice (often associated with cleft 
palate or submucosal cleft palate), and facial 
dysmorphism, known as conotruncal anomaly 
face. 
 
(Yagi, 
Furutani et al. 
2003) 
TGFBR1 (human) LDS1A 
LDS2A 
Non-FBN1 related 
Marfan syndrome 
TGFBR2 (human) Loeys-Dietz 
syndrome (LDS) 
type 1B and 2B 
Non-FBN1 related 
Marfan syndrome 
LDS1 and 2 are clinically indistinguishable 
autosomal dominant aortic aneurysm 
syndromes characterized by the triad of 
arterial tortuosity and aneurysms, 
hypertelorism, and bifid uvula or cleft palate; 
Type 1 category has craniofacial involvement 
consisting of cleft palate, craniosynostosis, or 
hypertelorism was observed. Patients assigned 
to the type 2 category had no evidence of 
these traits, but some had an bifid uvula.  
 
Marfan syndrome shows striking pleiotropism 
and clinical variability. The cardinal features 
occur in 3 systems: skeletal, ocular, and 
cardiovascular; a highly arched palate with 
crowding of the teeth are frequent skeletal 
features 
(Loeys, Chen 
et al. 2005; 
Loeys, 
Schwarze et 
al. 2006) 
 
 
 
 
 
 
 
 
 
 
(McKusick, 
Traisman et 
al. 1972; 
Pyeritz, 
Murphy et al. 
1979; 
Sponseller, 
Hobbs et al. 
1995) 
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TGFBR2 (mouse) TGFBR2 fl/fl; 
Wnt1-cre 
Severe skull defects, missing frontal and 
severely retarded parietal bone, cleft palate, 
reduced mandible and maxilla; skull size is 
25% smaller than littermates 
(Ito, Yeo et 
al. 2003; 
Loeys, Chen 
et al. 2005) 
Treacle (human) Treacher-Collins 
syndrome 
Antimongoloid slant of the eyes, coloboma of 
the lid, micrognathia, microtia and other ear 
deformities, hypoplastic zygomatic arches and 
macrostomia. Conductive hearing loss and 
cleft palate often apparent 
(Dixon 1996) 
Treacle (mouse) Tcof+/- 
haploinsufficient 
embryos generated 
Reduced head size, frontonasal dysplasia, 
failure of palatal shelves to fuse resulting in 
cleft palate, poorly formed nasal passages, die 
within 24h of birth from respiratory arrest due 
to cranioskeletal malformations.  Required for 
ribosome biogenesis necessary for crest cell 
proliferation. 
(Dixon, Jones 
et al. 2006) 
Treacle (Macaca 
mulatta) 
Resus Tcof1 
homolog is 93.8% 
identical in terms of 
protein 
Infant macaque discovered displaying 
Treacher-Collins phenotype. No mutation 
found in TCOF1 coding or splice sites, but 
87% reduction of spleen TCOF1 mRNA  
(Shows, Ward 
et al. 2006) 
Treacle (dog)  Genetic analysis showed mapping to this 
region of mutation leading to brachycephaly 
in domestic dog breeds 
(Haworth, 
Islam et al. 
2001) 
Twist (human) Saethre-Chotzen 
syndrome 
Craniosyntosis, limb deformities and 
dysmorphic facial features including facial 
asymmetry.  
(el Ghouzzi, 
Le Merrer et 
al. 1997; 
Howard, 
Paznekas et 
al. 1997) 
Twist (mouse) 
 
 
 
Twist conditional 
(mouse) 
Twist1-/- 
 
 
 
 
  
Embryonic lethal at E11.5, open cranial neural 
tube, retarded forelimb bud development and 
branchial arch malformations. 
 
Heterozygotes have craniofacial defects and 
polydactyly. 
(Chen and 
Behringer 
1995) 
 
 
 
(Chen, 
Akinwunmi et 
al. 2007) 
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Figure I.  Schematic of Neural Crest Development 
 
Representation of the early embryo (A) as well as the subsequent steps of neural crest 
induction (B), early migration (C), and later migration with some delineated 
derivatives (D). Figure adapted from Knecht et al 2002.  
          
                     
pigment cells
facial ca rtilage and bones sensory neu rons and glia
sypathoadrenal c ells
Trunk deriva tivesCranial derivatives
connective tissue
Neurons and glia 
of the c ranial ganglia
 
 
 
 45 
Adams, M. S., L. S. Gammill, et al. (2008). "Discovery of transcription factors and 
other candidate regulators of neural crest development." Dev Dyn 237(4): 
1021-33. 
Agoff, S. N., L. W. Lamps, et al. (2000). "Thyroid transcription factor-1 is expressed 
in extrapulmonary small cell carcinomas but not in other extrapulmonary 
neuroendocrine tumors." Mod Pathol 13(3): 238-42. 
Ahmed, S. and A. Nawshad (2007). "Complexity in interpretation of embryonic 
epithelial-mesenchymal transition in response to transforming growth factor-
beta signaling." Cells Tissues Organs 185(1-3): 131-45. 
Akitaya, T. and M. Bronner-Fraser (1992). "Expression of cell adhesion molecules 
during initiation and cessation of neural crest cell migration." Dev Dyn 
194(1): 12-20. 
Al-Rawi, M. and M. H. Wheeler (2006). "Medullary thyroid carcinoma--update and 
present management controversies." Ann R Coll Surg Engl 88(5): 433-8. 
Alexander, C. M. and Z. Werb (1992). "Targeted disruption of the tissue inhibitor of 
metalloproteinases gene increases the invasive behavior of primitive 
mesenchymal cells derived from embryonic stem cells in vitro." J Cell Biol 
118(3): 727-39. 
Anderson, D. J. (1993). "Molecular control of cell fate in the neural crest: the 
sympathoadrenal lineage." Annu Rev Neurosci 16: 129-58. 
Ansieau, S., J. Bastid, et al. (2008). "Induction of EMT by twist proteins as a 
collateral effect of tumor-promoting inactivation of premature senescence." 
Cancer Cell 14(1): 79-89. 
 46 
Aubry, M., S. Demczuk, et al. (1993). "Isolation of a zinc finger gene consistently 
deleted in DiGeorge syndrome." Hum Mol Genet 2(10): 1583-7. 
Badner, J. A., W. K. Sieber, et al. (1990). "A genetic study of Hirschsprung disease." 
Am J Hum Genet 46(3): 568-80. 
Baker, C. V. and M. Bronner-Fraser (1997). "The origins of the neural crest. Part I: 
embryonic induction." Mech Dev 69(1-2): 3-11. 
Baldini, A. (2002). "DiGeorge syndrome: the use of model organisms to dissect 
complex genetics." Hum Mol Genet 11(20): 2363-9. 
Baroffio, A., E. Dupin, et al. (1988). "Clone-forming ability and differentiation 
potential of migratory neural crest cells." Proc Natl Acad Sci U S A 85(14): 
5325-9. 
Baroffio, A., E. Dupin, et al. (1991). "Common precursors for neural and 
mesectodermal derivatives in the cephalic neural crest." Development 112(1): 
301-5. 
Barrionuevo, F., A. Naumann, et al. (2008). "Sox9 is required for invagination of the 
otic placode in mice." Dev Biol 317(1): 213-24. 
Basch, M. L., M. Bronner-Fraser, et al. (2006). "Specification of the neural crest 
occurs during gastrulation and requires Pax7." Nature 441(7090): 218-22. 
Batlle, E., E. Sancho, et al. (2000). "The transcription factor snail is a repressor of E-
cadherin gene expression in epithelial tumour cells." Nat Cell Biol 2(2): 84-9. 
Biddinger, P. W. and M. Ray (1993). "Distribution of C cells in the normal and 
diseased thyroid gland." Pathol Annu 28 Pt 1: 205-29. 
 47 
Bolos, V., H. Peinado, et al. (2003). "The transcription factor Slug represses E-
cadherin expression and induces epithelial to mesenchymal transitions: a 
comparison with Snail and E47 repressors." J Cell Sci 116(Pt 3): 499-511. 
Boyer, A. S., Ayerinskas, II, et al. (1999). "TGFbeta2 and TGFbeta3 have separate 
and sequential activities during epithelial-mesenchymal cell transformation in 
the embryonic heart." Dev Biol 208(2): 530-45. 
Britsch, S., D. E. Goerich, et al. (2001). "The transcription factor Sox10 is a key 
regulator of peripheral glial development." Genes Dev 15(1): 66-78. 
Bronner-Fraser, M. (1986). "Analysis of the early stages of trunk neural crest 
migration in avian embryos using monoclonal antibody HNK-1." Dev Biol 
115(1): 44-55. 
Bronner-Fraser, M. and S. Fraser (1989). "Developmental potential of avian trunk 
neural crest cells in situ." Neuron 3(6): 755-66. 
Bronner-Fraser, M. and S. E. Fraser (1988). "Cell lineage analysis reveals 
multipotency of some avian neural crest cells." Nature 335(6186): 161-4. 
Bronner-Fraser, M., M. Sieber-Blum, et al. (1980). "Clonal analysis of the avian 
neural crest: migration and maturation of mixed neural crest clones injected 
into host chicken embryos." J Comp Neurol 193(2): 423-34. 
Brown, C. B., A. S. Boyer, et al. (1996). "Antibodies to the Type II TGFbeta receptor 
block cell activation and migration during atrioventricular cushion 
transformation in the heart." Dev Biol 174(2): 248-57. 
Brown, C. B., A. S. Boyer, et al. (1999). "Requirement of type III TGF-beta receptor 
for endocardial cell transformation in the heart." Science 283(5410): 2080-2. 
 48 
Bryant, J., J. Farmer, et al. (2003). "Pheochromocytoma: the expanding genetic 
differential diagnosis." J Natl Cancer Inst 95(16): 1196-204. 
Burstyn-Cohen, T., J. Stanleigh, et al. (2004). "Canonical Wnt activity regulates trunk 
neural crest delamination linking BMP/noggin signaling with G1/S 
transition." Development 131(21): 5327-39. 
Bussolati, G. and A. G. Pearse (1967). "Immunofluorescent localization of calcitonin 
in the 'C' cells of pig and dog thyroid." J Endocrinol 37(2): 205-9. 
Cano, A., M. A. Perez-Moreno, et al. (2000). "The transcription factor snail controls 
epithelial-mesenchymal transitions by repressing E-cadherin expression." Nat 
Cell Biol 2(2): 76-83. 
Cebra-Thomas, J. A., E. Betters, et al. (2007). "Evidence that a late-emerging 
population of trunk neural crest cells forms the plastron bones in the turtle 
Trachemys scripta." Evol Dev 9(3): 267-77. 
Char, F. (1978). "Peculiar facies with short philtrum, duck-bill lips, ptosis and low-set 
ears--a new syndrome?" Birth Defects Orig Artic Ser 14(6B): 303-5. 
Chen, Y. T., P. O. Akinwunmi, et al. (2007). "Generation of a Twist1 conditional null 
allele in the mouse." Genesis 45(9): 588-92. 
Chen, Z. F. and R. R. Behringer (1995). "twist is required in head mesenchyme for 
cranial neural tube morphogenesis." Genes Dev 9(6): 686-99. 
Chibon, P. (1967). "[Nuclear labelling by tritiated thymidine of neural crest 
derivatives in the amphibian Urodele Pleurodeles waltlii Michah]." J Embryol 
Exp Morphol 18(3): 343-58. 
 49 
Chisaka, O. and M. R. Capecchi (1991). "Regionally restricted developmental defects 
resulting from targeted disruption of the mouse homeobox gene hox-1.5." 
Nature 350(6318): 473-9. 
Chou, D. K., M. Schachner, et al. (2002). "HNK-1 sulfotransferase null mice express 
glucuronyl glycoconjugates and show normal cerebellar granule neuron 
migration in vivo and in vitro." J Neurochem 82(5): 1239-51. 
Clark, K., G. Bender, et al. (2001). "Evidence for the neural crest origin of turtle 
plastron bones." Genesis 31(3): 111-7. 
Coles, E., J. Christiansen, et al. (2004). "A vertebrate crossveinless 2 homologue 
modulates BMP activity and neural crest cell migration." Development 
131(21): 5309-17. 
Coles, E. G., L. A. Taneyhill, et al. (2007). "A critical role for Cadherin6B in 
regulating avian neural crest emigration." Dev Biol 312(2): 533-44. 
Comijn, J., G. Berx, et al. (2001). "The two-handed E box binding zinc finger protein 
SIP1 downregulates E-cadherin and induces invasion." Mol Cell 7(6): 1267-
78. 
Correia, A. C., M. Costa, et al. (2007). "Bmp2 is required for migration but not for 
induction of neural crest cells in the mouse." Dev Dyn 236(9): 2493-501. 
Couly, G. F., P. M. Coltey, et al. (1992). "The developmental fate of the cephalic 
mesoderm in quail-chick chimeras." Development 114(1): 1-15. 
Couly, G. F., P. M. Coltey, et al. (1993). "The triple origin of skull in higher 
vertebrates: a study in quail-chick chimeras." Development 117(2): 409-29. 
 50 
Couto, S. S. and R. D. Cardiff (2008). "The genomic revolution and endocrine 
pathology." Endocr Pathol 19(3): 139-47. 
de Larco, J. E. and G. J. Todaro (1978). "Growth factors from murine sarcoma virus-
transformed cells." Proc Natl Acad Sci U S A 75(8): 4001-5. 
DeLellis, R., Lloyd, RV, Heitz, PU, Eng, C. , Ed. (2004). Tumours of Endocrine 
Organs. Pathology and Genetics. Lyon, World Health Organization IARC 
Press. 
Di Lauro, R. and M. De Felice (2001). Thyroid gland: anatomy and development. 
Philadelphia, Saunders. 
Dickinson, M. E., M. A. Selleck, et al. (1995). "Dorsalization of the neural tube by 
the non-neural ectoderm." Development 121(7): 2099-106. 
Dixon, J., N. C. Jones, et al. (2006). "Tcof1/Treacle is required for neural crest cell 
formation and proliferation deficiencies that cause craniofacial abnormalities." 
Proc Natl Acad Sci U S A 103(36): 13403-8. 
Dixon, J., P. Trainor, et al. (2007). "Treacher Collins syndrome." Orthod Craniofac 
Res 10(2): 88-95. 
Dixon, M. J. (1996). "Treacher Collins syndrome." Hum Mol Genet 5 Spec No: 
1391-6. 
Duband, J. L. and J. P. Thiery (1987). "Distribution of laminin and collagens during 
avian neural crest development." Development 101(3): 461-78. 
Duband, J. L., T. Volberg, et al. (1988). "Spatial and temporal distribution of the 
adherens-junction-associated adhesion molecule A-CAM during avian 
embryogenesis." Development 103(2): 325-44. 
 51 
Duong, T. D. and C. A. Erickson (2004). "MMP-2 plays an essential role in 
producing epithelial-mesenchymal transformations in the avian embryo." Dev 
Dyn 229(1): 42-53. 
Dutton, K. A., A. Pauliny, et al. (2001). "Zebrafish colourless encodes sox10 and 
specifies non-ectomesenchymal neural crest fates." Development 128(21): 
4113-25. 
Edelman, G. M., W. J. Gallin, et al. (1983). "Early epochal maps of two different cell 
adhesion molecules." Proc Natl Acad Sci U S A 80(14): 4384-8. 
Eisenhofer, G., S. R. Bornstein, et al. (2004). "Malignant pheochromocytoma: current 
status and initiatives for future progress." Endocr Relat Cancer 11(3): 423-36. 
Eisenhofer, G., T. T. Huynh, et al. (2004). "Distinct gene expression profiles in 
norepinephrine- and epinephrine-producing hereditary and sporadic 
pheochromocytomas: activation of hypoxia-driven angiogenic pathways in 
von Hippel-Lindau syndrome." Endocr Relat Cancer 11(4): 897-911. 
el Ghouzzi, V., M. Le Merrer, et al. (1997). "Mutations of the TWIST gene in the 
Saethre-Chotzen syndrome." Nat Genet 15(1): 42-6. 
Endo, Y., N. Osumi, et al. (2002). "Bimodal functions of Notch-mediated signaling 
are involved in neural crest formation during avian ectoderm development." 
Development 129(4): 863-73. 
Endo, Y., N. Osumi, et al. (2003). "Deltex/Dtx mediates NOTCH signaling in 
regulation of Bmp4 expression in cranial neural crest formation during avian 
development." Dev Growth Differ 45(3): 241-8. 
 52 
Erickson, C. A., J. F. Loring, et al. (1989). "Migratory pathways of HNK-1-
immunoreactive neural crest cells in the rat embryo." Dev Biol 134(1): 112-8. 
Erickson, C. A. and R. Perris (1993). "The role of cell-cell and cell-matrix 
interactions in the morphogenesis of the neural crest." Dev Biol 159(1): 60-74. 
Eswarakumar, V. P., F. Ozcan, et al. (2006). "Attenuation of signaling pathways 
stimulated by pathologically activated FGF-receptor 2 mutants prevents 
craniosynostosis." Proc Natl Acad Sci U S A 103(49): 18603-8. 
Favier, R., K. Jondeau, et al. (2003). "Paris-Trousseau syndrome : clinical, 
hematological, molecular data of ten new cases." Thromb Haemost 90(5): 
893-7. 
Fontaine, J. (1979). "Multistep migration of calcitonin cell precursors during 
ontogeny of the mouse pharynx." Gen Comp Endocrinol 37(1): 81-92. 
Freitas, R., G. Zhang, et al. (2006). "Developmental origin of shark electrosensory 
organs." Evol Dev 8(1): 74-80. 
Fujimoto, A., M. Lipson, et al. (1987). "New autosomal dominant branchio-oculo-
facial syndrome." Am J Med Genet 27(4): 943-51. 
Funahashi, J., T. Okafuji, et al. (1999). "Role of Pax-5 in the regulation of a mid-
hindbrain organizer's activity." Dev Growth Differ 41(1): 59-72. 
Gammill, L. S. and M. Bronner-Fraser (2002). "Genomic analysis of neural crest 
induction." Development 129(24): 5731-41. 
Gans, C. and R. G. Northcutt (1983). "Neural Crest and the Origin of Vertebrates: A 
New Head." Science 220(4594): 268-273. 
 53 
Garcia-Castro, M. I., C. Marcelle, et al. (2002). "Ectodermal Wnt function as a neural 
crest inducer." Science 297(5582): 848-51. 
Giehl, K. and A. Menke (2008). "Microenvironmental regulation of E-cadherin-
mediated adherens junctions." Front Biosci 13: 3975-85. 
Gimm, O. and H. Dralle (1999). "C-cell cancer--prevention and treatment." 
Langenbecks Arch Surg 384(1): 16-23. 
Giovannini, M., J. A. Biegel, et al. (1994). "EWS-erg and EWS-Fli1 fusion 
transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with 
variant translocations." J Clin Invest 94(2): 489-96. 
Glaser, R. L., W. Jiang, et al. (2000). "Paternal origin of FGFR2 mutations in 
sporadic cases of Crouzon syndrome and Pfeiffer syndrome." Am J Hum 
Genet 66(3): 768-77. 
Graff, J. R., J. G. Herman, et al. (1995). "E-cadherin expression is silenced by DNA 
hypermethylation in human breast and prostate carcinomas." Cancer Res 
55(22): 5195-9. 
Graveson, A. C., M. M. Smith, et al. (1997). "Neural crest potential for tooth 
development in a urodele amphibian: developmental and evolutionary 
significance." Dev Biol 188(1): 34-42. 
Gross, J. B. and J. Hanken (2008). "Review of fate-mapping studies of osteogenic 
cranial neural crest in vertebrates." Dev Biol 317(2): 389-400. 
Gumbiner, B. M. (2005). "Regulation of cadherin-mediated adhesion in 
morphogenesis." Nat Rev Mol Cell Biol 6(8): 622-34. 
 54 
Hadeball, B., A. Borchers, et al. (1998). "Xenopus cadherin-11 (Xcadherin-11) 
expression requires the Wg/Wnt signal." Mech Dev 72(1-2): 101-13. 
Hahm, K. B., K. Cho, et al. (1999). "Repression of the gene encoding the TGF-beta 
type II receptor is a major target of the EWS-FLI1 oncoprotein." Nat Genet 
23(2): 222-7. 
Hajra, K. M. and E. R. Fearon (2002). "Cadherin and catenin alterations in human 
cancer." Genes Chromosomes Cancer 34(3): 255-68. 
Hall, B. D., A. deLorimier, et al. (1983). "Brief clinical report: a new syndrome of 
hemangiomatous branchial clefts, lip pseudoclefts, and unusual facial 
appearance." Am J Med Genet 14(1): 135-8. 
Hall, B. K. (1999). The neural crest in development and evolution. New York, 
Springer-Verlag. 
Haworth, K. E., I. Islam, et al. (2001). "Canine TCOF1; cloning, chromosome 
assignment and genetic analysis in dogs with different head types." Mamm 
Genome 12(8): 622-9. 
Hay, E. D. (1968). Organization and fine structure of epithelium and mesenchyme 
in the developing chick embryo. Epithelial–Mesenchymal Interactions. R. a. B. 
Fleischmajer, R.E. . Baltimore, MD, USA, Williams & Wilkins Co: 31–55. 
Hazard, J. B., W. A. Hawk, et al. (1959). "Medullary (solid) carcinoma of the thyroid; 
a clinicopathologic entity." J Clin Endocrinol Metab 19(1): 152-61. 
Heanue, T. A. and V. Pachnis (2007). "Enteric nervous system development and 
Hirschsprung's disease: advances in genetic and stem cell studies." Nat Rev 
Neurosci 8(6): 466-79. 
 55 
Herbarth, B., V. Pingault, et al. (1998). "Mutation of the Sry-related Sox10 gene in 
Dominant megacolon, a mouse model for human Hirschsprung disease." Proc 
Natl Acad Sci U S A 95(9): 5161-5. 
Hilfer, S. R. (1968). Cellular interactions in the genesis and maintenance of thyroid 
characteristics. Baltimore, Williams and Wilkins Co. 
His, W. (1868). ""Die erste Entwicklung des Hühnchens im Ei: Untersuchungen über 
die erste Anlage des Wirbelthierleibes"." 
Hoffmann, I. and R. Balling (1995). "Cloning and expression analysis of a novel 
mesodermally expressed cadherin." Dev Biol 169(1): 337-46. 
Honore, S. M., M. J. Aybar, et al. (2003). "Sox10 is required for the early 
development of the prospective neural crest in Xenopus embryos." Dev Biol 
260(1): 79-96. 
Hörstadius, S. (1950). The Neural Crest: its Properties and Derivatives in the Light of 
Experimental Research. London, Oxford University Press. 
Hou, L. (1999). "Effects of local tissue environment on the differentiation of neural 
crest cells in turtle, with special reference to understanding the spatial 
distribution of pigment cells." Pigment Cell Res 12(2): 81-8. 
Houdayer, C., M. F. Portnoi, et al. (2001). "Pierre Robin sequence and interstitial 
deletion 2q32.3-q33.2." Am J Med Genet 102(3): 219-26. 
Houston, C. S., J. M. Opitz, et al. (1983). "The campomelic syndrome: review, report 
of 17 cases, and follow-up on the currently 17-year-old boy first reported by 
Maroteaux et al in 1971." Am J Med Genet 15(1): 3-28. 
 56 
Howard, T. D., W. A. Paznekas, et al. (1997). "Mutations in TWIST, a basic helix-
loop-helix transcription factor, in Saethre-Chotzen syndrome." Nat Genet 
15(1): 36-41. 
Hu, Y. F., Z. J. Zhang, et al. (2006). "An epidermal neural crest stem cell (EPI-
NCSC) molecular signature." Stem Cells 24(12): 2692-702. 
Huynh, T. T., K. Pacak, et al. (2006). "Transcriptional regulation of 
phenylethanolamine N-methyltransferase in pheochromocytomas from 
patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia 
type 2." Ann N Y Acad Sci 1073: 241-52. 
Ikenouchi, J., M. Matsuda, et al. (2003). "Regulation of tight junctions during the 
epithelium-mesenchyme transition: direct repression of the gene expression of 
claudins/occludin by Snail." J Cell Sci 116(Pt 10): 1959-67. 
Ishihara, N., K. Yamada, et al. (2004). "Clinical and molecular analysis of Mowat-
Wilson syndrome associated with ZFHX1B mutations and deletions at 2q22-
q24.1." J Med Genet 41(5): 387-93. 
Ito, K. and M. Sieber-Blum (1991). "In vitro clonal analysis of quail cardiac neural 
crest development." Dev Biol 148(1): 95-106. 
Ito, Y., J. Y. Yeo, et al. (2003). "Conditional inactivation of Tgfbr2 in cranial neural 
crest causes cleft palate and calvaria defects." Development 130(21): 5269-80. 
Jacks, T., T. S. Shih, et al. (1994). "Tumour predisposition in mice heterozygous for a 
targeted mutation in Nf1." Nat Genet 7(3): 353-61. 
Jeffery, W. R., A. G. Strickler, et al. (2004). "Migratory neural crest-like cells form 
body pigmentation in a urochordate embryo." Nature 431(7009): 696-9. 
 57 
Jerome, L. A. and V. E. Papaioannou (2001). "DiGeorge syndrome phenotype in 
mice mutant for the T-box gene, Tbx1." Nat Genet 27(3): 286-91. 
Jiang, X., B. Choudhary, et al. (2002). "Normal fate and altered function of the 
cardiac neural crest cell lineage in retinoic acid receptor mutant embryos." 
Mech Dev 117(1-2): 115-22. 
Joseph, N. M., J. T. Mosher, et al. (2008). "The loss of Nf1 transiently promotes self-
renewal but not tumorigenesis by neural crest stem cells." Cancer Cell 13(2): 
129-40. 
Karafiat, V., M. Dvorakova, et al. (2005). "Transcription factor c-Myb is involved in 
the regulation of the epithelial-mesenchymal transition in the avian neural 
crest." Cell Mol Life Sci 62(21): 2516-25. 
Katahira, T. and H. Nakamura (2003). "Gene silencing in chick embryos with a 
vector-based small interfering RNA system." Dev Growth Differ 45(4): 361-7. 
Kelberman, D., J. Tyson, et al. (2001). "Hemifacial microsomia: progress in 
understanding the genetic basis of a complex malformation syndrome." Hum 
Genet 109(6): 638-45. 
Kimura, Y., H. Matsunami, et al. (1995). "Cadherin-11 expressed in association with 
mesenchymal morphogenesis in the head, somite, and limb bud of early 
mouse embryos." Dev Biol 169(1): 347-58. 
Knecht, A. K. and M. Bronner-Fraser (2002). "Induction of the neural crest: a 
multigene process." Nat Rev Genet 3(6): 453-61. 
 58 
Koch, C. A., D. Mauro, et al. (2002). "Pheochromocytoma in von hippel-lindau 
disease: distinct histopathologic phenotype compared to pheochromocytoma 
in multiple endocrine neoplasia type 2." Endocr Pathol 13(1): 17-27. 
Kuratani, S. (2008). "Evolutionary developmental studies of cyclostomes and the 
origin of the vertebrate neck." Dev Growth Differ 50 Suppl 1: S189-94. 
Kwok, C., P. A. Weller, et al. (1995). "Mutations in SOX9, the gene responsible for 
Campomelic dysplasia and autosomal sex reversal." Am J Hum Genet 57(5): 
1028-36. 
LaBonne, C. and M. Bronner-Fraser (1998). "Neural crest induction in Xenopus: 
evidence for a two-signal model." Development 125(13): 2403-14. 
Lajeunie, E., H. W. Ma, et al. (1995). "FGFR2 mutations in Pfeiffer syndrome." Nat 
Genet 9(2): 108. 
Landacre, F. L. (1921). "The fate of the neural crest in the head of urodeles." Journal 
of Comparative Neurology(33): 1-44. 
Le Douarin, N., J. Fontaine, et al. (1974). "New studies on the neural crest origin of 
the avian ultimobranchial glandular cells--interspecific combinations and 
cytochemical characterization of C cells based on the uptake of biogenic 
amine precursors." Histochemistry 38(4): 297-305. 
Le Douarin, N. M., S. Creuzet, et al. (2004). "Neural crest cell plasticity and its 
limits." Development 131(19): 4637-50. 
Le Douarin, N. M. and M. A. Teillet (1974). "Experimental analysis of the migration 
and differentiation of neuroblasts of the autonomic nervous system and of 
 59 
neurectodermal mesenchymal derivatives, using a biological cell marking 
technique." Dev Biol 41(1): 162-84. 
Le Dourarin, N. M. and C. Kalcheim (1999). The Neural Crest. Cambridge, UK, 
Cambridge University Press. 
Le Lievre, C. S. and N. M. Le Douarin (1975). "Mesenchymal derivatives of the 
neural crest: analysis of chimaeric quail and chick embryos." J Embryol Exp 
Morphol 34(1): 125-54. 
Lee, G., H. Kim, et al. (2007). "Isolation and directed differentiation of neural crest 
stem cells derived from human embryonic stem cells." Nat Biotechnol 25(12): 
1468-75. 
Lee, S., E. Nakamura, et al. (2005). "Neuronal apoptosis linked to EglN3 prolyl 
hydroxylase and familial pheochromocytoma genes: developmental culling 
and cancer." Cancer Cell 8(2): 155-67. 
Lee, W. K., A. W. Root, et al. (1982). "Bilateral branchial cleft sinuses associated 
with intrauterine and postnatal growth retardation, premature aging, and 
unusual facial appearance: a new syndrome with dominant transmission." Am 
J Med Genet 11(3): 345-52. 
Levayer, R. and T. Lecuit (2008). "Breaking down EMT." Nat Cell Biol 10(7): 757-9. 
Liem, K. F., Jr., G. Tremml, et al. (1995). "Dorsal differentiation of neural plate cells 
induced by BMP-mediated signals from epidermal ectoderm." Cell 82(6): 
969-79. 
 60 
Linnoila, R. I., H. R. Keiser, et al. (1990). "Histopathology of benign versus 
malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 
cases including unusual histologic features." Hum Pathol 21(11): 1168-80. 
Lloyd, R. V., J. C. Sisson, et al. (1986). "Immunohistochemical localization of 
epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and 
chromogranin in neuroendocrine cells and tumors." Am J Pathol 125(1): 45-
54. 
Loeys, B. L., J. Chen, et al. (2005). "A syndrome of altered cardiovascular, 
craniofacial, neurocognitive and skeletal development caused by mutations in 
TGFBR1 or TGFBR2." Nat Genet 37(3): 275-81. 
Loeys, B. L., U. Schwarze, et al. (2006). "Aneurysm syndromes caused by mutations 
in the TGF-beta receptor." N Engl J Med 355(8): 788-98. 
Lumsden, A. G. (1988). "Spatial organization of the epithelium and the role of neural 
crest cells in the initiation of the mammalian tooth germ." Development 103 
Suppl: 155-69. 
Machado, J. C., C. Oliveira, et al. (2001). "E-cadherin gene (CDH1) promoter 
methylation as the second hit in sporadic diffuse gastric carcinoma." 
Oncogene 20(12): 1525-8. 
Maher, E. R. and C. Eng (2002). "The pressure rises: update on the genetics of 
phaeochromocytoma." Hum Mol Genet 11(20): 2347-54. 
Maka, M., C. C. Stolt, et al. (2005). "Identification of Sox8 as a modifier gene in a 
mouse model of Hirschsprung disease reveals underlying molecular defect." 
Dev Biol 277(1): 155-69. 
 61 
Mancilla, A. and R. Mayor (1996). "Neural crest formation in Xenopus laevis: 
mechanisms of Xslug induction." Dev Biol 177(2): 580-9. 
Manley, N. R. and M. R. Capecchi (1998). "Hox group 3 paralogs regulate the 
development and migration of the thymus, thyroid, and parathyroid glands." 
Dev Biol 195(1): 1-15. 
Martins-Green, M. and C. A. Erickson (1987). "Basal lamina is not a barrier to neural 
crest cell emigration: documentation by TEM and by immunofluorescent and 
immunogold labelling." Development 101(3): 517-33. 
Massague, J. (1990). "The transforming growth factor-beta family." Annu Rev Cell 
Biol 6: 597-641. 
McDonald, M. T. and J. L. Gorski (1993). "Nager acrofacial dysostosis." J Med 
Genet 30(9): 779-82. 
McKusick, V. A., H. S. Traisman, et al. (1972). "More speculation on Marfan 
syndrome." J Pediatr 80(3): 530-1. 
Meulemans, D. and M. Bronner-Fraser (2004). "Gene-regulatory interactions in 
neural crest evolution and development." Dev Cell 7(3): 291-9. 
Meulemans, D. and M. Bronner-Fraser (2005). "Central role of gene cooption in 
neural crest evolution." J Exp Zoolog B Mol Dev Evol 304(4): 298-303. 
Milunsky, J. M., T. A. Maher, et al. (2008). "TFAP2A mutations result in branchio-
oculo-facial syndrome." Am J Hum Genet 82(5): 1171-7. 
Montero-Balaguer, M., M. R. Lang, et al. (2006). "The mother superior mutation 
ablates foxd3 activity in neural crest progenitor cells and depletes neural crest 
derivatives in zebrafish." Dev Dyn 235(12): 3199-212. 
 62 
Moreno-Bueno, G., E. Cubillo, et al. (2006). "Genetic profiling of epithelial cells 
expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and 
E47 factors in epithelial-mesenchymal transition." Cancer Res 66(19): 9543-
56. 
Morrison, S. J., P. M. White, et al. (1999). "Prospective identification, isolation by 
flow cytometry, and in vivo self-renewal of multipotent mammalian neural 
crest stem cells." Cell 96(5): 737-49. 
Moseley, J. M., E. W. Matthews, et al. (1968). "The ultimobranchial origin of 
calcitonin." Lancet 1(7534): 108-10. 
Moser, M., A. Pscherer, et al. (1997). "Enhanced apoptotic cell death of renal 
epithelial cells in mice lacking transcription factor AP-2beta." Genes Dev 
11(15): 1938-48. 
Moury, J. D. and A. G. Jacobson (1989). "Neural fold formation at newly created 
boundaries between neural plate and epidermis in the axolotl." Dev Biol 
133(1): 44-57. 
Moury, J. D. and A. G. Jacobson (1990). "The origins of neural crest cells in the 
axolotl." Dev Biol 141(2): 243-53. 
Mowat, D. R., G. D. Croaker, et al. (1998). "Hirschsprung disease, microcephaly, 
mental retardation, and characteristic facial features: delineation of a new 
syndrome and identification of a locus at chromosome 2q22-q23." J Med 
Genet 35(8): 617-23. 
Muenke, M., U. Schell, et al. (1994). "A common mutation in the fibroblast growth 
factor receptor 1 gene in Pfeiffer syndrome." Nat Genet 8(3): 269-74. 
 63 
Muller, T., A. Choidas, et al. (1999). "Phosphorylation and free pool of beta-catenin 
are regulated by tyrosine kinases and tyrosine phosphatases during epithelial 
cell migration." J Biol Chem 274(15): 10173-83. 
Murray, S. A., K. F. Oram, et al. (2007). "Multiple functions of Snail family genes 
during palate development in mice." Development 134(9): 1789-97. 
Nagoshi, N., S. Shibata, et al. (2008). "Ontogeny and multipotency of neural crest-
derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker 
pad." Cell Stem Cell 2(4): 392-403. 
Nakagawa, S. and M. Takeichi (1995). "Neural crest cell-cell adhesion controlled by 
sequential and subpopulation-specific expression of novel cadherins." 
Development 121(5): 1321-32. 
Nakagawa, S. and M. Takeichi (1998). "Neural crest emigration from the neural tube 
depends on regulated cadherin expression." Development 125(15): 2963-71. 
Nakajima, Y., E. L. Krug, et al. (1994). "Myocardial regulation of transforming 
growth factor-beta expression by outflow tract endothelium in the early 
embryonic chick heart." Dev Biol 165(2): 615-26. 
Nakamura, E. and W. G. Kaelin, Jr. (2006). "Recent insights into the molecular 
pathogenesis of pheochromocytoma and paraganglioma." Endocr Pathol 
17(2): 97-106. 
Nakamura, H., Y. Watanabe, et al. (2000). "Misexpression of genes in brain vesicles 
by in ovo electroporation." Dev Growth Differ 42(3): 199-201. 
 64 
Naora, H., M. Kimura, et al. (1994). "Transgenic mouse model of hemifacial 
microsomia: cloning and characterization of insertional mutation region on 
chromosome 10." Genomics 23(3): 515-9. 
Newgreen, D. and I. Gibbins (1982). "Factors controlling the time of onset of the 
migration of neural crest cells in the fowl embryo." Cell Tissue Res 224(1): 
145-60. 
Newgreen, D. F. and D. Gooday (1985). "Control of the onset of migration of neural 
crest cells in avian embryos. Role of Ca++-dependent cell adhesions." Cell 
Tissue Res 239(2): 329-36. 
Nichols, D. H. (1981). "Neural crest formation in the head of the mouse embryo as 
observed using a new histological technique." J Embryol Exp Morphol 64: 
105-20. 
Nichols, D. H. (1987). "Ultrastructure of neural crest formation in the 
midbrain/rostral hindbrain and preotic hindbrain regions of the mouse 
embryo." Am J Anat 179(2): 143-54. 
Nicholson, A. D. and S. Menon (1995). "Hallerman-Streiff syndrome." J Postgrad 
Med 41(1): 22-3. 
Nijhawan, N., Y. Morad, et al. (2002). "Caruncle abnormalities in the oculo-auriculo-
vertebral spectrum." Am J Med Genet 113(4): 320-5. 
Noden, D. M. (1991). "Cell movements and control of patterned tissue assembly 
during craniofacial development." J Craniofac Genet Dev Biol 11(4): 192-
213. 
 65 
Palacios, F., J. S. Tushir, et al. (2005). "Lysosomal targeting of E-cadherin: a unique 
mechanism for the down-regulation of cell-cell adhesion during epithelial to 
mesenchymal transitions." Mol Cell Biol 25(1): 389-402. 
Paratore, C., D. E. Goerich, et al. (2001). "Survival and glial fate acquisition of neural 
crest cells are regulated by an interplay between the transcription factor Sox10 
and extrinsic combinatorial signaling." Development 128(20): 3949-61. 
Pardono, E., Y. van Bever, et al. (2003). "Waardenburg syndrome: clinical 
differentiation between types I and II." Am J Med Genet A 117A(3): 223-35. 
Park, S. M., A. B. Gaur, et al. (2008). "The miR-200 family determines the epithelial 
phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and 
ZEB2." Genes Dev 22(7): 894-907. 
Parsons, S. L., S. A. Watson, et al. (1997). "Matrix metalloproteinases." Br J Surg 
84(2): 160-6. 
Pearse, A. G. (1966). "The cytochemistry of the thyroid C cells and their relationship 
to calcitonin." Proc R Soc Lond B Biol Sci 164(996): 478-87. 
Pearse, A. G. and A. F. Carvalheira (1967). "Cytochemical evidence for an 
ultimobranchial origin of rodent thyroid C cells." Nature 214(5091): 929-30. 
Pearse, A. G. and J. M. Polak (1971). "Cytochemical evidence for the neural crest 
origin of mammalian ultimobranchial C cells." Histochemie 27(2): 96-102. 
Peinado, H., D. Olmeda, et al. (2007). "Snail, Zeb and bHLH factors in tumour 
progression: an alliance against the epithelial phenotype?" Nat Rev Cancer 
7(6): 415-28. 
 66 
Perez-Moreno, M. A., A. Locascio, et al. (2001). "A new role for E12/E47 in the 
repression of E-cadherin expression and epithelial-mesenchymal transitions." 
J Biol Chem 276(29): 27424-31. 
Perris, R. and D. Perissinotto (2000). "Role of the extracellular matrix during neural 
crest cell migration." Mech Dev 95(1-2): 3-21. 
Pfeiffer, R. A. (1964). "[Dominant Hereditary Acrocephalosyndactylia.]." Z 
Kinderheilkd 90: 301-20. 
Pingault, V., N. Bondurand, et al. (1998). "SOX10 mutations in patients with 
Waardenburg-Hirschsprung disease." Nat Genet 18(2): 171-3. 
Polak, J. M., A. G. Pearse, et al. (1974). "Immunocytochemical confirmation of the 
neural crest origin of avian calcitonin-producing cells." Histochemistry 40(3): 
209-14. 
Potts, J. D., J. M. Dagle, et al. (1991). "Epithelial-mesenchymal transformation of 
embryonic cardiac endothelial cells is inhibited by a modified antisense 
oligodeoxynucleotide to transforming growth factor beta 3." Proc Natl Acad 
Sci U S A 88(4): 1516-20. 
Powers, J. F., M. J. Evinger, et al. (2007). "Pheochromocytomas in Nf1 knockout 
mice express a neural progenitor gene expression profile." Neuroscience 
147(4): 928-37. 
Pyeritz, R. E., E. A. Murphy, et al. (1979). "Clinical variability in the Marfan 
syndrome(s)." Birth Defects Orig Artic Ser 15(5B): 155-78. 
Raible, D. W. (2006). "Development of the neural crest: achieving specificity in 
regulatory pathways." Curr Opin Cell Biol 18(6): 698-703. 
 67 
Read, A. P. and V. E. Newton (1997). "Waardenburg syndrome." J Med Genet 34(8): 
656-65. 
Reardon, W., R. M. Winter, et al. (1994). "Mutations in the fibroblast growth factor 
receptor 2 gene cause Crouzon syndrome." Nat Genet 8(1): 98-103. 
Reilly, K. M. and T. Van Dyke (2008). "It takes a (dysfunctional) village to raise a 
tumor." Cell 135(3): 408-10. 
Rickmann, M., J. W. Fawcett, et al. (1985). "The migration of neural crest cells and 
the growth of motor axons through the rostral half of the chick somite." J 
Embryol Exp Morphol 90: 437-55. 
Robbins, J. R., P. G. McGuire, et al. (1999). "Diminished matrix metalloproteinase 2 
(MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: 
regulation of MMP-2 by PDGF and effects on mesenchymal cell migration." 
Dev Biol 212(2): 255-63. 
Rollhauser-ter Horst, J. (1979). "Artificial neural crest formation in amphibia." Anat 
Embryol (Berl) 157(1): 113-20. 
Rollhauser-ter Horst, J. (1980). "Neural crest replaced by gastrula ectoderm in 
amphibia. Effect on neurulation, CNS, gills and limbs." Anat Embryol (Berl) 
160(2): 203-11. 
Rutland, P., L. J. Pulleyn, et al. (1995). "Identical mutations in the FGFR2 gene cause 
both Pfeiffer and Crouzon syndrome phenotypes." Nat Genet 9(2): 173-6. 
Sadaghiani, B. and J. R. Vielkind (1990). "Distribution and migration pathways of 
HNK-1-immunoreactive neural crest cells in teleost fish embryos." 
Development 110(1): 197-209. 
 68 
Sakai, D., T. Suzuki, et al. (2006). "Cooperative action of Sox9, Snail2 and PKA 
signaling in early neural crest development." Development 133(7): 1323-33. 
Sanchez-Martin, M., A. Rodriguez-Garcia, et al. (2002). "SLUG (SNAI2) deletions in 
patients with Waardenburg disease." Hum Mol Genet 11(25): 3231-6. 
Satoda, M., F. Zhao, et al. (2000). "Mutations in TFAP2B cause Char syndrome, a 
familial form of patent ductus arteriosus." Nat Genet 25(1): 42-6. 
Sauka-Spengler, T. and M. Barembaum (2008). "Gain- and loss-of-function 
approaches in the chick embryo." Methods Cell Biol 87: 237-56. 
Sauka-Spengler, T. and M. Bronner-Fraser (2006). "Development and evolution of 
the migratory neural crest: a gene regulatory perspective." Curr Opin Genet 
Dev 16(4): 360-6. 
Sauka-Spengler, T. and M. Bronner-Fraser (2008). "A gene regulatory network 
orchestrates neural crest formation." Nat Rev Mol Cell Biol 9(7): 557-68. 
Sauka-Spengler, T. and M. Bronner-Fraser (2008). "Insights from a sea lamprey into 
the evolution of neural crest gene regulatory network." Biol Bull 214(3): 303-
14. 
Sauka-Spengler, T., D. Meulemans, et al. (2007). "Ancient evolutionary origin of the 
neural crest gene regulatory network." Dev Cell 13(3): 405-20. 
Schell, U., A. Hehr, et al. (1995). "Mutations in FGFR1 and FGFR2 cause familial 
and sporadic Pfeiffer syndrome." Hum Mol Genet 4(3): 323-8. 
Schorle, H., P. Meier, et al. (1996). "Transcription factor AP-2 essential for cranial 
closure and craniofacial development." Nature 381(6579): 235-8. 
 69 
Sela-Donenfeld, D. and C. Kalcheim (1999). "Regulation of the onset of neural crest 
migration by coordinated activity of BMP4 and Noggin in the dorsal neural 
tube." Development 126(21): 4749-62. 
Sela-Donenfeld, D. and C. Kalcheim (2000). "Inhibition of noggin expression in the 
dorsal neural tube by somitogenesis: a mechanism for coordinating the timing 
of neural crest emigration." Development 127(22): 4845-54. 
Selleck, M. A. and M. Bronner-Fraser (1995). "Origins of the avian neural crest: the 
role of neural plate-epidermal interactions." Development 121(2): 525-38. 
Selleck, M. A., M. I. Garcia-Castro, et al. (1998). "Effects of Shh and Noggin on 
neural crest formation demonstrate that BMP is required in the neural tube but 
not ectoderm." Development 125(24): 4919-30. 
Shows, K. H., C. Ward, et al. (2006). "Reduced TCOF1 mRNA level in a rhesus 
macaque with Treacher Collins-like syndrome: further evidence for 
haploinsufficiency of treacle as the cause of disease." Mamm Genome 17(2): 
168-77. 
Sieber-Blum, M. (1989). "Commitment of neural crest cells to the sensory neuron 
lineage." Science 243(4898): 1608-11. 
Sieber-Blum, M. and A. M. Cohen (1980). "Clonal analysis of quail neural crest cells: 
they are pluripotent and differentiate in vitro in the absence of noncrest cells." 
Dev Biol 80(1): 96-106. 
Sieber-Blum, M., M. Grim, et al. (2004). "Pluripotent neural crest stem cells in the 
adult hair follicle." Dev Dyn 231(2): 258-69. 
 70 
Sieber-Blum, M., L. Schnell, et al. (2006). "Characterization of epidermal neural crest 
stem cell (EPI-NCSC) grafts in the lesioned spinal cord." Mol Cell Neurosci 
32(1-2): 67-81. 
Smith, M. M. and B. K. Hall (1990). "Development and evolutionary origins of 
vertebrate skeletogenic and odontogenic tissues." Biol Rev Camb Philos Soc 
65(3): 277-373. 
Smith, S. H., R. G. Murray, et al. (1994). "The surface structure of Leptotrichia 
buccalis." Can J Microbiol 40(2): 90-8. 
Song, Y. S., H. J. Lee, et al. (2008). "Human neural crest stem cells transplanted in rat 
penile corpus cavernosum to repair erectile dysfunction." BJU Int 102(2): 
220-4; discussion 224. 
Southard-Smith, E. M., L. Kos, et al. (1998). "Sox10 mutation disrupts neural crest 
development in Dom Hirschsprung mouse model." Nat Genet 18(1): 60-4. 
Splendore, A., M. R. Passos-Bueno, et al. (2002). "TCOF1 mutations excluded from a 
role in other first and second branchial arch-related disorders." Am J Med 
Genet 111(3): 324-7. 
Sponseller, P. D., W. Hobbs, et al. (1995). "The thoracolumbar spine in Marfan 
syndrome." J Bone Joint Surg Am 77(6): 867-76. 
Spritz, R. A., P. W. Chiang, et al. (2003). "Human and mouse disorders of 
pigmentation." Curr Opin Genet Dev 13(3): 284-9. 
Stemple, D. L. and D. J. Anderson (1992). "Isolation of a stem cell for neurons and 
glia from the mammalian neural crest." Cell 71(6): 973-85. 
 71 
Strong, W. B. (1968). "Familial syndrome of right-sided aortic arch, mental 
deficiency, and facial dysmorphism." J Pediatr 73(6): 882-8. 
Taneyhill, L. A., E. G. Coles, et al. (2007). "Snail2 directly represses cadherin6B 
during epithelial-to-mesenchymal transitions of the neural crest." 
Development 134(8): 1481-90. 
Teng, L., N. A. Mundell, et al. (2008). "Requirement for Foxd3 in the maintenance of 
neural crest progenitors." Development 135(9): 1615-24. 
Theveneau, E., J. L. Duband, et al. (2007). "Ets-1 confers cranial features on neural 
crest delamination." PLoS ONE 2(11): e1142. 
Thiery, J. P. and J. P. Sleeman (2006). "Complex networks orchestrate epithelial-
mesenchymal transitions." Nat Rev Mol Cell Biol 7(2): 131-42. 
Tischler, A. S. (2008). "Pheochromocytoma and extra-adrenal paraganglioma: 
updates." Arch Pathol Lab Med 132(8): 1272-84. 
Tischler, A. S., N. Kimura, et al. (2006). "Pathology of pheochromocytoma and extra-
adrenal paraganglioma." Ann N Y Acad Sci 1073: 557-70. 
Tischler, A. S., T. S. Shih, et al. (1995). "Characterization of Pheochromocytomas in 
a Mouse Strain with a Targeted Disruptive Mutation of the Neurofibromatosis 
Gene Nf1." Endocr Pathol 6(4): 323-335. 
Tobin, J. L., M. Di Franco, et al. (2008). "Inhibition of neural crest migration 
underlies craniofacial dysmorphology and Hirschsprung's disease in Bardet-
Biedl syndrome." Proc Natl Acad Sci U S A 105(18): 6714-9. 
 72 
Trentin, A., C. Glavieux-Pardanaud, et al. (2004). "Self-renewal capacity is a 
widespread property of various types of neural crest precursor cells." Proc 
Natl Acad Sci U S A 101(13): 4495-500. 
Tucker, R. P. and C. A. Erickson (1984). "Morphology and behavior of quail neural 
crest cells in artificial three-dimensional extracellular matrices." Dev Biol 
104(2): 390-405. 
Unsicker, K. (1993). "The chromaffin cell: paradigm in cell, developmental and 
growth factor biology." J Anat 183 ( Pt 2): 207-21. 
Unsicker, K., K. Huber, et al. (2005). "The chromaffin cell and its development." 
Neurochem Res 30(6-7): 921-5. 
Van de Putte, T., A. Francis, et al. (2007). "Neural crest-specific removal of Zfhx1b 
in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-
Wilson syndrome." Hum Mol Genet 16(12): 1423-36. 
Van de Putte, T., M. Maruhashi, et al. (2003). "Mice lacking ZFHX1B, the gene that 
codes for Smad-interacting protein-1, reveal a role for multiple neural crest 
cell defects in the etiology of Hirschsprung disease-mental retardation 
syndrome." Am J Hum Genet 72(2): 465-70. 
Waardenburg, P. J. (1951). "A new syndrome combining developmental anomalies of 
the eyelids, eyebrows and nose root with pigmentary defects of the iris and 
head hair and with congenital deafness." Am J Hum Genet 3(3): 195-253. 
Wadham, C., J. R. Gamble, et al. (2003). "The protein tyrosine phosphatase Pez is a 
major phosphatase of adherens junctions and dephosphorylates beta-catenin." 
Mol Biol Cell 14(6): 2520-9. 
 73 
Wagner, T., J. Wirth, et al. (1994). "Autosomal sex reversal and campomelic 
dysplasia are caused by mutations in and around the SRY-related gene 
SOX9." Cell 79(6): 1111-20. 
Wakamatsu, N., Y. Yamada, et al. (2001). "Mutations in SIP1, encoding Smad 
interacting protein-1, cause a form of Hirschsprung disease." Nat Genet 27(4): 
369-70. 
Wang, R., M. L. Martinez-Frias, et al. (2002). "Infants of diabetic mothers are at 
increased risk for the oculo-auriculo-vertebral sequence: A case-based and 
case-control approach." J Pediatr 141(5): 611-7. 
Wang, Y., R. Xiao, et al. (2005). "Abnormalities in cartilage and bone development 
in the Apert syndrome FGFR2(+/S252W) mouse." Development 132(15): 
3537-48. 
Weston, J. A. (1963). "A radioautographic analysis of the migration and localization 
of trunk neural crest cells in the chick." Dev Biol 6: 279-310. 
Wilkie, A. O., S. F. Slaney, et al. (1995). "Apert syndrome results from localized 
mutations of FGFR2 and is allelic with Crouzon syndrome." Nat Genet 9(2): 
165-72. 
Williams, E. D. (1966). "Diarrhoea and thyroid carcinoma." Proc R Soc Med 59(7): 
602-3. 
Williams, E. D. (1966). "Histogenesis of medullary carcinoma of the thyroid." J Clin 
Pathol 19(2): 114-8. 
Williams, E. D., C. E. Toyn, et al. (1989). "The ultimobranchial gland and congenital 
thyroid abnormalities in man." J Pathol 159(2): 135-41. 
 74 
Wilson, D. I., I. E. Cross, et al. (1991). "DiGeorge syndrome with isolated aortic 
coarctation and isolated ventricular septal defect in three sibs with a 22q11 
deletion of maternal origin." Br Heart J 66(4): 308-12. 
Wong, D. L. (2003). "Why is the adrenal adrenergic?" Endocr Pathol 14(1): 25-36. 
Wyatt, L., C. Wadham, et al. (2007). "The protein tyrosine phosphatase Pez regulates 
TGFbeta, epithelial-mesenchymal transition, and organ development." J Cell 
Biol 178(7): 1223-35. 
Yagi, H., Y. Furutani, et al. (2003). "Role of TBX1 in human del22q11.2 syndrome." 
Lancet 362(9393): 1366-73. 
Yan, Y. L., C. T. Miller, et al. (2002). "A zebrafish sox9 gene required for cartilage 
morphogenesis." Development 129(21): 5065-79. 
Youn, Y. H., J. Feng, et al. (2003). "Neural crest stem cell and cardiac endothelium 
defects in the TrkC null mouse." Mol Cell Neurosci 24(1): 160-70. 
Zhang, J., S. Hagopian-Donaldson, et al. (1996). "Neural tube, skeletal and body wall 
defects in mice lacking transcription factor AP-2." Nature 381(6579): 238-41. 
Zito, G., P. Richiusa, et al. (2008). "In vitro identification and characterization of 
CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines." 
PLoS ONE 3(10): e3544. 
Zweier, C., B. Albrecht, et al. (2002). ""Mowat-Wilson" syndrome with and without 
Hirschsprung disease is a distinct, recognizable multiple congenital 
anomalies-mental retardation syndrome caused by mutations in the zinc finger 
homeo box 1B gene." Am J Med Genet 108(3): 177-81. 
 
 75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter II: Discovery of transcription factors and 
other candidate regulators of neural crest 
development 
 
This chapter has been published as Discovery of transcription factors and other 
candidate regulators of neural crest development. Adams MS, Gammill LS, 
Bronner-Fraser M. Dev Dyn. 2008 Apr; 237(4):1021–33. 
 
 
 
 
 
 
 
 76 
 
2.1: Abstract 
Neural crest cells migrate long distances and form divergent derivatives in vertebrate 
embryos. Despite previous efforts to identify genes upregulated in neural crest 
populations, transcription factors have proved to be elusive due to relatively low 
expression levels and often transient expression. We screened newly induced neural 
crest cells for early target genes with the aim of identifying transcriptional regulators 
and other developmentally important genes. This yielded numerous candidate 
regulators, including fourteen transcription factors, many of which were not 
previously associated with neural crest development. Quantitative real-time PCR 
confirmed upregulation of several transcription factors in newly induced neural crest 
populations in vitro.  In a secondary screen by in situ hybridization, we verified the 
expression of >100 genes in the neural crest.  We note that several of the transcription 
factors and other genes from the screen are expressed in other migratory cell 
populations and have been implicated in diverse forms of cancer. 
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2.2: Introduction 
The neural crest is a cell population that forms at the border between the neural and 
non-neural ectoderm of vertebrate embryos.  As the neural folds elevate, cells induced 
to become neural crest cells become incorporated into the dorsal neural tube, and 
subsequently undergo an epithelial to mesenchymal transition and depart from the 
future central nervous system.  These multipotent precursors then migrate along 
prescribed and stereotypic pathways to defined and diverse sites in the periphery.  
Upon completion of migration, they differentiate into a wide variety of derivatives 
including melanocytes, peripheral neurons and glia, adrenomedullary cells, and much 
of the bone and cartilage of the face (Knecht and Bronner-Fraser 2002; Le Douarin, 
Brito et al. 2007).  As a population, the neural crest is of widespread interest because 
of its plasticity, mobility, and contribution to developmental disorders and cancers.  
 
Previous work in a number of species, including mice, chick, frogs and zebrafish, has 
implicated a set of transcriptional regulators in conferring neural crest identity.  This 
set of genes, termed neural crest specifier genes (Meulemans and Bronner-Fraser 
2004), include Sox9, Sox10, FoxD3, Snail2/Slug, c-Myc and AP2 (Spokony, Aoki et 
al. 2002;  Honore, Aybar et al. 2003; Sasai, Mizuseki et al. 2001; Aoki, Saint-
Germain et al. 2003; Luo, Lee et al. 2003; Bellmeyer, Krase et al. 2003). These 
transcription factors are expressed in premigratory and/or early migrating neural crest 
cells and thought to be involved in induction and survival of the premigratory 
population, their epithelial to mesenchymal transition from the neural tube, migratory 
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ability, and cell lineage decisions (Anderson 1994; Cheung, Chaboissier et al. 2005).  
However, it seems unlikely that these complicated processes would be controlled by 
the relatively few transcription factors identified to date in newly formed neural crest 
cells.   
 
In a genomic analysis previously performed in our lab, a large number of genes were 
identified as upregulated in premigratory and migratory neural crest (Gammill and 
Bronner-Fraser 2002).  However, this yielded only two transcription factors that had 
not been previously associated with the neural crest. Because transcription factors are 
essential for understanding proximal portions of the gene cascades that regulate 
neural crest migration and differentiation, it is critical to identify the complete 
repertoire of genes in order to build testable gene regulatory networks (Davidson 
2006; Ben-Tabou de-Leon and Davidson 2007).  Data from various organisms have 
led to the formulation of putative gene regulatory networks in different organisms 
(Mayor, Morgan et al. 1995; Mayor and Aybar 2001; Meulemans and Bronner-Fraser 
2004; Steventon, Carmona-Fontaine et al. 2005). Further work in identifying the 
function of transcription factors and downstream genes will help refine and expand 
upon these networks.  In turn, this work may give new insight into related gene 
circuits that may be operative in other migratory and metastatic cell types.   
 
To identify putative neural crest transcription factors, we completed a subtractive 
screen for newly induced neural crest cells using a macroarrayed cDNA library from 
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early chick embryos.  This allowed identification of over 200 genes, many of which 
were not previously associated with neural crest development. As a secondary screen, 
we performed in situ hybridization to verify expression of 101 genes in premigratory 
and/or migrating neural crest cells.  Quantitative PCR (QPCR) was used to confirm 
the level of upregulation of several transcription factors in newly induced neural crest 
cells.  The results reveal many previously unknown transcriptional regulators in the 
neural crest and suggest interesting commonalities between neural crest cells, various 
metastatic cancers and other migratory cell types.   
 
2.3: Materials and methods 
Embryos and Explants 
Fertile chicken eggs were incubated from 24 hours to three days to obtain 
embryos from HH stage 4 to HH stage 24.  Embryos to be used for in situ 
hybridization were fixed overnight in 4% paraformaldehyde (PFA) at 4°C. They were 
then washed 4 x 5 minutes in PTW and dehydrated in a MeOH/PTW series at RT 
before being stored at –20°C in 100% MeOH for more than 3 days.  Explants were 
dissected from embryos in Ca2+/Mg2+-free Tyrodes saline with .05% trypsin 
(Sigma). Conjugates were assembled and allowed to recover as previously described 
before embedding in collagen gels and culturing for 24 hours (Dickinson, Selleck et 
al. 1995; Gammill and Bronner-Fraser 2002). 
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RNA preparation and QPCR 
RNA was prepared from tissues in collagen gels using Stratagene’s RNA isolation 
kit.  Collagen gels were transferred to an Eppendorf microcentrifuge tube with 
forceps and triturated in lysis buffer.  
 
Quantitative polymerase chain reaction  (QPCR) was performed using the 96 well 
plate ABI 7000 QPCR machine in a TaqMan assay (Applied Biosciences) with 
Sybrgreen Itaq Supermix with ROX (BioRad), 300 nM of each primer, and 200-500 
ng of cDNA in a 25 µL reaction volume. Gene specific primers were designed using 
the Primer Express program (Applied Biosystems) and synthesized by IDT.  
 
During the exponential phase of the QPCR reaction a threshold and baseline was set 
according to the protocols of Applied Biosystems.  The threshold cycle (CT) is 
defined as the cycle number at which the fluorescence generated by a reaction meets 
this threshold and is critical in determining the amount of the amplicon produced in 
the RT-QPCR reaction. The results for different samples were then interpolated on a 
line created by running standard curves for each primer set and then normalized 
against the results for a housekeeping gene, which is assumed to be a measure of the 
amount of cDNA used in each reaction.  These calculations were performed 
according to the standard curve assay method, which is detailed in the Applied 
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Biosystems protocols. Each reaction plate was run with five point standard curves 
(three replicates each) for the gene of interest (GOI) and the chosen housekeeping 
gene, 18s. Each plate also held three non-template controls (in which no amplification 
was seen) for each set of primers. Standards are always run on the same plate as the 
unknown samples in order to ensure the validity of CT measurements. 
QPCR primer sequences were as follows:  
slug forward 5’-GGGCTGCTACCGTCTCCTCTA-3’ 
slug reverse 5’-GCTGACCCTTCCCAAAGATG-3’ 
gcnf forward 5'-TTCCCCCAAGATGTCATTGAC-3' 
gcnf reverse 5'-TGATGGCTGCAATGCAGAAG-3' 
elk-3 forward 5'-CAGCCCCACCTTTGGTTCTT-3' 
elk-3 reverse 5'-TGAGGGCAATGGAACCGATA-3' 
zf469 forward 5'-CCAGCTCCAAAGAAGCAACAA-3' 
zf469 reverse 5'-TGCCGAGAAGAGTCCAAAGTG-3' 
srebp2 forward 5'-GATCACAGGCTGGCTTCTCC-3' 
srebp2 reverse 5'-GGCTTCCTGGCTCTGAATCA-3' 
gtfIIe forward 5'-CCAAGTATGTCGTGCGTGGT-3' 
gtfIIe reverse 5'-CCAGAGCCAAAGCGTGTTC-3' 
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In Situ Hybridization 
Antisense, digoxygenin labeled RNA probes were prepared from clones categorized 
as being upregulated by the macroarray screen.  The probes were hydrolyzed and in 
situs were performed as described (Xu 1992). Embryos were visually examined at 
different angles to aid in scoring and photographed on a Zeiss Axioskop2 Plus. 
Selected embryos were then coarsely sectioned using a scalpel or finely sectioned 
using a cryostat (Bright) and mounted or immunostained. 
 
Immunostaining 
Wholemount in situs were post-fixed in 4% PFA (paraformaldehyde) + 0.02% 
glutaraldehyde and washed in PTW 4x15 minutes. They were nutated at 4°C 
overnight in 15% sucrose, kept for 8 hours at 37°C in 7.5% gelatin/15% sucrose and 
between 8 and 20 hours in 20% gelatin. The embryos were then embedded, frozen 
and cryosectioned at approximately 25 µM.  Sections were briefly dried onto slides 
and degelatinized for 20 minutes at 42°C in PBS. They were then placed in PBS 
(phosphate buffered saline) + 0.1% Tween 20 + 5% goat serum block for hours at 
room temperature before an overnight 4°C incubation with 1:20 anti-HNK-1 antibody 
(American Type Culture Collection hybridoma).  Sections were then washed several 
times in PBS + 0.1% Tween over several hours, blocked for 3 hours at RT with PTW 
(phosphate-buffered saline [PBS], pH 7.5, 0.1% Tween 20) and 5% goat serum, and 
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incubated with 1:400 anti-IgM RRX goat anti mouse (Jackson ImmunoResearch) in 
PTW at 4°C overnight. Slides were then washed again in PTW several times, rinsed 
twice in dH20 and then coverslipped using PermaFluor (Immunotech). 
 
 
2.4: Results and discussion 
 
In order to identify novel neural crest regulators, we performed a genome-level screen 
for genes upregulated in newly induced neural crest cells.  Neural crest induction was 
recapitulated in vitro by culturing intermediate neural plate and non-neural ectoderm 
in apposition (Dickinson, Selleck et al. 1995; Selleck and Bronner-Fraser 1996; 
Gammill and Bronner-Fraser 2002). cDNA enriched for neural crest genes was 
generated by subtracting intermediate neural plate and non-neural ectoderm cultured 
in isolation from tissue cultured as conjugates, and a macroarrayed early chick cDNA 
library screened as previously described (Gammill and Bronner-Fraser 2002). 
 
In this paper, we now describe the completion of the neural crest screen.  We 
previously reported the early results from this screen and the identification of only 
three transcription factors, including snail-2 (slug) (Gammill and Bronner-Fraser 
2002).  We and others went on to demonstrate the functional importance of candidate 
neural crest regulators from the screen, validating its relevance for neural crest 
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development (Gammill, Gonzalez et al. 2006; Coles, Gammill et al. 2006; Gessert, 
Maurus et al. 2007; Taneyhill, Coles et al. 2007; Eroglu, Wang et al. 2006; Suzuki, 
Sakai et al. 2006) (the unknown from Gammill and Bronner-Fraser, 2002 was 
ultimately identified as cadherin-6b).  In characterizing additional clones, we were 
particularly interested in identifying new transcription factors expressed in the neural 
crest.  We reasoned that because transcription factors are generally the least abundant 
transcripts, they would be represented with the fewest clones in the arrayed library 
and would exhibit the weakest hybridization signals since they would have the lowest 
copy number in the hybridized cDNA.  It seemed highly probable, therefore, that by 
picking all upregulated clones, not just the most obvious, that we should increase the 
number of transcription factors in our collection.  As we previously performed only a 
sampling of upregulated clones (Gammill and Bronner-Fraser 2002), here we 
comprehensively analyzed all genes with a two-fold or greater hybridization signal 
from the subtracted probe compared to the unsubtracted probe.  It is important to 
appreciate that this differential hybridization signal is not a direct measure of gene 
expression levels, rather it reflects the efficiency of subtraction for that gene, which is 
determined by a variety of factors including differential expression levels, sequence 
polymorphism, and non-specific loss.  Clones meeting this two-fold criterion were 
picked, sequenced, and compared to the Genbank non-redundant database and the GO 
ontology database. This resulted in the identification of 223 new candidate neural 
crest genes that fell into logical functional categories.  
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To independently confirm the specificity of our results, in situ hybridization analysis 
was performed at multiple stages of neural crest development on 112 of the identified 
genes from the most functionally interesting categories: chromatin, cytoskeletal, 
ECM, mitochondria, mitosis/cell cycle, nucleocytoplasmic export, protein production 
and degradation, receptors or downstream signaling molecules, rho pathway genes, 
RNA binding proteins, secreted signals or signal production, transcription coupled 
processes, transcription factors,  transporters, and unknown genes (Figures 1–6). This 
provided the additional advantage of revealing dynamic aspects of gene expression 
patterns over the course of neural crest development.  In this way, we confirmed that 
101 of 112 genes were strongly expressed in premigratory neural crest cells in the 
neural folds and/or in migrating neural crest relative to neighboring tissues.  These 
clones were kept as verified candidate neural crest regulators (Table 1).  
 
Transcription factors:   
By completing the screen, we identified several additional transcription factors 
expressed in the neural crest.  These include:  Ccar1, CTCF, Elk-3, GCNF, GTFIIE, 
ILF2, ILF3, PhD, SRF, SREBP2, Similar to Tcf20/AR1/SPBP, WHSC1L1, ZFP3, and 
ZFP469. All of the genes were expressed in premigratory neural crest cells within the 
neural folds and/or migrating neural crest cells moving through the periphery. 
 
We verified the upregulation of a subset of transcription factors by quantitative 
polymerase chain reaction (QPCR).  Intermediate neural plate and non-neural 
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ectoderm were dissected and cultured as isolates or as conjugates in exactly the same 
manner as the subtracted probe was generated.   We then quantitated the expression 
level of known (Snail2/Slug) and novel (identified in our screen) transcription factors 
in isolates and conjugates.  The QPCR results showed that Snail2/Slug levels in the 
conjugated tissues consistently were upregulated by 5-7 fold (5.998 + 0.642 s.d. in 
conjugates compared with 0.775 + 0.059 s.d. in isolates, p=0.00015 by Student’s t test 
for our samples) (Fig.2). Most of the transcription factors identified in our screen 
were upregulated approximately two-fold in the conjugates by QPCR (Figs. 2-6, 
Table 2).  These levels were reproducible across replicates and experiments.  This 
minimal induction likely reflects a variety of factors.  Some genes may be expressed 
at low levels in isolates, and were upregulated relative to background levels in 
conjugates.  Other genes may not have reached maximal expression levels at the 
endpoint of the assay, which represented premigratory crest (Dickinson, Selleck et al. 
1995), and so the difference by QPCR likely appeared less dramatic than by in situ 
(for example in the case of Elk-3, Fig.3).  Moreover, in all cases the conjugates 
contained neural and ectodermal cells in addition to newly induced neural crest cells, 
which will have diluted the neural crest signal.  In sum, these results confirm that the 
transcription factors identified in the screen were upregulated in conjugates, and 
illustrate the advantages of the spatial and temporal information available when 
screening clones by in situ hybridization. 
 
Two of the transcription factors, Elk-3 (Fig.3) and Serum Response Factor (SRF), 
were expressed in migrating neural crest cells but absent from the premigratory neural 
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crest. Elk-3 (also known as Sap-2, ERP and Net) is a member of the ternary complex 
factor (TCF) subfamily of the Ets transcription factors.  With the exception of 
migrating neural crest cells and some cranial mesenchyme, Elk-3 mRNA was not 
observed in other tissues at the developmental stages examined.  Mice with a 
homozygous mutation resulting in the deletion of the DNA binding domain in Elk-3 
have defects in both vasculature and wound healing (Ayadi, Zheng et al. 2001). Elk-3 
has further been shown to act as a repressor of PAI-1 to allow cellular migration 
(Buchwalter, Gross et al. 2005). The pattern of SRF is similar to that of Elk-3.  SRF 
regulates the expression of cytoskeletal genes and is required for neuronal migration 
in the mouse forebrain (Alberti, Krause et al. 2005). When examined closely, SRF 
deficient murine ES cells display impaired migration, adhesion and cell spreading 
(Schratt, Philippar et al. 2002), consistent with an important role in cell movement.  
 
The majority of transcription factors identified in our screen were expressed in both 
premigratory and migratory neural crest cells. Several appear to be transcriptional 
activators (TCF20, GTFIIH and SREBP2), or of unknown function (ZFP3, ZFP469). 
TCF20 (AR1, SPBP) is a nuclear factor that can enhance the transcriptional activity of 
various transcription factors, such as c-Jun, Ets, Sp1, and Pax6, which suggests that 
TCF20 is a transcriptional activator.  It probably acts as a coactivator for structurally 
and functionally disparate transcription factors binding to target sequences in 
promoters or enhancers (Rekdal, Sjottem et al. 2000). Germ cell nuclear factor 
(GCNF, NR6A1) (Fig.4) is a nuclear orphan receptor that was first described in the 
mouse testis. GCNF is expressed in the neural plate and the neural crest of Xenopus 
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midneurula embryos, with later expression in the central nervous system and 
branchial arches (Joos, David et al. 1996). When GCNF is depleted from the Xenopus 
embryo using a morpholino, there is improper formation of the neural tube as well as 
defective differentiation in the head (Barreto, Reintsch et al. 2003). GTFIIE (Fig.5) is 
the alpha subunit (56kDa) of general transcription factor IIE is a part of a tetramer 
that is required to recruit TFIIH and in the opening of an RNA polymerase II 
promoter (Holstege, van der Vliet et al. 1996). SREBP2 (Fig.6) is a member of a 
family of basic-helix-loop-helix-leucine zipper (bHLH-ZIP) transcription factors that 
recognize sterol regulatory element 1 (SRE-1) (Hua, Yokoyama et al. 1993). Little is 
known about PhD finger protein 12 except that it can bind DNA and is shown by GO 
gene ontology to have transcription factor activity.  Similarly, ZFP3 and ZFP469 are 
zinc-finger transcription factors about which not much is known.  
 
Intriguingly, many of the transcription factors identified in our screen also are 
abnormally regulated in cancer cells.  This is not surprising since many of the 
characteristics of a neural crest cell – motility, the ability to undergo an epithelial to 
mesenchymal transition, the ability to break through the basal lamina and form many 
derivatives – are also features of cancer cells. Genes found in both neural crest and 
associated with tumorigenesis include Ccar1, CTCF, ILF2 and WHSC1L1.  For 
example, Cell Cycle and Apoptosis Regulatory Protein-1 (Ccar1 or Carp1) was first 
identified by a yeast two hybrid screen and found to interact with DED caspases 
(McDonald and El-Deiry 2004). It mediates apoptosis signaling by CD437, a retinoid 
that causes cell cycle arrest and apoptosis in a number of cancer cells including HBC 
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(human breast carcinoma) by utilizing an undefined retinoic acid receptor/retinoid X 
receptor-independent mechanism. Reduced levels of Ccar1 result in inhibition of 
apoptosis by CD437 or adriamycin, whereas increased expression of Ccar1 causes 
elevated levels of cyclin-dependent kinase inhibitor p21WAF1/CIP1 and apoptosis 
(Rishi, Zhang et al. 2006). CTCF is an evolutionarily conserved zinc finger 
containing transcription factor and insulator binding protein that was originally 
identified and characterized as a transcriptional repressor of the c-Myc oncogene. It 
has been shown to regulate transcriptional activation as well as repression, and in 
addition is involved in cell-cycle regulation, apoptosis and cell differentiation 
(Pugacheva, Kwon et al. 2006; Ladomery and Dellaire 2002).  In Xenopus, CTCF 
was shown to have strong expression in the neural tube and developing brain as well 
as later expression in the branchial arches (Burke, Hollemann et al. 2002). Mutations 
of CTCF have been identified in Wilm’s tumors, as well as in breast and prostate 
cancers (Pugacheva, Kwon et al. 2006) (Ladomery and Dellaire 2002). ILF2 (NF45) 
associates with ILF3 (NF90) in the nucleus to regulate IL-2 gene transcription (Zhao, 
Shi et al. 2005) (Reichman, Muniz et al. 2002). Both of these proteins are widely 
expressed in normal tissues and are seen at higher levels in the brain (Zhao, Shi et al. 
2005) (Buaas, Lee et al. 1999). ILF2 is increased in lymphoma, leukemia, and 
hepatocellular carcinoma cell lines while ILF3 expression is increased in 
nasopharyngeal carcinomas, suggestive of a role in cell proliferation and the cell 
cycle (Zhao, Shi et al. 2005). WHSC1L1 (Wolf-Hirschhorn syndrome candidate 1 like 
1) is another gene that is frequently rearranged in cancers, including breast cancer. 
WHSC1L1 is closely related to WHSC1, a disorder in which patients display a 
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craniofacial defect known as ‘Greek helmet face’ (Bergemann, Cole et al. 2005).  It 
had previously been suggested that this gene may be involved in embryonic 
development as well as cancers (Stec, van Ommen et al. 2001), and our identification 
of the gene in the neural crest is consistent with a possible role in craniofacial 
development.   
 
 
Other genes implicated in metastasis: 
In addition to the transcription factors we identified, several genes in other categories 
that are likely to be downstream targets also have been associated with various types 
of cancer.  Of these Lactate dehydrogenase A, Septin 9, and Cathepsin B were 
observed in premigratory but not in migrating neural crest cells. LDHA (lactate 
dehydrogenase A) was originally shown to be required for cell transformation by c-
Myc (Hirota, Katsumata et al. 1990; Lewis, Prescott et al. 2000). Additionally, 
injection of cells co-expressing both LDHA and Rcl are able to form tumors in nude 
mice in a similar manner to c-Myc expressing cells, suggesting that these genes are 
downstream of c-Myc (although neither Rcl or LDHA overexpression alone induces 
tumorigenesis) (Lewis, Prescott et al. 2000).  Similarly, Septin 9 (Sept9, Sint1, Septin 
D1, MSF, MLL septin-like fusion) was originally described as a fusion partner gene of 
MLL in acute myeloid leukemia and maps to a region commonly affected in breast 
and ovarian cancers. The septin gene is a member of a family of nucleotide-binding 
proteins first discovered in yeast due to their role in the cell division cycle. Consistent 
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with our findings, Sept9 expression has been reported in murine neural crest cells 
(Sorensen, Warming et al. 2002). Cathepsin B is a lysosomal cysteine proteinase 
involved in the effectiveness of invasive and metastatic cancers (Szpaderska and 
Frankfater 2001) and cells appear to have differential abilities to migrate invasively 
based on cathepsin B expression both in vitro and in vivo (Szpaderska and Frankfater 
2001; Lakka, Gondi et al. 2004). Direct injections into tumor-containing animals of 
plasmids containing cathepsin B inhibited gliomal tumor growth and regressed pre-
established tumor cells (Lakka, Gondi et al. 2004).  
 
Our screen revealed that the Neurofibromatosis 2 (NF2) gene, implicated in tumor 
production, is upregulated by neural crest induction. NF2 was previously shown to be 
expressed throughout development in the neural tube as well as in migrating neural 
crest cells and their derivatives (Akhmametyeva, Mihaylova et al. 2006). The NF2 
gene encodes the protein merlin, which is a member of the ezrin, radaxin, and moesin 
(ERM) family of membrane-cytoskeleton associated proteins. It is thought to have 
roles in cell adhesion, motility, and proliferation during development. Mutations in 
NF2 result in a predisposition to schwannomas, tumors of a neural crest origin. 
Familial schwannomas and meningiomas contain mutations that result in truncations 
of NF2. NF2 homozygous mutants are lethal at an early stage.  However, conditional 
mutants targeted to Schwann and neural crest cells recapitulate the types of tumors 
seen in humans (Giovannini, Robanus-Maandag et al. 2000).  
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Two different type IV collagens, col4a5 and col4a6, were expressed by migratory 
neural crest and also have been implicated in malignant cell types. There are six 
collagen IV molecules that are arranged in a paired head-to-head fashion on three 
different chromosomes. Col4a5 and Col4a6 are the pair located on chromosome X 
and are found in patients with Alport syndrome associated with diffuse 
leiomyomatosis.  
 
Other genes found in our screen, including PGK (Fig.1), EWS, and HEPH, have 
transcripts that are expressed in both the premigratory and migratory neural crest cells 
and associated with various types of cancers. Phosphoglycerate kinase (PGK) is a 
glycolytic enzyme that catalyzes the reversible conversion of 1,3-diphosphoglycerate 
to 3-phosphoglycerate. It also is secreted by mouse fibrosarcoma tumor cells, and 
may participate in angiogenesis (Lay, Jiang et al. 2000). EWS is a member of the 
TET family (TLS/FUS, EWS, TAFII68) that occurs in a translocation breakpoint 
associated with Ewing’s sarcoma, a primitive neuroectodermal tumor.  The 
translocation generates a fusion with FLI-1, a member of the ETS family of 
transcription factors, and the fusion can function as a transcription factor (Ladomery 
and Dellaire 2002). HEPH is involved in iron transport and shows altered expression 
in human colorectal carcinogenesis, resulting in increased intracellular iron that may 
induce proliferation and repress cell adhesion (Brookes, Hughes et al. 2006). Wound 
healing assays have long been used to look for cell migration defects. We found 
several genes in addition to those already described above as associated with wound 
healing and cell migration.  
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Genes involved in wound healing and cell migration: 
Col1a2 and Von Willebrand factor type A and cache domain containing 1 genes were 
expressed in the premigratory but not the migratory neural crest. Col1a2 is a major 
collagen subunit that plays a role in neural crest cell migration and may regulate 
cellular differentiation (He, Feng et al. 2005). In mouse, it is expressed in the head 
folds at e8.5-9.0. In adult tissues, it is upregulated in response to wounding, indicating 
that it may be involved in cell migration (Ponticos, Abraham et al. 2004). Col1a2 also 
seems to mediate the adhesion and migration of germ cells during spermatogenesis in 
the mouse (He, Feng et al. 2005). Von Willebrand factor type A and cache domain 
containing 1 (VWCD1) is likely to be a voltage gated calcium channel or an ECM 
protein; genes containing similar domains participate in cell adhesion, migration, 
homing, pattern formation, and signal transduction (Colombatti, Bonaldo et al. 1993).  
 
Paxillin, periplakin, and G-protein coupled receptor GPR144 are genes associated 
with wound healing and cell migration.  They were distributed in the migrating neural 
crest but absent from premigratory neural crest. Paxillin expression was previously 
described in migrating mouse neural crest cells and derivatives such as dorsal root 
and trigeminal ganglia, and branchial arches. Loss of paxillin led to a decrease in 
focal adhesions and lamellipodia (Hagel, George et al. 2002). In Drosophila, 
overexpression of paxillin results in a “blistered wing” phenotype considered 
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characteristic of changes in cell adhesion. Paxillin also plays a role in the developing 
Drosophila eye (Chen, Turano et al. 2005). Plakins are proteins that make contact 
with intermediate filaments (Aho, McLean et al. 1998).  Periplakin, a member of this 
family, localizes to the plasma membrane and is believed to play a major role in cell-
cell adhesion (Nishimori, Tomonaga et al. 2006). Plakins were shown by Aho et al. to 
be well expressed in the brain (Aho, McLean et al. 1998). G-protein coupled receptor 
GPR144 is a membrane bound adhesion protein with a GPS domain in the N-terminal 
region as well as a pentraxin domain (Bjarnadottir, Fredriksson et al. 2004).  Its 
developmental role is as yet unexplored. 
 
Other genes previously implicated in wound healing and migration include TPM-γ, 
TRIO, MACF/ACF7, nonerythroid α-spectrin, PTK9L.  Their mRNA transcripts were 
present in premigratory and migratory neural crest cells. Tropomyosins such as TPM-
γ are components of the microfilament cytoskeleton that bind to the helical groove of 
the actin filament. Several tropomyosin isoforms have been shown to regulate cell 
contractility, morphology, migration and the organization of the cytoskeleton (Bryce, 
Schevzov et al. 2003). TRIO is a guanine nucleotide exchange factor (GEF) that 
functions in the activation of Rho GTPases such as RhoA, Rac1, and Cdc42 (Medley, 
Buchbinder et al. 2003). It is essential for embryonic development and for the 
development of neural tissue in mouse (O'Brien, Seipel et al. 2000). Furthermore, the 
TRIO-like unc-73 gene is essential for cell migration and axon guidance in C. elegans 
(Steven, Kubiseski et al. 1998). MACF/ACF7 is from the family of cytoskeletal 
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linkers and is the vertebrate homolog of Drosophila Shortstop/Kakapo. It binds both 
to microtubules through its GAR and GSR-repeat domains and to actin (Leung, Liem 
et al. 2001). In MACF-null cells, microtubules are destabilized and microtubule 
tracking along actin cables is perturbed (Kodama, Karakesisoglou et al. 2003). It was 
previously shown to be expressed in the spinal cord and brain of the developing 
mouse as well as neural crest derivatives such as the dorsal root ganglia (Leung, Sun 
et al. 1999). Our data confirm that MACF1 is also expressed in the premigratory and 
migratory neural crest of chickens. Spectrins, including nonerythroid α-spectrin, are 
members of the cytoskeletal proteins that cross-link actin filaments or link actin to the 
cell membrane (Djinovic-Carugo, Gautel et al. 2002). Anti-spectrin antibodies lead to 
the collapse of the intermediate filament network in cultured cells. Furthermore, 
depletion of alpha-spectrin in Drosophila results in the loss of cell-cell contact (Lee, 
Coyne et al. 1993). Very little is known about PTK9L (protein tyrosine kinase 9-like 
or A6RP), but preliminary immunolocalization studies have previously indicated that 
it might be involved in focal adhesions (Rohwer, Kittstein et al. 1999). 
  
Genes associated with human craniofacial and other birth abnormalities:  
Because it contributes to such a diversity of structures, the neural crest has been 
implicated in many birth abnormalities, including those that involve craniofacial 
malformations, intestinal innervation defects, and malformations of the cardiac 
system (Chai and Maxson 2006; Iwashita, Kruger et al. 2003) (Wurdak, Ittner et al. 
2005).  Several of the identified genes from this screen have been associated with 
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birth abnormalities that are reminiscent of alterations in the normal course of neural 
crest cell development.  
 
Nectins are molecules that are involved in adhesion, migration and polarization. We 
observed nectin-1 expression in migrating neural crest cells, but not in the dorsal 
neural tube, suggesting a possible role in cell movement and morphogenesis.  
Consistent with this, human mutations in nectin-1 result in various cleft lip/palate and 
ectodermal dysplasia disorders. Nectin functions as a cell adhesion molecule and are 
highly concentrated at adherens junctions. They signal through alpha-catenin, and are 
associated with F-actin bundles (Nakanishi and Takai 2004; Takai and Nakanishi 
2003). Trans-interactions of nectin induce the activation of Cdc42 and Rac small G 
proteins. The nectin-induced activation of Cdc42 increases the number of both 
filopodia and cell-cell contact sites while the activation of Rac induces formation of 
lamellipodia (Nakanishi and Takai 2004). They also appear to form micro-clusters at 
sites of cell-cell contact (Takai, Irie et al. 2003).  
 
GARS-AIRS-GART, and WBSCR20A (present in the region critical for the Williams-
Beuren syndrome) have transcripts in both premigratory and migratory neural crest. 
Human GARS-AIRS-GART encodes two different proteins that are differentially 
expressed during human brain development but down-regulated after birth. They 
continue to be expressed postnatally in the cerebellum of patients with Down 
syndrome and have been suggested to contribute to this syndrome (Brodsky, Barnes 
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et al. 1997). Williams-Beuren syndrome displays many features consistent with 
neural crest pathology, including congenital heart and vascular disease, dental 
abnormalities, dysmorphic facial features, and mental retardation. One of the genes 
that are present in the region critical for this syndrome is WBSCR20A (Nol1, p120), a 
120 kDA protein that was found to be expressed in the human fetal brain by RT-PCR 
(Merla, Ucla et al. 2002). 
 
Cell cycle genes:  
Neural crest cells actively proliferate as they delaminate and migrate.  Thus, it is not 
surprising that numerous genes identified in our screen were associated with the cell 
cycle including Lamin B2 (Figure 1), Cyclin B2, Cyclin B3, FMS Interacting Protein, 
Mcm2 and Mcm5.  All of these were expressed in both premigratory and migratory 
neural crest cells in early development. Lamin proteins are filaments that form a mesh 
that lines the inner side of the nuclear envelope (Lehner, Stick et al. 1987). Lamin B2 
is an essential gene that is associated with spindles in mitosis and deficit results in 
spindle defects (Harborth, Elbashir et al. 2001; Tsai, Wang et al. 2006). Cyclin B2 
has been shown to be essential for the control of the cell cycle at the G2/M transition 
and, in embryonic heart cells undergoing EMT, appears to be regulated by RhoA 
(Tavares, Mercado-Pimentel et al. 2006). Cyclin B3 is localized to the nucleus and is 
degraded during anaphase entry. Its prolonged expression interferes with progression 
through G1 and entry into S-phase (Nguyen, Manova et al. 2002). Human Mcm2 and 
Mcm5 proteins form a complex that localizes to the nucleus. Blocking Mcm2 inhibits 
 98 
 
DNA synthesis, indicating that these proteins may play a role in DNA replication and 
regulation of the cell cycle (Tsuruga, Yabuta et al. 1997).  Finally, FMIP (FMS 
Interacting Protein) has been shown to control differentiation of granulocytes and 
macrophages (Tamura, Mancini et al. 1999). 
  
Neural crest cells are induced at the border of the neural plate and the non-neural 
ectoderm, migrate through stereotyped pathways, and finally form such disparate cell 
types as melanocytes and cartilage. Identifying the different gene cascades that are 
active in these cells is critical to a greater understanding of neural crest cells as well 
as the many disorders in which they are implicated. With the results from this screen, 
we expand the known genes, including transcription factors, involved in neural crest 
development.  These data provide new players to be included in existing gene 
transduction networks and further our understanding of the development of neural 
crest cells.   
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Figure 1:  
Neural crest gene expression: In situ hybridization was performed to confirm the 
expression of genes seen to be upregulated in macroarray screen.  Selected genes from 
different categories are shown in dorsal view with anterior at the top.  (A) chromatin: 
safB1; (B) cytoskeletal: nestin; (C) ECM: lamin B2; (D) mitochondria: hexokinase 2; (E) 
mitosis/cell cycle: TD-60; (F) Nucleocytoplamic export: importin 9; (G) protein 
production/degradation: makorin; (H) receptors/downstream signaling: MHC-B; (I) rho 
pathway: kinectin; (J) RNA binding proteins: HNRPM; (K) secreted signals/signal 
production: PEBP; (L) transport: OSBP2; (M) miscellaneous: PGK; (N) unknown: 
chEST872f20 
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Figure 2: 
Neural crest expression of and QPCR results for Snail 2 (slug). (A–D) Snail2 expression 
is seen specifically in premigratory (dorsal neural tube) and migratory neural crest.  
Shown are in situ hybridizations of 10 somite (A) and 13 somite (B–D) embryos in whole 
mount (A and B) and sections of whole mount stained embryos (C and D).  
Immunofluorescence for HNK-1 is in red (D).  Arrowheads mark premigratatory neural 
crest,  arrows mark migratory neural crest. (E) Results of conjugate QPCR showing a 
very highly significant difference between control and conjugate tissues (p = 0.00015) 
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Figure 3: 
Neural crest expression of and QPCR results for Elk-3. (A–D) Elk-3 expression is seen 
specifically in premigratory (dorsal neural tube) and migratory neural crest.  Shown are in 
situ hybridizations of 10 somite (A) and 16 somite (B–D) embryos in whole mount (A 
and B) and sections of whole mount stained embryos (C and D).  Immunofluorescence 
for HNK-1 is in red (D).  Arrowheads mark premigratatory neural crest, arrows mark 
migratory neural crest. (E) QPCR results showing a highly significant difference between 
control and conjugated tissues (p = 0.005)  
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Figure 4: 
Neural crest expression of and QPCR results for GCNF. (A–D) GCNF expression is seen 
specifically in premigratory (dorsal neural tube) and migratory neural crest.  Shown are in 
situ hybridizations of 12 somite (A) and 15 somite (B–D) embryos in whole mount (A 
and B) and sections of whole mount stained embryos (C and D).  Immunofluorescence 
for HNK-1 is in red (D).  Arrowheads mark premigratatory neural crest, arrows mark 
migratory neural crest. (E) Results of QPCR showing a significant difference between 
control and conjugated tissues (p = 0.0384)  
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Figure 5:  
Neural crest expression of and QPCR results for GTF2E. (A–D) GTF2E expression is 
seen specifically in premigratory (dorsal neural tube) and migratory neural crest.  Shown 
are in situ hybridizations of 10 somite (A) and 12 somite (B–D) embryos in whole mount 
(A and B) and sections of whole mount stained embryos (C and D).  Immunofluorescence 
for HNK-1 is in red (D).  Arrowheads mark premigratatory neural crest, arrows mark 
migratory neural crest. (E) Results of QPCR showing a significant difference between 
control and conjugated tissues (p = 0.041) 
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Figure 6: 
Neural crest expression of and QPCR results for SREBP2. (A–D) SREBP2 expression is 
seen specifically in premigratory (dorsal neural tube) and migratory neural crest.  Shown 
are in situ hybridizations of 9 somite (A) and 18 somite (B–D) embryos in whole mount 
(A and B) and sections of whole mount stained embryos (C and D).  Immunofluorescence 
for HNK-1 is in red (D).  Arrowheads mark premigratatory neural crest, arrows mark 
migratory neural crest. (E) Results of QPCR showing a significant difference between 
control and conjugated tissues (p = 0.030)  
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Table 1 Summary of functional categories and genes identified. 
Clones were organized into categories based upon functions assigned by sequence homology.  Degree of homology is 
indicated by colored spots (• = BLAST bit score > 200; • = bit score 80–200; • = bit score 50–80; • = bit score 
40–50; • = bit score < 40). In situ hybridization patterns in 4–16 somite embryos were scored for expression in neural 
folds (premigratory neural crest; pNC) and cranial migratory neural crest (mNC) under the assumption that the in vitro 
induced neural crest examined in the subtraction corresponds to a timepoint between these stages of neural crest 
development.  General specificity of expression (SP) was also scored (-, expression in many tissues at varying levels; 
+/-, expression broad, but discrete patterns obvious; +, expression limited to only a few tissues; ++, expression highly 
specific).   
 
 A. Chromatin pNC mNC SP  
• H3,3B + + - replacement histone; restricted to cells of meiotic prophase 
• HP1BP74 + + +/- nucleosome assembly; DNA binding 
• SAFB1 + + +/- may act in attaching base of chromatin loops to nuclear matrix 
 B. Cytoskeleton     
•  lpha E-catenin + + +/- major binding partner of beta-catenin 
• CAP-23 - + +/- BASP1; regulates cell cortex actin dynamics 
• MACF1 + + +/- may stabilize actin where microtubules and microfilaments meet 
• NFM + + +/- neurofilament triplet M; intermediate filament family 
• Nectin1 + +/- +/- part of adherens junctions; may interact with cadherin-catenin 
• Nestin + + +/- NES; intermediate filament protein 
• Merlin - + +/- gene responsible for neurofibromatosis-2 
• Nonerythroid  -spectrin + + +/- SPTAN1; filamentous cytoskeletal protein 
• Paxillin - + +/- important for labile adhesions required for rapid cell migration 
• Periplakin - + +/- thought to contact the intermediate filaments of keratinocytes 
• PTK9L + + +/- protein contains an actin-binding site and an ATP-binding site 
• TPM-  + + +/- may alter actin filament organization, cell size, and shape 
 C. ECM     
• COL1A2 + - +/- fibrillar forming collagen; collagen  2 precursor 
• COL4 5 - + +/- may be involved in Alport syndrome: deafness and renal problems 
• COL4 6 - + +/- involved in basement membrane formation, Alport syndr variant 
• LMNB2 + + +/- Lamin B2: intermediate filament protein  D. Mitochondria     
• BID + + - death agonist; member of BCL-2 family of cell death regulators 
• Hexokinase 2 - + +/- catalyzes first committed step of glycolysis 
• HADHB + + - part of multienzyme complex; mitochondrial fatty acid oxidation 
• LDHA + - +/- promoter contains essential binding sites for HIF-1;  
• Similar to BLCAP + + +/- seen in mitochondria; downregulated during bladder cancer  
• Similar to NADH dehydrogenase + - - first enzyme in the mitochondrial electron transfer chain 
  
E. Mitosis/cell cycle 
    
• CycB2 + + +/- essential for the control of the cell cycle at the G2/M transition 
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• CycB3 + + +/- nuclear sublocalization, belongs to cyclin family AB 
• MCM2 + + +/- may play an important role in 2 crucial steps of the cell cycle 
• MCM5 + + +/- forms complex with MCM2 
• Septin 9 - + +/- cell division control protein 
• SEC14-like 1 + - +/- may be involved in E-cadherin-mediated adhesion and signaling 
• TD-60 + + +/- RCC1 family; binds nucleotide-free form of Rac1 preferentially 
 F. Nucleocytoplasmic export     
• DEAD box polypeptide 23 + + +/- RNA helicase, nuclear pore protein, mRNA export 
• Importin 9 + + +/- can mediate nuclear import of core histones into cell nuclei  
 G. Protein production/degradation     
• Cathespin B - + - intracellular degradation and turnover of proteins 
• CBS - + +/- enzyme deficient in classical homocystinuria 
• GARS-AIRS-GART + + +/- catalyzes 2nd, 3rd and 5th steps of de novo purine biosynthesis  
• Glutathione S-transferase CL2 + + - conjugates reduced glutathione to hydrophobic electrophiles 
• Makorin 1 + + +/- E3 ubiquitin ligase, promotes proteasomal degradation 
• PSMD3 - + - proteasome 26S subunit, non-ATPase; subunit 3 
• Roxan + + - contains TPR, LD, and zf motifs, forms complex with eIF4G 
 H. Receptors/downstream signaling     
• Anamorsin (Ciapin) + + +/- critical in hematopoiesis, med. of cytokine-induced antiapoptosis 
• Axl-related RTK (Rek) + - +/- Axl/Tyro3 family with a potential role in neural cell development 
• MHC B complex protein + + +/- non-classical MHC protein, encodes G-protein like molecule 
• FMIP + + - serum/glucocorticoid related kinase 2 
• GPR144 + - +/- G protein coupled receptor; integral part of membrane 
• MHC Bcomplex protein + + +/- non-classical MHC protein, encodes G-protein like molecule 
• Ptprf + + - protein tyrosine phosphatase LAR: interacts with TRIO 
• SPINT1 + - + member of Kunitz family of serine protease inhibitors 
 I. Rho pathway     
• KTN1 + - + mediator of RhoG  and RhoA activity 
• Trio + + +/- Interacts with PTPRF; displays two Rho-GEF domains 
 J. RNA binding proteins     
• Akap1 + +/- +/- bifunctional helical element: for ER and mitochondrion targeting 
• ANKRD17 isoform a + - +/- Studies suggest that this protein is involved in liver development. 
• G3BP1 + + +/- element of the Ras signal transduction pathway  
• EWS + + +/- mutated in Ewing sarcoma: cancer thought to have NCC origin 
• HnrpA2/B1 + + +/- involved with pre-mrna processing 
• Hnrp M + + +/- pre-mRNA-binding proteins in vivo 
• Lark + + +/- has RT zinc finger; regulates protein production; RNA binding 
• NONO + - - mammalian homolog of nonAdiss; nuclear RNA binding protein 
• WBSCR20A + + +/- p120; Proliferation-associated nucleolar protein 
•        SH3DBP + + +/- binds Ras-GTPase-activating protein; associates with SH3 domain 
 K. Secreted signals/signal 
production 
    
 
• Collapsin-2 + - + Sema3D 
• CFR + + +/- p70; ER and golgi localization 
• PEBP + + +/- RAF kinase inhibitor protein; regulates Raf/MEK/ERK module 
• Vav2 + + +/- oncogene; activates c-fos serum response element and CD69 
 L. Transcription Coupled Processes     
• Rel assoc pp40 + + +/- functionally related to I kappa B (inhibitor of the NF-kappa B) 
 M. Transcription Factors     
• Ccar1 + + +/- DNA binding transcriptional regulator; conserved SAP domain 
• CTCF + + +/- CCCTC-binding factor (zinc finger protein); represses c-myc 
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• Elk3 - + + ETS domain transcription factor family; TCF subfamily 
• GTFIIE + + +/- part of a multiprotein complex near the transcription start site 
• GCNF + + +/- essential transcription factor in vertebrate embryogenesis 
• ILF2 + + +/- binds NFAT and stimulates its ability to enhance gene expression 
• ILF3 + + - subunit of nuclear factor of activated T cells, dimerizes with ILF2 
• PHD + + +/- has PHD-finger domain; folds into interleaved type of Zn-finger 
• SRF - + + Serum Response Factor: binds specific sequences as a homo-dimer 
• SREBP2 + + +/- bHLH protein that stimulates transcription by binding a SRE 
• Sim to TCF20 + + +/- stromylesin 1 PDGF-responsive element-binding protein 
• WHSC1L1 + + +/- Wolf-Hirschhorn syndrome candidate 1-like 1; multiple ZF repeats 
• Sim to Zinc finger protein 3 + + - binds and regulates the J and/or S elements in MHC II promoter 
• ZFP469 + + +/- may be involved in txnl regulation; potential nuclear localization 
 N. Transporters     
• ATP1A1 + + +/- plays a very important role in nerve cell membranes 
•  HEPH, variant 2 + + - Cu-containing iron oxidase; iron export from intestinal enterocytes 
•  OSBP2 + + +/- may mediate oxysterol cytotoxicity in tissues 
• RANBP3 + + - promote export complexes of the CRM1/NES/RanGTP type 
• VWCD1 + - + Ca++-channel protein; important in excitation-contraction coupling 
 O. Miscellaneous     
• Adat1 - + +/- participate in the pre-mRNA editing of nuclear transcripts 
• Adh5 + + +/- class III : glutathione-dependent formaldehyde dehydrogenase  
• Aldehyde dehydrogenase 9a1 + +/- - catalyzes dehydrogenation of γ-aminobutyraldehyde to GABA 
• sim to autoantigen NGP-1 - + +/- gtpase that associates with pre-60s ribosomal subunits in nucleolus 
• GTBP/mutS + + +/- forms heterodimer with hMSH2; binds G/T mismatches in dsDNA 
• Heparin binding protein RI-HB + - - RA-induced heparin-binding protein; essential for embryogenesis 
• JIF-1 + + - interacts with presinillin1 to suppress function of c-Jun homodimers 
• PGK + + +/- catalyses 1,3-diphosphoglycerate is to 3-phosphoglycerate 
• RNH1 + - +/- blocks function of ribonucleases 
• Taldo1 + + - key enzyme of the pentose phosphate pathway 
• Tumor protein D52-like 2 - + +/- involved in cell proliferation, Ca2+-mediated signal transduction 
 P. Unknown/EST/no homology     
• finished cDNA ChEST648l12 + + +/- similar to Homo sapiens K+ channel tetramerization protein 
• finished cDNA ChEST872f20 + + -  
• Gallus sim to hypoth LOC419534 + + +/-  
• Gallus sim to FLJ00068 protein + - +  
• Hypothetical protein MGC15523 + - -  
 
 108 
 
Table 2 QPCR Results 
 
 Slug Elk-3 GCNF GTF2E SREBP2 
Isolates Avg 0.775 2.086 0.303 1.826 4.539 
Isolates StDev 0.059 0.416 0.040 0.413 0.886 
Conjugates Avg 5.998 3.786 0.479 3.171 6.960 
Conjugates StdDev 0.642 0.243 0.092 0.664 0.909 
P-value 0.00015 0.005 0.0384 0.041 0.030 
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Chapter III: Functional perturbations of  candidate 
regulators of neural crest development 
 
 
This chapter presents the analysis of two different genes discovered in the screen for 
genes with functional relevance in neural crest described in Chapter 2. M.S.A.’s 
contribution to the work on Ccar1 encompasses the spatiotemporal analysis of the mRNA 
pattern of Ccar1, a portion of the morpholino injections of Ccar1, and the analysis of 
those injected embryos by in situ for Sox10. M.S.A. also performed the entirety of the 
work described herein on Adh5. 
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3.1: Abstract 
Here we present the results of our studies on two different candidates that have resulted 
from our screen for genes important in neural crest cell development. We have 
characterized the expression patterns of these genes and examined their functional 
importance using perturbation analysis via morpholino-mediated knock-down. The levels 
of Ccar1 in neural crest cells induced in vitro were analyzed by quantitative PCR.  
 
3.2: Introduction 
To date, a dozen or so genes have been functionally analyzed and found to be important 
members of a neural crest gene regulatory network involved in specification and 
formation of this important cell type. However, many more genes are likely to be 
involved in this network.  With this in mind, we successfully performed a screen 
(described in Chapter 2) to increase the number of genes that might be functionally 
investigated.  
 
To begin functional characterization of the genes discovered in our screen (seen in 
Chapter 2), we chose two of the genes that previous literature suggested might be 
particularly relevant to the neural crest. Ccar1 is a transcription factor that was found not 
only in the screen described in this thesis, but also emerged in a concurrent screen 
performed to identify vertebrate orthologues of  genes involved in long-range migration 
of the hermaphrodite specific neuron in Caenorhabditis elegans. The second gene, Adh5, 
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is an enzyme of unknown function, but is related to enzymes involved in retinoic acid 
signaling.   
 
 
Ccar1: 
Cell cycle and apoptosis-regulatory protein-1 (CCAR1 or CARP1) is a perinuclear 
protein first identified by Rishi et al. as a regulator of apoptotic signaling (Rishi, Zhang et 
al. 2003). The Ccar1 sequence has been identified in many different genomes including 
nematodes, honey bees, frogs, avians, mice, rats, dogs, chimpanzees, and humans and 
there is a great deal of sequence similarity and highly conserved domains, indicating its 
importance across the evolutionary scale (Zhang, Levi et al. 2007; Rishi, Zhang et al. 
2006; Anantharaman and Aravind 2008). The human Ccar-1 gene is located on the long 
arm of chromosome 10 and the mRNA is approximately 3.5 kb long, encoding a 1146 aa 
protein with a mass of 130 kDa (Zhang, Levi et al. 2007; Rishi, Zhang et al. 2003; Kim, 
Yang et al. 2008). The protein includes a 35 amino acid SAP domain, which is common 
in chromatin-associated proteins (Aravind and Koonin 2000; Kim, Yang et al. 2008). 
 
Ccar1 has been traditionally thought to be a strictly apoptotic molecule in malignant cell 
types such as breast or prostate cancers as well as leukemias (Zhang, Levi et al. 2007). 
Reduced levels of Ccar1 in these types of malignant cells result in a decrease in apoptosis 
signaling by CD437 ([3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid), 
the chemotherapeutic (anthracycline toxin) adriamycin, etoposide, and EGFR inhibitor(s) 
(Rishi, Zhang et al. 2006). CD437 is an apoptotic retinoid from a family that is known to 
cause growth arrest and stimulate apoptosis in malignant cell types such as breast cancer 
and leukemia (among others) through a retinoic acid receptor/retinoid X receptor-
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independent mechanism (Shao, Dawson et al. 1995; Hsu, Rishi et al. 1997; Liang, 
Fontana et al. 1999). Ccar1 had been further shown to bind to p53 and to perform a 
critical role in transcriptional activation by p53 (Kim, Yang et al. 2008).  
 
Although in the literature, Ccar1 is mostly considered an inducer of apoptosis, it also has 
been shown to act as a coactivator for several other classes of transcription factors as it is 
important in the recruitment of the Mediator to their target genes. As an example, it was 
convincingly demonstrated that Ccar1 also has a role in estrogen-induced cell 
proliferation (Kim, Yang et al. 2008).  
 
ADH5: 
ADH family members are known to catalyze the conversion of alcohol to acetaldehyde as 
well as the metabolism of retinoids, steroids and 5-hydroxyfatty acids (Beisswenger, 
Holmquist et al. 1985; Pares and Vallee 1981; Wagner, Pares et al. 1984; Kaiser, 
Holmquist et al. 1988; Giri, Linnoila et al. 1989; Hempel and Pietruszko 1979; Iborra, 
Renau-Piqueras et al. 1992). There are four defined classes of ADH genes; Class I and II 
and IV have a high affinity for alcohol and have functions catalyzing ethanol metabolism 
(Iborra, Renau-Piqueras et al. 1992). Adh5 is a member of the class III (X) alcohol 
dehydrogenase family and is the only isozyme shown to be present in the human, simian, 
equine, bovine, canine, and rat brain, where it is likely to be present in the nucleus 
(Beisswenger, Holmquist et al. 1985; Iborra, Renau-Piqueras et al. 1992). Furthermore, 
this class does not have a large capacity for the oxidation of ethanol or methanol as many 
of the other alcohol dehydrogenase genes do, but it efficiently oxidizes long chain 
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alcohols and ω-hydroxyfatty acids (Beisswenger, Holmquist et al. 1985; Pares and Vallee 
1981; Wagner, Pares et al. 1984; Kaiser, Holmquist et al. 1988; Giri, Linnoila et al. 
1989). For this reason, Adh5 is also known as FALDH or FDH (NAD+/glutathione-
dependent formaldehyde dehydrogenase) (Uotila and Koivusalo 1974; Iborra, Renau-
Piqueras et al. 1992). This enzyme functions as a homodimer and has a zinc at the active 
site that is essential (Wagner, Pares et al. 1984). 
 
The human ADH5 gene was first mapped to chromosome 4, and this was further refined 
to chromosome 4q21-q25 (or 4q21-q25) where seven genes are clustered (Meera Khan, 
Wijnen et al. 1984) (Smith 1986). The corresponding murine gene has been mapped to 
chromosome 3, along with the other mouse ADH genes. The human Adh5 gene contains 
9 exons and 8 introns, and the region 5’ of ADH5 is extremely G and C rich and contains 
neither a TATA box nor a CAAT box but does contain a multitude of known binding 
sites. Several of these binding sites are for proteins important for neural crest 
development such as Sp1 (specificity protein 1) and AP2 as well as those that are known 
to be involved in pathologies of neural crest origin, like NF-1 (Hur and Edenberg 1992). 
Sp1 is a sequence specific Krüppel-like C2H2-type zinc finger superfamily member and 
has been shown to activate many viral and cellular genes as well as being important for 
the transactivation of the RET promoter within a known neural crest-derived cell line 
(Suske 1999). FBI-1, a POZ domain transcription factor, is a potent inhibitor of ADH5 
and represses transcription by interfering with the DNA binding domain of Sp1 (Lee, Suh 
et al. 2002).  
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Chi-like alcohol dehydrogenases are highly conserved through mammalian evolution and 
have also been seen in very basal organisms such as Escheria coli (60% amino acid 
sequence identity) (Sharma, Fox et al. 1989; Giri, Krug et al. 1989; Edenberg, Brown et 
al. 1991; Hur and Edenberg 1992; Gutheil, Holmquist et al. 1992). The only family 
member seen in invertebrates is a glutathione-dependent formaldehyde dehydrogenase, 
most closely related to Class III family members (and sometimes referred to as ADH3) 
and specifically homologous to Adh5 (Koivusalo, Baumann et al. 1989; Canestro, Albalat 
et al. 2002; Gonzalez-Duarte and Albalat 2005). Studies of ADH genes in fish have lead 
to the discovery of an enzyme that has the characteristics of a class I ADH gene, but has 
more structural similarity to a member of class III. This suggests that a class III Adh gene 
was the evolutionary precursor of the ADH family (Kaiser, Fernandez et al. 1993).  
 
 
3.3: Materials and methods 
Embryos and Explants 
Fertile chicken eggs were incubated from 24 hours to three days to obtain embryos from 
HH stage 4 to HH stage 24.  Embryos to be used for in situ hybridization were fixed 
overnight in 4% paraformaldehyde (PFA) at 4°C. They were then washed 4 x 5 minutes 
in PTW and dehydrated in a MeOH/PTW series at RT before being stored at –20°C in 
100% MeOH for more than 3 days.  Explants were dissected from embryos in 
Ca2+/Mg2+-free Tyrodes saline with .05% trypsin (Sigma). Conjugates were assembled 
and allowed to recover as previously described before embedding in collagen gels and 
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culturing for 24 hours (Dickinson, Selleck et al. 1995; Gammill and Bronner-Fraser 
2002) 
 
RNA preparation and QPCR 
RNA was prepared from tissues in collagen gels using Stratagene’s RNA isolation kit.  
Collagen gels were transferred to an Eppendorf microcentrifuge tube with forceps and 
triturated in lysis buffer.  
 
Quantitative polymerase chain reaction  (QPCR) was performed using the 96 well plate 
ABI 7000 QPCR machine in a TaqMan assay (Applied Biosciences) with Sybrgreen Itaq 
Supermix with ROX (BioRad), 300 nM of each primer, and 200-500 ng of cDNA in a 25 
µL reaction volume. Gene specific primers were designed using the Primer Express 
program (Applied Biosystems) and synthesized by IDT. During the exponential phase of 
the QPCR reaction a threshold and baseline was set according to the protocols of Applied 
Biosystems as described in Chapter 2.   
 
QPCR primer sequences were as follows:  
Snail2 forward 5’-GGGCTGCTACCGTCTCCTCTA-3’ 
Snail2  reverse 5’-GCTGACCCTTCCCAAAGATG-3’ 
ccar1 forward 5'-TCGACCAGCTGCTGCTTGTA-3' 
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ccar1 reverse 5'-CCGCTCAGAGTGGGAAACC-3' 
 
 
Cloning 
Partial chick cDNA fragments of Ccar1 and ADH5 were identified in a 8-12 somite stage 
macroarrayed chick cDNA library. Primers were designed to allow the cloning of these 
genes into pCIG-GFP and pCIG-RFP from Topo-TA the vector after High-Fidelity PCR 
amplification. 
Adh5 has been identified as NM_001031152.1 and the sequence of the gene is  
ATGGCCAGCGGGGTTATTAAATGCAAGGCTGCTGTTGCCTGGGAGGCAGGTA
AACCTCTCTCTATTGAGGAGGTGGAAGTCGCTCCGCCAAAAGCTCATGAAGT
TCGCATCAAGATAGTTGCCACTGCTCTCTGTCACACTGATGCCTATACTCTGA
GTGGTGCTGATCCCGAGGGATGTTTCCCTGTGATTCTGGGTCATGAAGGAGC
AGGAATTGTAGAAAGTGTTGGGGAAGGAGTAACAAAAGTAAAGCCAGGGGA
CACCGTGATCCCTCTGTACATCCCCCAGTGTGGCGAGTGCAAGTACTGCAAG
AATCCTAAAACTAATCTGTGCCAAAAGATAAGAGTTACTCAAGGGAAAGGAC
TCATGCCTGATGGTACGATCAGATTCACCTGCAAAGGAAAGCAGATTTACCA
CTTCATGGGGACTAGCACCTTCTCGGAGTACACAGTGGTGGCCGATATCTCA
GTAGCTAAGATAGATCCTGCAGCACCTTTCGATAAAGTGTGCCTGCTGGGTTG
TGGCGTCTCTACAGGTTATGGGGCTGCTGTTAACACTGCTAAGGTGGAACCTG
GCTCCACGTGTGCAGTCTTTGGTTTAGGAGGAGTTGGGCTGGCTACTGTTATG
GGCTGTAAAGCGGCAGGAGCATCCCGGATCATTGGCATTGACATAAACAAGA
ATACCTATGCCAAAGCCAAGGAGTTTGGAGCTGCTGAGTGCATTAGCCCTCA
AGACTTTGAGAAGCCCATACAGGAGGTGCTGGTTGAAATGACTGATGGTGGT
GTAGACTACTCATTTGAGTGTATTGGTAACGTTGGAGTCATGAGGGCTGCCTT
GGAAGCCTGCCACAAAGGCTGGGGAGTCAGTGTGATAGTTGGAGTAGCTGCT
GCTGGTCAGGAGATCTCAACGCGGCCGTTCCAGCTAGTAACCGGTCGGACAT
GGAAAGGGACTGCGTTTGGAGGCTGGAAGAGCGTAGACAGTGTACCAAAGC
TGGTGAATGACTACATGGCCAAAAAGATCAAAGTAGATGAGTTTGTGACTCA
TACCCTGCCTTTTGACAAAATTAATGAGGCTTTTGATCTCCTGCATAAAGGAA
AGAGCATTCGAACAGTTCTAAAGTTTTAG 
 
The Adh5 amino acid sequence is: 
MASGVIKCKAAVAWEAGKPLSIEEVEVAPPKAHEVRIKIVATALCHTDAYTLSG
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ADPEGCFPVILGHEGAGIVESVGEGVTKVKPGDTVIPLYIPQCGECKYCKNPKTN
LCQKIRVTQGKGLMPDGTIRFTCKGKQIYHFMGTSTFSEYTVVADISVAKIDPAA
PFDKVCLLGCGVSTGYGAAVNTAKVEPGSTCAVFGLGGVGLATVMGCKAAGA
SRIIGIDINKNTYAKAKEFGAAECISPQDFEKPIQEVLVEMTDGGVDYSFECIGNV
GVMRAALEACHKGWGVSVIVGVAAAGQEISTRPFQLVTGRTWKGTAFGGWKS
VDSVPKLVNDYMAKKIKVDEFVTHTLPFDKINEAFDLLHKGKSIRTVLKF 
 
Ccar1 has been identified as XM_421573 and the sequence of the gene is  
ATGGCTCAGTTCGGAGGACAGAAGAACCCTCCGTGGGCCACTCAGTTTACAG
CCACCGCCGTGTCCCAGCCAGCTGCTCTTGGTGTGCAGCAGCCGTCGCTGCTT
GGAGCCTCTCCTACAATATACACCCAGCAGACGGCGCTGGCCGCGGCGGGCC
TGACTACGCAAACACCAACCAACTACCAGCTAACTCAGACGGCCGCTTTGCA
GCAGCAGGCGGCAGCTGCAGCAGCTGCCTTACAGCAGCAATATTCACAGCCT
CAGCAGACTCTCTATAGTGTACAGCAACAGTTGCAGCAACCTCAGCAGACCA
TTTTAACTCAGCCAGCTGTTGCACTACCTACCAGTCTTAGCCTATCTACTCCTC
AGCCAGCAGCCCAGATAACTGTTTCTTACCCAGCACCCCGCTCAAGTCAGCA
GCAAACACAACCACAAAAGCAGCGCGTCTTCACTGGGGTCGTTACTAAACTG
CATGATACGTTCGGTTTTGTGGATGAAGATGTCTTTTTTCAACTTAGTGCTGTT
AAAGGGAAGACACCTCAAGTGGGCGACAGAGTTTTAGTAGAAGCTACTTACA
ATCCTAATATGCCGTTCAAATGGAATGCACAAAGGATCCAGACGCTTCCAAA
TCAGAACCAGACACAGGCTCAACCGTTACTCAAGACGCCTCCGGCAGTTCTT
CAGCCCATTGCGCAGCAGACGGCGTTTGGTGTTCAGGCACAGCCTCAGCCAC
AGTCCTTGCTGCAGGCACAGATATCGGCAGCTTCAATCACACCTCTGCTTCAG
ACACAGCCTCAGCCATTGCTGCAGCAGCCACAGCAAAAAGGTGGTTTGTTAC
AGCCCCCTGTCCGTCTAGTTTCACAGCCTCAACCAGCTCGAAGATTGGACCCA
CCATCCAGATTTTCTGGGAGGAATGACAGAGGAGGAGATCCTATGCCAAACC
GAAAAGATGACAGGAGCCGTGAGAGAGATCGGGAGAGACGTCGATCTCGGG
AAAGATCACCCCAGAGAAAACGCTCCAGAGAGAGATCGCCTCGACGAGAGA
GGGAGAGGTCGCCTCGAAGACCGCGACGTGTTGTTCCTCGTTACACCGTTCA
GTTTTCTAAGTTTTCATTGGACTGCCGCAGCTGTGATATGATGGAGCTGAGGA
GGCGTTACCAGAACTTGTATATCCCAAGTGATTTCTTCGATGCTCAGTTTACA
TGGGTGGATGCTTTCCCAATGTCTAGACCATTTCAACTGGGAAACTACTGTAA
CTTCTATGTAATGCATAGGGAAGTAGACCCTATAGATAAAAATGCTGCTGTC
CTCGATCCACCTGATGCTGATCATCTGTACAGTGCTAAGGTGATGTTGATGGC
TAGCCCTAGTATGGAAGACCTCTATCACAAGTCCTGTGCTCTGGCTGAAGATC
CCCAAGAACTTCGTGATGGATTTCAGCATCCTGCTAGACTTGTAAAGTTTTTA
GTGGGTATGAAAGGCAAAGATGAAGCTATGGCTATTGGAGGACACTGGTCCC
CATCACTAGATGGACCTGATCCGGAGAAGGACCCTTCGGTGCTGATAAAGAC
GGCTATTCGTTGTTGCAAGGCTCTTACAGGGATTGACTTAAGTGTGTGCACAC
AATGGTACCGTTTTGCAGAGATTCGCTACCATCGCCCTGAGGAGACGCACAA
GGGGCGTACAGTTCCAGCTCATGTGGAGACAGTGGTTTTATTTTTCCCGGATG
TTTGGCATTGCCTTCCCACCCGCTCAGAGTGGGAAACCCTCTCCCGAGGATAC
AAGCAGCAGCTGGTCGAGAAGCTTCAGGGTGAACGCAAGGAGGCTGATGGA
GAACAGGATGAAGAGGAAAAGGATGATGGGGAAGCAAAAGAGATCTCTACA
CCTACACACTGGTCTAAACTGGATCCGAAAACAATGAAGGTAAATGACCTTC
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GCAAAGAATTAGAAAGTCGAACTCTTAGCTCTAAAGGACTGAAATCTCAGTT
GATAGCTCGACTGACAAAGCAACTGAAAGTAGAGGAGCAAAAAGAAGAGCA
AAAGGAGCTAGAGAAGTCTGAGAAAGAAGAGGAAGAGGAGGAGGATAGGA
AATCTGAAGATGACAAAGAGGAAGAGGAAAGAAAGCGTCAAGAAGAAATG
GAACGTCAGCGACGGGAGAGACGGTACATCTTGCCTGATGAACCAGCGATCA
TTGTGCATCCTAACTGGGCAGCCAAGAGCGGGAAGTTTGACTGTAGCATAAT
GTCACTCAGTGTTCTTCTGGACTATAGGTTGGAGGATAATAAAGAACATTCCT
TTGAGGTTTCATTGTTTGCAGAACTCTTCAATGAAATGCTTCAGAGGGATTTT
GGTGTCAGAATTTATAAAGCACTGATTTCCCTCCCAGAGAGGGAGGACAAAA
AAGATAAAAAAAGCAAAAAAGATGAACGAAAAGAAAAAAAGGAAGAAAAA
GAAGAAGAAAATGATGAACCAAAACCGAAGAGGAGAAAATCTGGAGATGAT
AAAGAAAAAAAAGAAGATAAAGATGAAAAGAAGAGGGAAGAGAAAAGGAA
AGATGATTCCAAAGATGAAGAAGAAACTGAAGATGACAATAATCAAGAAGA
ATATGATCCAATGGAGGCGGAAGAAGCTGAAGATGAAGATGAAGAATGCAG
ACCACTCGCAACTCCCATTGAAGTCAGTAGGAGATACCGGGAAGAAGAAGA
AATGAATAAACGAGAGGACAGAAGAGAGGGAAATAAGCATTGTAAAGAGAG
GTCATCTAAAGATAAAGAGAAAGACAAGACACAGATGGTAACTGTTAATAG
GGATCTTCTGATGGCTTTCGTTTATTTTGACCAAAGTCACTGTGGATATCTTCT
GGAGAAGGACATGGAGGAGATACTGTATACTCTTGGACTACACCTGTCTCGT
GCTCAGGTCAAGAAGCTACTTAACAAAGTAGTACTTAGAGAATCCTGCTTCT
ACAGAAGACTAACAGATACTTCTAAAGATGAGGAAAACCAAGAAGAATCAG
AAGAACTACAAGAAGACATGTTAGGAAACAGATTGCTGTTGCCATCACCTAC
AGTAAAGCAAGAATCAAAAGCTGTAGAAGAAAATGTTGGCCTTATTGTATAC
AACGGAGCTATGGTAGATGTCGGGAGCCTTTTACAGAAGCTGGAGAAGAGTG
AAAGAGTGCGGGCAGAGATAGAACAAAAGCTACAGCTCCTTGAAGAAAAAA
CAGATGAGGATGAAAAGACCATACTGCAGCTGGAAAATTCTAACAAAAGTCT
GTCTGCGGAGCTCAGAGATGTCAAAAAGGACCTTAGTCAGCTGCAAGAGAAC
TTGAAGATCTCAGATGAGAAAAATTTGCAATTTGAGAGTCAGCTGAATAAGA
CAATCAAAAATTTAGCTACTGTTATGGATGAAATGCAGAGTGTGCTTAAGCA
GGATATTGTGAAAAGTGAAGATAAAGATCAGAAATCCAAAGAAAATGGAGC
AAGCGTATGA 
 
 
The Ccar1 amino acid sequence is: 
MAQFGGQKNPPWATQFTATAVSQPAALGVQQPSLLGASPTIYTQQTALAAAGL
TTQTPTNYQLTQTAALQQQAAAAAAALQQQYSQPQQTLYSVQQQLQQPQQTIL
TQPAVALPTSLSLSTPQPAAQITVSYPAPRSSQQQTQPQKQRVFTGVVTKLHDTF
GFVDEDVFFQLSAVKGKTPQVGDRVLVEATYNPNMPFKWNAQRIQTLPNQNQT
QAQPLLKTPPAVLQPIAQQTAFGVQAQPQPQSLLQAQISAASITPLLQTQPQPLLQ
QPQQKGGLLQPPVRLVSQPQPARRLDPPSRFSGRNDRGGDPMPNRKDDRSRERD
RERRRSRERSPQRKRSRERSPRRERERSPRRPRRVVPRYTVQFSKFSLDCRSCDM
MELRRRYQNLYIPSDFFDAQFTWVDAFPMSRPFQLGNYCNFYVMHREVDPIDKN
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AAVLDPPDADHLYSAKVMLMASPSMEDLYHKSCALAEDPQELRDGFQHPARLV
KFLVGMKGKDEAMAIGGHWSPSLDGPDPEKDPSVLIKTAIRCCKALTGIDLSVCT
QWYRFAEIRYHRPEETHKGRTVPAHVETVVLFFPDVWHCLPTRSEWETLSRGYK
QQLVEKLQGERKEADGEQDEEEKDDGEAKEISTPTHWSKLDPKTMKVNDLRKE
LESRTLSSKGLKSQLIARLTKQLKVEEQKEEQKELEKSEKEEEEEEDRKSEDDKEE
EERKRQEEMERQRRERRYILPDEPAIIVHPNWAAKSGKFDCSIMSLSVLLDYRLE
DNKEHSFEVSLFAELFNEMLQRDFGVRIYKALISLPEREDKKDKKSKKDERKEKK
EEKEEENDEPKPKRRKSGDDKEKKEDKDEKKREEKRKDDSKDEEETEDDNNQE
EYDPMEAEEAEDEDEECRPLATPIEVSRRYREEEEMNKREDRREGNKHCKERSS
KDKEKDKTQMVTVNRDLLMAFVYFDQSHCGYLLEKDMEEILYTLGLHLSRAQV
KKLLNKVVLRESCFYRRLTDTSKDEENQEESEELQEDMLGNRLLLPSPTVKQESK
AVEENVGLIVYNGAMVDVGSLLQKLEKSERVRAEIEQKLQLLEEKTDEDEKTIL
QLENSNKSLSAELRDVKKDLSQLQENLKISDEKNLQFESQLNKTIKNLATVMDE
MQSVLKQDIVKSEDKDQKSKENGASV 
 
Morpholino oligo design: 
Morpholinos were designed against the above sequences as shown below: 
The Adh5 morpholino is designed against the 5’-UTR region of the gene shown above. 
The oligo was designed and manufactured by GeneTools in both a lissaminated and a 
FITC-labeled form.  
ADH5 UTR morpholino: 5'- TGTCGTTCCCGGACGGAGAAGAAAG -3' 
 
The Ccar1 morpholino is designed against the start site of the gene shown above. The 
oligo was designed and manufactured by GeneTools in both a lissaminated and a FITC-
labeled form.  
Ccar1 start site morpholino: 5'- CTTCTGTCCTCCGAACTGAGCCATG-3' 
 
Electroporation 
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Chicken embryos were collected on filter paper rings and electroporated ex ovo using the 
a vertical stage 4 electroporation apparatus. They were electroporated at 7 volts 5 pulses, 
50 msec on and 100 msec off.  They were then cultured in a 37°C incubator for between 
12 and 36 hours in dishes on a minimal layer of thin albumin.  
 
In Situ Hybridization 
Antisense, digoxygenin labeled RNA probes were prepared from clones categorized as 
being upregulated by the macroarray screen.  The probes were hydrolyzed and in situs 
were performed as described (Xu 1992). Embryos were visually examined at different 
angles to aid in scoring and photographed on a Zeiss Axioskop2 Plus. Selected embryos 
were then coarsely sectioned using a scalpel or finely sectioned using a cryostat (Bright) 
and mounted or immunostained. 
 
Sections 
Wholemount in situs were post-fixed in 4% PFA (paraformaldehyde) + 0.02% 
glutaraldehyde and washed in PTW 4x15 minutes. They were nutated at 4°C overnight in 
15% sucrose, kept for 8 hours at 37°C in 7.5% gelatin/15% sucrose and between 8 and 20 
hours in 20% gelatin. The embryos were then embedded, frozen and cryosectioned at 
approximately 25 µM.  Sections were briefly dried onto slides and degelatinized for 20 
minutes at 42°C in PBS. 
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Immunostaining 
Sections were performed as described above. They were then placed in PBS (phosphate 
buffered saline) + 0.1% Tween 20 + 5% goat serum block for hours at room temperature 
before an overnight 4°C incubation with 1:20 anti-HNK-1 antibody (American Type 
Culture Collection hybridoma).  Sections were then washed several times in PBS + 0.1% 
Tween over several hours, blocked for 3 hours at RT with PTW (phosphate-buffered 
saline [PBS], pH 7.5, 0.1% Tween 20) and 5% goat serum, and incubated with 1:400 
anti-IgM RRX goat anti mouse (Jackson ImmunoResearch) in PTW at 4°C overnight. 
Slides were then washed again in PTW several times, rinsed twice in dH20 and then 
coverslipped using PermaFluor (Immunotech). 
 
3.4: Results 
Ccar1 
Ccar1 mRNA is present in the both the dorsal neural folds and in the migratory neural 
crest cells (Figures 1 and 2). This is further confirmed by overlay with HNK-1 on a 
section of a Ccar1 in situ. In addition, up-regulation of the gene in neural plate/ectoderm 
conjugates was confirmed by QPCR.  To this end, intermediate neural plate and non-
neural ectoderm were dissected and cultured as isolates or as conjugates in exactly the 
same manner as the subtracted probe was generated in order to perform our screen for 
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genes important in neural crest cells (described in Chapter 2). We then quantitated the 
expression level of Snail2 and Ccar1 in isolates and conjugates. Ccar1 showed 
asignificant difference between these two populations with an average value in 
conjugates of 0.777, standard deviation 0.104 and an average value in control tissue of 
0.464, standard deviation 0.149. The student t-test value is significant, with p=0.0405. In 
this same set of samples, the values of Snail2 were an average conjugate value of 5.995, 
standard deviation 0.637 and an average non-conjugate value of 0.748, standard deviation 
0.241 (results for Snail2 reported previously in another paper) (Adams, Gammill et al. 
2008). The student t-test value for the Snail2 results is also significant, with p=0.0002. 
Since the culture system is designed as a subtractive scheme in which the difference 
between the cultures should reflect the additional cell type induced therein, namely the 
neural crest, it makes sense that transcripts of Ccar-1 would be increased in this 
population.  
 
Next, we examined the effects of loss-of-function of Ccar-1 using translation-blocking 
morpholino antisense oligonucleotides.  Using Sox10 as a neural crest marker, in situ 
hybridization revealed that Ccar11 morpholino injected embryos showed a significant 
reduction of Sox10 mRNA on the injected side as compared with the contralateral side. 
Out of 26 electroporated embryos, 13 showed no difference, 10 showed a slight deficit, 
and 3 showed a severe deficit of Sox10 transcripts. In contrast, control morpholino 
electroporated embryos under identical conditions at the same time, showed no deficits 
on the injected side (20/22 embryos) or very mild deficits (2/22 embryos). Contingency 
testing on this data set using Prism software gave a Chi-square value of 9.551 with a p 
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value of 0.0084, a statistically significant difference.  
 
Our examination of these embryos for the root cause of the loss of Sox10 mRNA on the 
morpholinated side of the embryo has led us to investigate the relative levels of cell death 
seen there, as this would very well explain the loss of Sox10 expressing cells. Our 
preliminary data indicates that these embryos have a significant cell death increase in the 
dorsal neural folds of the injected side of the embryo when compared to the control side 
of the embryo and with embryos injected with the control morpholino (Figure 3).  
 
Adh5 
In situ hybridization in very early embryonic stages has not previously been reported for 
Adh5 mRNA, nor has the expression pattern of this gene been previously published in 
chicken embryos. While previous reports have indicated that Adh5 mRNA is present in a 
ubiquitous manner during development, the reports examined embryos older than those 
studied here, and thus are not reflective of early neural crest development. We therefore 
performed a survey of expression during early development, confirming the presence of 
Adh5 mRNA in both the dorsal neural folds and the early migrating neural crest cells 
(Figure 4).  
 
Functional analysis was carried out by perturbing the translation of Adh5 using a 
morpholino with a FITC or lissamine tag (along with control morpholinos carrying the 
same fluorescent tag). Sox10 in situ hybridization performed on Adh5 morpholino 
injected embryos showed a significant reduction of Sox10 mRNA on the injected side 
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(Figure 5: A and A’). Out of 17 electroporated embryos, 4 showed no difference, 7 
showed a slight deficit, and 6 showed a severe deficit of Sox10 mRNA on the injected 
side of the embryo. Control morpholino electroporated embryos from the same batch 
showed only slight deficits in 2/22 emryos on the injected side and none with severe 
deficits (Figure 5: B and B’). Contingency testing on this data set using Prism software 
gave a Chi-square value of 19.12 with a p value of <0.0001, a statistically significant 
difference.   
 
When Snail2 was examined by in situ hybridization on Adh5 morpholino injected 
embryos, there was a significant reduction of Snail2 mRNA on the injected side. Out of 
13 electroporated embryos, 5 showed no difference, 5 showed a slight deficit, and 3 
showed a severe deficit of Snail2 mRNA on the injected side of the embryo (Figure 5: E 
and E’). This result is validated through comparison to embryos electroporated with a 
control morpholino at the same time, which showed slight deficits on the injected side in 
only two out of 17 embryos and no embryos exhibiting severe deficits (Figure 5: F and 
F’). Contingency testing on this data set using Prism software gave a Chi-square value of 
10.06 with a p value of 0.0065, a statistically significant difference.  
 
Finally, embryos injected with the Adh5 morpholino were examined for FoxD3 
expression by in situ hybridization. This also showed a significant reduction of FoxD3 
mRNA on the injected side. Out of 12 electroporated embryos, 5 showed no difference, 4 
showed a slight deficit, and 3 showed a severe deficit of FoxD3 mRNA on the injected 
side of the embryo (Figure 5: C and C’). In control morpholino electroporated embryos 
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performed concurrently, slight deficits on the injected side were observed in only one out 
of 16 embryos, with none exhibiting severe deficits (Figure 5: D and D’). Contingency 
testing on this data set using Prism software gave a Chi-square value of 9.421 with a p 
value of 0.009, a statistically significant difference.  
 
 
3.5: Discussion 
 
Here we have demonstrated the functional relevance of two of the genes we discovered in 
our screen for novel neural crest effectors. When we began to study induced populations 
of neural crest cells, we used an in vitro method that has been used for many years and 
across several organisms. This culture method, in which non-neural ectoderm and 
intermediate neural plate are co-cultured, produces cells that are considered to be neural 
crest as they are migratory, and HNK-1 positive. As we discovered the involvement of 
several other transcription factors in neural crest cell development, we further reaffirmed 
the upregulation in the co-cultured tissues of several transcription factors, including 
Ccar1, by QPCR. These results not only confirm the relative levels of upregulation seen 
in the cultures, giving us an idea of the sensitivity of our screen, but also further validates 
this culture method as one that produces neural crest cells that approach those seen in 
vivo.  
 
The genes that we chose to examine further, Ccar1 and Adh5, have expression patterns 
that confirm a spatiotemporal mRNA presence that would support their involvement in 
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the developing neural crest (despite earlier reports that indicated the ubiquitous presence 
of Adh5 in the developing embryo). We have further examined both Ccar1 and Adh5 for 
functional relevance in the neural crest cells through morpholino knockdown. We have 
found that the loss of Ccar1 or Adh5 causes a loss of the mRNA expression of a neural 
crest specifier gene, Sox10, as compared to the contralateral (uninjected) side of the 
embryo or embryos injected with a control morpholino. Furthermore, the loss of Adh5 
through morpholino-mediated knockdown results in the loss of the mRNA expression of 
two other neural crest specifier genes, Snail2 and FoxD3, on the injected side as 
compared to the aforementioned controls. Upon closer examination through Tunel 
staining, we have preliminary data that suggests that the loss of Sox10 mRNA in Ccar1-
morpholino injected sites of the embryo is most likely due to cell death.   
 
Although our understanding of the root causes of the changes observed in these 
morpholinated embryos is not yet complete, we know that the described differences in 
these embryos are statistically significant, indicating the functional relevance of these 
genes. With continued experimentation, we should be able to firmly seat both of these 
genes and their effects in our understanding of the way in which neural crest cells 
develop, and in the genetic network controlling neural crest cells.  
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Figure 1: Ccar1 expression  
Ccar1 mRNA is present in stage 4 and 5 embryos in the neural plate border, in the dorsal 
neural folds of stage 7–9 embryos, and in the dorsal neural folds and migrating neural crest 
of older embryos. 
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Figure 2: Ccar1 in situs with HNK1 overlay and QPCR of in vitro cultures  
Ccar1 in situs of st 10 (A) and stage 12 (B) embryos are shown along with a section 
through the older embryo (C). A closeup of HNK-1 immunostaining of the same section 
shown in (C) is seen in (D). (E) QPCR in vitro conjugates as compared to individually 
cultured tissue pieces: an average conjugate value of 0.777, standard deviation 0.104 and 
an average non-conjugate value of 0.464, standard deviation 0.149. The student t-test 
value is significant, with p = 0.0405. 
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Figure 3: Morpholino knockdown of Ccar1, Sox10 in situ, and Tunel staining 
(A) Sox10 in situs of embryos injected with Ccar1 morpholino (a and c) while the 
distribution of the lissaminated morpholino is shown in the adjoining photograph (b and 
d). (B) Tunel staining showing the difference between cell death in sections from Carp-1 
(a–c) and (d–f) control morpholino injected embryos. Adjoining photos show DAPI 
staining and the morpholino distribution. 
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Figure 4: In situs of ADH5 
In situ hybridizations of Adh5 mRNA reveal its specific expression in the dorsal neural 
folds and the migrating neural crest cells. Below are embryos representing stages 8–15 of 
chicken development.  
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Figure 5: Morpholino knockdown of ADH5, Sox10, slug, and foxd3 in situ 
Significant differences were seen in embryos injected with ADH5 morpholino and control 
morpholino by Sox10, FoxD3, and Snail2 in situ hybridizations.  
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The importance and relevance of studying the neural crest cells 
 
Arising concurrently with the vertebrate lineage, neural crest cells cells were largely 
responsible for the development of the “new head” and “new neck” of these animals as 
well as the predatory behaviors that follow from these morphological changes (Gans and 
Northcutt 1983) (Kuratani 2008). Indeed, much of the diversity immediately visible not 
only in humans, but in such animals as Darwin’s finches (where beak shape and size 
determines the niches they may occupy) is due to the control of neural crest cells that 
form the bones and cartilage of the face, as well as other determinants such as 
melanocytes.  Crest cells, which form at the border between the neural and non-neural 
ectoderm, are unique in that they are able to migrate great distances along stereotypical 
paths before giving rise to derivatives that are far flung and incredibly diverse (see 
Chapter 1 for a more comprehensive overview) (Knecht and Bronner-Fraser 2002; Le 
Douarin, Brito et al. 2007). As we study the neural crest cells, each piece of data allows 
us to see a bit more into the intricate levels of control that allow this population to 
achieve its tasks in the developing embryo, and later during processes such as types of 
wound healing in adults. In fact, our understanding is thus not restricted to the 
developmental potential of these cells, but also informs our knowledge of other self-
renewing populations such as somatic stem cells and cancers. In all these cases, the 
potential for translational approaches is great, as the genes that control the neural crest 
may ultimately represent therapeutic targets.  
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Pathologies that involve the neural crest are astounding, due to their rates of proliferation, 
their ability to metastasize, and their resiliency against different treatment schemes. 
While a great deal has been learned about the neural crest and related pathologies, many 
questions remain. These will continue to inspire researchers and clinicians to study the 
formation and differentiation of these complex cells and tissues. As new results come 
from genomic screens and evolutionary analyses of neural crest cells, medical researchers 
will benefit from new markers and the discovery of new genetic pathways. Analysis of 
these genes as well as NCSCs may lead to better understandings of why certain cancers, 
including those of the endocrine system, are so persistent, and subsequently lead to new 
approaches in diagnosis and treatment.  
 
Identification of new genes involved in the neural crest 
 
 
This thesis project was designed to discover new genes important in the induction and 
migration of neural crest cells, and to validate a selected subset of those genes through 
functional perturbation. Previous studies have laid the groundwork for understanding the 
control of neural crest cells (Mayor, Morgan et al. 1995; Mayor and Aybar 2001) 
(Meulemans and Bronner-Fraser 2004) (Steventon, Carmona-Fontaine et al. 2005). One 
network module is composed of transcriptional regulators seen in early migrating and/or 
premigratory neural crest. This grouping includes Sox9, Sox10, FoxD3, Snail2/Slug, c-
Myc, and AP2 and has been termed the “neural crest specifier genes” (Meulemans and 
Bronner-Fraser 2004) (Spokony, Aoki et al. 2002) (Honore, Aybar et al. 2003) (Sasai, 
Mizuseki et al. 2001) (Aoki, Saint-Germain et al. 2003) (Luo, Lee et al. 2003) 
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(Bellmeyer, Krase et al. 2003). For all of the excellent work that has been done, however, 
we are still far from a complete picture of the neural crest cell and the genetic control that 
it is under.  
 
Thus, we performed a screen based on a subtraction scheme in which an in vitro culture 
system known to give rise to crest was compared to its component parts. The subtracted 
and unsubtracted pools of cDNA were sequentially hybridized against a macroarrayed 
library generated from 8–12 somite stage chicken embryos, and the selected clones were 
catalogued. In the initial analysis of this work, a large number of genes with possible 
importance in premigratory and migratory neural crest were identified. (Gammill and 
Bronner-Fraser 2002).  Despite this surge of new candidates to analyze, this initial 
analysis only revealed two transcription factors previously unassociated with the neural 
crest. Since transcription factors are generally upstream of other factors present in these 
networks, and as these upstream genes are critically important when attempting to build 
testable gene regulatory networks, we set about trying to unmask more of them 
(Davidson 2006) (Ben-Tabou de-Leon and Davidson 2007). Since transcription factors 
are generally upstream of other factors present in these networks, and are thus generally 
not as abundant at the transcriptional level, we reasoned that they would be represented 
by fewer library clones and weaker hybridization signals in the screen. While this 
differential hybridization signal is certainly not a direct measure of gene expression levels 
but rather reflects the efficiency of subtraction for that gene. Nonetheless, we decided to 
revisit the screen results using different selection criteria to see if we might discover 
additional new genes, and amongst them, more transcriptional regulators. As initially 
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only a sampling of upregulated clones was examined, we opted to comprehensively 
analyze all clones with a two-fold or greater hybridization signal from the subtracted 
probe as compared to the unsubtracted probe (Gammill and Bronner-Fraser 2002).  
 
Therefore, we examined a total of 553 clones for a total of 223 genes with possible 
implications in the development of neural crest cells. The results of sequencing analysis 
allowed us to blast search for gene identity against the newly released chicken genome. 
The identification of clones by blast permitted us to search for background information 
about these genes, which directed our focus to those genes and gene classes we found to 
be particularly interesting. We then performed in situ hybridization on chicken embryos 
of different ages to examine the spatiotemporal pattern of 112 different genes’ mRNA 
including all identified transcription factors and several unknown genes (summarized in 
Table 1, Chapter 2). Our screen was highly successful as more than 90% of the in situ 
patterns revealed expression in the premigratory and/or migratory neural crest cells. 
Remarkably, our attempt to identify new transcription factors with expression in the 
neural crest was also successful. Indeed, 14 transcription factors (Ccar1, CTCF, Elk-3, 
GCNF, GTFIIE, ILF2, ILF3, PhD, SRF, SREBP2, Similar to Tcf20/AR1/SPBP, 
WHSC1L1, ZFP3, and ZFP469) were all expressed in premigratory neural crest cells 
within the neural folds and/or migrating neural crest cells moving through the periphery.  
 
In order to understand the sensitivity of our screen more precisely, we further 
characterized the upregulation of several of the transcription factors that arose from this 
screen and in so doing we also aided in the definition of the in vitro culture system used 
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as its basis. All of the transcription factors that were analyzed by QPCR showed 
significant upregulation in the non-neural ectoderm and intermediate neural plate 
conjugates when compared to those tissues cultured separately. Snail2/Slug levels in the 
conjugated tissues were used as a positive control and were consistently upregulated by 
5–7 fold  (Chapter 2, Figure 2 and Table 2). The other transcription factors identified in 
our screen were upregulated approximately two-fold in the conjugates by QPCR 
(statistically significant and reproducible across replicates and experiments) (Chapter 2, 
Figs. 2-6, Table 2 and Chapter 3, Figure 2).   
 
 
 
Determining relevance of two newly identified genes through functional 
perturbation 
 
As one of our goals with this thesis was to understand more about the impact of the 
identified genes on neural crest cell development, we performed loss-of-function analyses 
of two of these genes using morpholino oligos. To that end, we performed in situ 
hybridizations for a panel of three different neural crest specifiers, Sox10, Snail2 (slug), 
and FoxD3, on morpholinated embryos.  
 
Ccar1 (Carp-1) is a transcription factor that piqued our interest when we analyzed it by in 
situ and by QPCR. It was concurrently identified by another screen in our lab that was 
attempting to identify genes important in neural crest cells through analysis of genes 
 152 
known to be important in hermaphrodite specific neuron (HSN) migration in 
Caenorhabditis elegans. Therefore, Ccar1 was a good candidate for functional 
perturbation. When we injected morpholinos designed against the start site of Ccar1, we 
were able to see significant differences between the injected and non-injected sides of the 
embryo through examination of Sox10 expression by in situ hybridization. Additional 
analysis through Tunel staining revealed that this effect is likely due to an increase in cell 
death on the injected side. We were initially surprised to see this increase in cell death, as 
Ccar1 is mostly considered to be an inducer of apoptosis, and its loss might be considered 
to be anti-apoptotic. However, it has recently been discovered that Ccar1 has also been 
shown to act as a coactivator for several other classes of transcription factors as it is 
important in the recruitment of the Mediator complex to their target genes. As an 
example, it was convincingly demonstrated that Ccar1 has a role in estrogen-induced cell 
proliferation (Kim, Yang et al. 2008). With the complexity of the processes occurring in 
the embryo and the amount of regulation between different genes, it is impossible to 
predict exactly what the results might be from an experimental perturbation. It is exactly 
for this reason that functional experiments are interesting as they can truly reveal what it 
happening in the embryo itself.  
 
We also investigated the functional importance of Adh5 (alcohol dehydrogenase 5, 
formaldehyde dehydrogenase) in neural crest cells of the developing chicken. This gene 
is highly evolutionarily conserved and previously reported to be the only member of its 
family present in the brain. While it has also been reported to be expressed widely in the 
embryo, we find that in the early stages of chicken development the mRNA is expressed 
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quite specifically in the dorsal neural folds and the migrating neural crest. When we 
injected morpholinos designed against the 5’UTR region of Adh5, we were able to see 
significant differences between the injected and non-injected sides of the embryos 
through examination of Sox10, FoxD3, and Snail2 (Slug) expression by in situ 
hybridization.  We look forward to examining these embryos for the root cause of these 
changes, and discovering what partners of Adh5 might be involved in this phenotype.  
 
Further directions 
 
Future work on this project would necessarily include trying to form a deeper 
understanding of the mechanism by which the knockdown of Adh5 affects the expression 
of certain neural crest genes (Sox10, FoxD3, and Snail2) on the injected side. First, we 
would like to examine the pattern of HNK-1 in these embryos through the use of an 
antibody. This will give us a better indication as to whether the mRNA of the markers is 
missing, or if there is a loss of neural crest cells on the injected side. If there are fewer 
neural crest cells on the injected side, additional analysis though Tunel and 
phosphohistone H3 staining will reveal whether the decrease is due to cell death or to a 
decreased amount of proliferation (or combination of the two).  
 
Rescue experiment would also be important; we will test whether overexpression of a 
construct containing the gene of interest (Adh5 or Ccar1) is sufficient to promote 
expression recovery of the neural crest specifiers. This will allow us to say that the 
knockdown and subsequent phenotypic recovery is entirely based on the absence or 
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presence of the gene in question. We will further make use of this construct in 
overexpression experiments to determine the effect of adding more of the gene products 
in areas where they are expressed endogenously as well as ectopically.  
 
In the long term, it will also be important to assess the other genes known to have neural 
crest cell involvement for their functional effects, and to be able to insert them into the 
neural crest gene network. It will be exciting to see the genes discussed in our screen 
(Chapter 2) continue to follow this path and to see their relevance determined. Finally, 
this future expansion of the neural crest gene network will hopefully have far reaching 
consequences in terms of understanding NCSC development, their use for therapeutic 
regeneration, and an even greater ability to devise treatments for pathologies involving 
their derivatives.  
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